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Symmetrical pattern of skin psoriasis 
Symmetrical pattern of vitiligo
Capsaicin injection is given into the left arm (white arrow). 
Hyperalgesia (lines) and allodynia (crosses) are mapped every ten 
minutes in different colours to both arms over 1 hour 
Partially denervated psoriatic plaque
The erosions occur in the bare areas adjacent to the cartilaginous 
perimeter. Evidence from a DIP joint
E-selectin and CD31 staining in consecutive sections from skin 
biopsies obtained from a single individual from control, capsaicin 
and immunisation sites
Negative control sections for E-selectin immunohistochemistry 
Effects of diluting the primary antibody on the staining pattern 
Highlighted regions of interest using Zeiss Image Analysis
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immediately following the immunisation; 2 months later (control); 
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optimal and supraoptimal dilutions
10


















Scheme demonstrating identified routes through the dorsal
commissure of sensory fibres entering the dorsal horn
The percentage of responders to intradermal capsaicin over time
Microfocal X-ray unit demonstrating very small focal point
Microfocal radiography
Division of the wrist joint into 10 regions
Colour-coded distribution o f the points affected by erosions in the 
digits and wrists at baseline (TO)
Colour-coded distribution of the points affected by erosions in the 
digits and wrists at baseline (T1 - TO)
Colour-coded distribution o f the points affected by erosions in the 
digits and wrists 17 months later (T l)
The number of erosions plotted against the log of the symmetry 
score
Bland-Altman plot of interobserver differences (PU) from free 
drawing around digital camera image of region o f interest (ROI)
The role o f acclimatisation in skin blood flow variability (n=14) 
showing mean flux at baseline and for 30 minutes following the 
removal o f capsaicin in control regions distant to the capsaicin 
application
Secondary analysis: Increase in skin blood flow following topical 
capsaicin is correlated negatively with age
Differences over time between the regions following immunisation. 
Changes in skin blood flow following immunisation in the different 
regions
Differences in skin blood flow over time since immunisation in the 4 
different regions of interest
Bland Altman plot of the differences over time for all four scanned 
regions in a control cohort
Mean skin blood flow values (standard errors shown) of the four 











Blood flow in the different regions over four days since immunisation 
Blood flow plotted against age and its relationship with immunisation 
Age against skin blood flow at each region 2 months after 
immunisation (T2)
Age against skin blood flow at each region after immunisation (Tl) 
Age against skin blood flow at each region. Skin blood flow from 2 
months after immunisation (T2) subtracted from immunisation (Tl) 
Bland-Altman plot o f intraobserver readings for staining percentages 
from 10 samples with a mixture o f E-selectin and CD31 stained 
sections
Bland-Altman plot of interobserver readings for staining percentages 
from 10 samples with a mixture of E-selectin and CD31 stained 
sections
Supraoptimal:optimal dilution for e-selectin immunohistochemistry 
The percentage of E-selectin staining as a proportion of CD31 
(endothelial) staining at different concentrations of primary antibody 
(optimal (50); supraoptimal (200) and end-point (15000)
12
Acknowledgements
With many thanks to Bo, Csilla, Sam and Maya without whose understanding this
would have been impossible.
I also thank the support and love of my family
I could not have done this work without the guidance of my supervisors:
Professor David Blake 
Dr Nigel Harris 
Professor J Christopher Buckland-Wright 
Dr Paul Mapp
I have had the luck to have worked with and been helped by very generous co- 
workers and would like to acknowledge Ms Emma Roberts, Dr Cliff Stevens, Dr Viv 
Winrow, Mr Gordon Taylor, Dr Elizabeth Messent, Ms Emily Bennett, Mr David 
Elvins, Dr Richard Haigh, Mrs Jean Hueting, Mrs Jana Stott, Mrs Alison MacKenzie
and Mr Stefan Ivanavicius.
Declaration
I declare that this work has been produced by my own endeavour and that no part of 
this has been carried out by anyone else, except where acknowledged. This work has 
been carried out whilst registered as a postgraduate student at the University o f Bath.
13
Abstract
Two observations are made. Firstly, many chronic inflammatory diseases manifest a 
bilateral symmetry far greater than expected by chance. This observation is 
supported by examining the distribution of erosions in the hands and wrists o f 42 
patients with rheumatoid arthritis using a microfocal radiographic technique. This 
demonstrated that particular areas were predisposed to erosions and that these areas 
contributed most to the symmetry seen in this disease. Secondly, from published 
literature afferent neural pathways that cross through the spinal cord, or via higher 
order connections, are anatomically identifiable, physiologically active and 
implicated in the distant transmission o f inflammation in several animal models. The 
f thesis is that local inflammation can be neurally reflected to the topographically 
precise contralateral region in man. This can then explain the symmetrical phenotype 
of chronic inflammatory diseases and expose new targets for anti-inflammatory 
treatments.
The first hypothesis is that the skin blood flow in the area o f the contralateral arm, 
precisely topographical to an active immunisation given 2-4 days prior, will be 
different to that o f control areas in a group of healthy volunteers. Using a laser 
Doppler imager to semi-quantify the skin blood flow there were no differences seen 
between the experimental and control contralateral regions.
The second hypothesis is that there is greater expression o f endothelial E-selectin in 
skin biopsies taken from the exact contralateral area to an MMR immunisation (given 
1-3 days prior) when compared to the control biopsy taken from a different 
contralateral dermatomal area. Using a supraoptimal dilutional immunohistochemical 
technique there were no differences in E-selectin expression between the 
experimental and control groups contralateral to the MMR immunisation. The null 
hypothesis is again supported.
Further work should consider a different stimulus or extending the timing o f the 
observations before the thesis can be rejected.
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Chapter 1. Symmetry in clinical practice
Summary
There is a recognition that biological patterns can instruct underlying mechanisms. 
The observation o f bilateral symmetrical patterns occurring in mainly chronic 
inflammatory diseases is made. Possible explanations for this symmetry are 
explored. These include neurogenic, genetic, anatomical and biomechanical reasons. 
These influences may not be mutually exclusive. A neurogenic hypothesis to explain 
the symmetrical nature of chronic inflammatory disease is preferred.
1.1.1 Introduction
Biological patterns are the result o f overlapping combinations o f underlying complex 
processes. Understanding some of these underlying processes can reveal the 
generation of the biological pattern. Recognising the presence o f a pattern for which 
an underlying mechanism has been previously described may also shed light onto 
other hitherto undiscovered processes. These ‘higher’ organisational operations 
necessary for the structure of life are constrained by physico-chemical laws and may 
influence biological processes well after the genome has spawned proteins.
D’Arcy Wentworth Thompson’s ‘On Growth and Form’, first published in 1917, 
provides many examples o f the value o f studying form and physical properties 
outside o f the Darwinian constraints o f function and utility. One such famous 
example is the observation of the Fibonacci sequence and the Golden Angle (about 
137°) in the number of, and spatial relationship between, the petals of plants such as 
daisies and sunflowers, or the leaves on their stalks. The Fibonacci sequence 
(1,1,2,3,5,8,13 etc...) is related to the Golden Angle mathematically. The ratio of 
consecutive Fibonacci numbers later in the sequence is defined as <|) (about 1.6), 
which happens to be the square root of the number required to divide into 360 
degrees to obtain the Golden Angle. This somewhat tortuous link is in fact 
mathematically robust. The plant phenotype is understood better as the underlying 
developmental processes were discovered, and is guided by the principle that the 
distribution o f a new structure, i.e. petal or leaf, should be as far away from previous
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structures in order to allow more colour to radiate from the petal or sunlight to reach 
the leaf. Structures that are nascent every 137° around a circumference support the 
surrounding space more efficiently than at any other angle. By recognising the 
pattern and understanding the evolutionary pressures, the underlying process, namely 
the build up of chemokines and growth factors spatially and temporally along the 
developing bud, makes more sense and explains why this property exists across 
many plant species. That this is governed ultimately by genetic transcription and 
translation is remarkable and it is this that has yet to be satisfactorily explained.
1.1.2 Phenotypical patterns demonstrate insight into developmental biology 
Causal biological systems imply that a pattern observed in the adult has 
embryological implications. These were enlighteningly explored by the famous 
computing pioneer Turing (1952). His proposal, a reaction-diffusion system, 
consisted of two homogeneously distributed substances each o f which has differing 
consequences for the differentiation of cells under their influence. The two 
substances’ properties are such that one would auto-catalyse and affect the 
concentration of the other. Furthermore, their diffusion rates would be different. 
These properties dictate a programmed interaction that produces stable patterns, such 
as stripes on the skin, during morphogenesis. The phenotypic patterns would 
therefore represent regional differences in the concentrations o f the two substances 
whose interaction has generated an order from seemingly unrelated chaotic 
processes.
An example demonstrating that this process is likely to be operational in 
developmental biology is recent work examining the morphogenesis o f the zebra 
fish’s stripes (Asai et al, 1999). They describe several mutations within a single 
gene, each allele o f which produces a characteristically different pattern o f spot size, 
density and connectivity on the skin of the zebra fish. These patterns can be 
modelled using reaction-diffusion kinetics by substituting certain parameter values. 
This suggests that the gene products are components o f a similar operational system 
that exists in the generation of the skin pattern.
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1.1.3 Symmetry, broken symmetry and underlying mechanisms
“Something in the human mind is attracted to symmetry. Symmetry 
appeals to our visual sense of beauty. However, perfect symmetry is 
repetitive and predictable, and our minds also like surprises, so we often 
consider imperfect symmetry to be more beautiful than exact 
mathematical symmetry. Nature, too, seems to be attracted to symmetry, 
for many o f the most striking patterns in the natural world are symmetric.
And nature also seems to be dissatisfied with too much symmetry, for 
nearly all the symmetric patterns in nature are less symmetric than the 
causes that give rise to them.”
(Stewart and Golubitsky, 1992)
Symmetry as a mathematical concept allows classification and discernment of 
different types o f regular patterns. Biological systems operate as equilibria. Breaking 
o f symmetry to a less mathematically symmetrical form is significant and indicates 
the presence o f an additional influence within the biological system.
The external human phenotype is bilaterally symmetrical based on a reflection 
transformation around the mid-sagittal plane. The human egg however is grossly 
spherically symmetrical with rotational as well as reflective symmetry. In a similar 
vein to Turing’s work, the disruption of this spherical symmetry to a more restricted 
form has been recognised and explored at an embryo logical level.
The symmetry o f the ball o f cells in the very early developing embryo is broken 
several times so that at approximately day 15 in the embryo’s development there are 
a prechordal plate and a primitive streak defining the anteroposterior and 
dorsoventral axes, and thus also defining left and right. Different genes and 
promoters are thought to be important each time that the symmetry is broken. 
Although not identified in mammalian embryos yet some o f these have been 
described in other species. In Drosophila the follicle surrounding the egg recognises 
the Spatze ligand and activates a Toll receptor to induce a breaking of symmetry. In 
the amphibian embryo prelocalised VegT (Vegetal T-box gene) mRNA in the 
maternal egg has been identified as being important in symmetry breaking, as well as
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another unidentified factor that activates Wnt (Wingless-type MMTV integration site 
family) signalling pathways (Fraser SE and Harland RM, 2000).
Observing form in biology can therefore guide more detailed investigations into 
basic processes. Can this same approach be used to study and inform mechanisms of 
disease?
1.2.1 Patterns of disease
Disease patterns are constrained by a number o f factors, including the organism’s 
anatomy, environment and systems organisation. The following patterns, their 
examples and inferred conclusions are included here for illustrative reasons only, the 
central thrust being that underlying mechanisms of disease can be suggested by 
carefully studying the pattern of disease involvement.
1.2.2 Local pattern of disease
Diseases that induce local patterns of involvement include, in the initial stages, 
tumours, infection and trauma. This pattern simplistically suggests that a single event 
local to the affected tissue has been an important factor in the aetiology. For 
example, the introduction of a pathogenic organism in the case of an abscess or the 
novel generation of a neoplastic cell lineage in the case o f a tumour are the known 
causes for these diseases. The origin o f the problem is to be found locally, either 
through internal or external factors.
1.2.3 Widespread pattern of disease
Conversely there are those diseases where widespread damage is seen and most 
structures and cells are affected in most systems. This points more to a fundamental 
problem in the metabolism or genetic make-up of the individual. Such patterns o f 
pathology might include metabolic diseases such as diabetes or genetic problems that 
may similarly affect the functioning of a wide variety o f cells, such as cystic fibrosis. 
Whilst the problem may well be found locally, it also exists on a more global nature 
with specific manifestations exhibiting themselves dependent upon conditions 
peculiar to their local environment. Studying these diseases is probably better 
performed on a more global nature.
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1.2.4 Systemic pattern of disease
Another pattern of disease points to a specific problem with one particular part of the 
cell or structure even though the pattern of the disease might be widespread. Again 
these diseases are often genetic, such as Duchenne Muscular Dystrophy or 
Huntington’s chorea. Identifying that the pattern of disease involvement is restricted 
to one particular system, such as the musculoskeletal or neurological, is important in 
understanding these diseases better.
1.2.5 Symmetrical pattern of disease
Finally, symmetrical diseases follow neither a local nor a widespread distribution. 
For example in rheumatoid arthritis, the joints affected are far more likely to be the 
second and third metacarpophalangeal (MCP) and proximal interphalangeal (PIP) 
joints symmetrically, than any distal interphalangeal (DIP) joint or the fifth MCP 
joint unilaterally (see chapter 4). It appears that the property of their symmetrical 
distribution is an important part of the disease process. Several diseases that have 
bilaterally symmetrical patterns will now be discussed.
1.3.1 Symmetrical diseases: Rheumatoid arthritis (RA)
A symmetrical pattern of involvement in rheumatoid arthritis is so important that it is 
a feature of the diagnostic criteria (Arnett et al, 1988). Rheumatoid arthritis affects 
about 1% of the population, mainly women, and typically presents between the third 
and fifth decades of life although it can affect an individual o f any age. It is 
characterised by inflammatory exudates with immune components accumulating 
mainly in, but importantly not limited to, synovial joints. Pain and swelling coupled 
with the destruction o f the joint cartilage and underlying bone prevents normal 
functioning. There are genetic associations, the strongest described being HLA-DR4 
and immune dysregulation has been documented in countless publications involving 
both T-cell and B-cell dominated pathways. Current treatments aimed at correcting 
immune dysregulation are partially successful at slowing and controlling the disease, 
but an effective cure has yet to be demonstrated (Gordon and Hastings, 1997).
Rheumatoid arthritis has long been recognised to be bilaterally symmetrical in the 
distribution of joints affected (Flemming et al, 1976; Fuchs et al, 1988). This is 
discussed in more detail in chapter 4.
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The pattern o f RA is not locally confined. For example, patients with a chronic knee 
monoarthritis rarely develop RA and rarely give a histological picture consistent with 
RA (Devlin et al, 2000, Gallagher et al, 1985). Neither is the disease widespread as 
the internal organs, such as the liver, gastrointestinal tract and kidneys are invariably 
never involved. There may be a case to suggest that RA is confined to one particular 
system (immune dysregulation) and that the disease’s effects are the result o f the 
misdirection o f the autoimmune process. This is clearly the current thinking and 
undoubtedly there is strong evidence to support such an argument. This does not 
explain the symmetrical distribution of the disease. Why should an autoimmune 
process have a predilection for particular MCP joints with a relative sparing of the 
DIP joints and a predisposition for radially located digit joints with a relative sparing 
of the ulnar joints? Are there other influential mechanisms in the pathogenesis o f the 
disease that produce such patterns?
1.3.2 Other forms of chronic inflammatory arthritis
Seronegative arthritides, such as psoriatic arthritis, reactive arthritis, ankylosing 
spondylitis and colitis-associated arthritis are seronegative for rheumatoid factor and 
viewed clinically as being asymmetrical diseases. These diseases have different 
genetic associations, immunological abnormalities and clinical presentations. It is 
likely however that the arthritic asymmetry is a reflection o f the paucity of joints that 
are involved. As the number of affected joints increase a symmetrical pattern 
becomes evident. For example Bhukari et al (2002) described the location o f 
erosions from X-rays taken over the course of 5 years in all patients presenting with 
inflammatory arthritis, regardless of whether they were rheumatoid factor positive, 
from patients in the Norfolk Arthritis Register. There were no differences in the 
amount of symmetry exhibited by the erosive damage between the group that was 
rheumatoid factor positive, and those who were not. This implies that in this 
unselected group of patients it is not the presence of rheumatoid factor (i.e. the 
diagnosis of rheumatoid arthritis) that is influential in determining the symmetry of 
disease, but that all chronic polyarthritis is symmetrical.
This view is further supported by Helliwell et al (2000) who studied the distribution 
of erosions in patients with early and late disease in both psoriatic arthritis and RA. 
Using a mathematical model they demonstrated that the presence of symmetry was
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related to the number o f joints involved and that when this confounder was corrected 
psoriatic arthritis was as symmetrical as RA. Perhaps the same factors that are 
influential in producing the symmetrical expression in RA are at work in all forms of 
chronic inflammatory polyarthritis?
1.3.3 Osteoarthritis (OA)
Osteoarthritis affects generally an older population or those with a predisposition to 
the disease through previous trauma, infection or metabolic abnormality. This 
degenerative disease affects up to 60% of 60 year olds and the prevalence increases 
further as the age increases. There are genetic influences in the expression o f OA. 
Although asymptomatic in a large proportion o f people, sufferers are affected by 
pain, swelling and deformities. Non-surgical treatment is targeted towards muscle 
strengthening and palliation, and when indicated, joint replacement is the most 
effective treatment.
Osteoarthritis is both a symmetrical disease and it is limited to the articular system. 
Examining articular cartilage loss in the ankles and knees o f post-mortem specimens 
accentuated a symmetry for osteoarthritis that was not as clear clinically (Koepp et 
al, 1999). Symmetry of OA in the hands is demonstrated by a recent epidemiological 
survey from the Framingham population (Niu et al, 2003), especially in women.
1.3.4 Psoriasis
This chronic inflammatory disease, predominantly o f the skin, affects about 2% o f 
the population and can occur at any age, although there are two peaks at the second 
and sixth decades (Langley et al, 2005). Patients suffer with itchy scaly skin that is 
sometimes sore and prone to complications such as infection. Up to 25% can have 
joint involvement. Although the patches of skin are typically on the extensor surfaces 
and scalp, they can occur anywhere on the body. Genetic associations have been 
made, most strongly with HLA-Cw6. Immune dysregulation has been shown to be 
important in the pathophysiology of psoriasis, mainly involving T-cell processes. 
Treatments for severe psoriasis are immunosuppressive and can include vitamin A 
derivatives and ultraviolet light treatments.
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Image 1.1 Symmetrical pattern of skin psoriasis (Langley et aL 2005)
Reproduced with permission from BMJ Publishing Group Ltd 
Image 1.2 Sym m etrical pa ttern  of vitiligo
Skin psoriasis is classically described as being symmetrical (Farber et al, 1986) 
although there is a poverty o f literature to document this. However when symmetry 
o f skin psoriasis is encountered clinically, it is striking (see Image 1.1).
1.3.5 Vitiligo
Progressive symmetrical vitiligo is a condition that affects 1-2% of the population 
and whose peak incidence (about 50% of cases) is between 10-30 years old although 
it can affect individuals of any age. Individuals suffer a loss of melanocytes in a 
patchy albeit sometimes strikingly symmetrical pattern (Image 1.2). The resultant 
discolouration can lead to psychosocial disadvantages. Vitiligo is limited to the skin 
in its disease effects, but links with other ‘autoimmune’ diseases such as RA and 
thyroiditis have been observed. No clear cause of vitiligo has been suggested 
although an interplay o f genetic and autoimmune hypotheses involving activated 
cytotoxic T-cells have been advanced, as well as neurotrophic, toxic metabolite and 
melanocyte growth factor hypotheses. There are no effective treatments directed 
against this process although there have been reports o f success with ultraviolet light 
and immunosuppressive treatments (Njoo et al, 2001).
1.3.6 Sympathetic ophthalmia
This diffuse chronic uveitis occurs in both eyes several weeks, or even months and 
years, after penetrating eye injury. It can affect any age group susceptible to such 
trauma. Thought to be an autoimmune condition of the delayed hypersensitivity type 
it is characterised by an accumulation of epithelioid, multinucleated giant cells and 
lymphocytes while classically sparing the choriocapillaris. Treatment is based on 
immunosuppression although removal of the traumatised eye will prevent the 
development o f the reaction.
1.4.1 Common factors between the symmetrical diseases
These diseases are directed against structures that have anatomical bilaterality, i.e. 
joints, skin and eyes. The presence o f disease symmetry may merely reflect a 
widespread effect on these structures which then in turn appear to be bilaterally 
symmetrical. With respect to rheumatoid arthritis, this is examined in more detail in 
chapter 4 and refuted. The distribution of erosions occurs in a symmetrical 
distribution greater than by chance.
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A common thread running through the aetiology of these symmetrical diseases is the 
presence of immunologically directed inflammatory processes. These diseases have 
genetic susceptibility and they affect, broadly, the mature young adult, 
premenopausally if female. These conditions are examples o f a group that have 
broadly been categorised as Immune-Mediated Inflammatory Diseases (IMID). 
Other examples of IMID are Crohn’s disease and multiple sclerosis (MS).
Whilst Crohn’s disease affects an asymmetrical organ the distribution o f white 
matter plaques of MS in the central nervous system has been examined by Werring et 
al (2000). Interestingly, they found subtle white matter changes occurring exactly 
contralateral to the appearance o f a new demyelinating lesion and persisting for up to 
6 months using sensitive serial gadolinium enhanced MRI sequences in 5 patients 
with multiple sclerosis. These results were similar to de Stefano et al (1999) who 
also found subtle contralateral white matter changes in the metabolism of A-acetyl 
aspartate appearing about 1 month after the appearance of three large areas of 
demyelination in a patient with MS. The MRI changes seen by Werring et al and the 
metabolic changes seen by de Stefano et al, both indicate a change in the functional 
state and integrity o f the neurons and surrounding structures different to that 
expected by chance. MS has not been included in the list o f bilaterally symmetrical 
diseases above because clinically the lesions have not been hitherto described. As 
neuroimaging techniques improve however, this may perhaps change.
The presence o f one of the IMID predisposes the individual to developing another. 
For example, affected individuals with vitiligo are more likely to have rheumatoid 
arthritis and psoriasis, as well as the more focal auto-immune diseases affecting the 
thyroid and adrenal glands (Addison’s disease) (Laberge et al, 2005; Liu et al, 2005). 
Could the same mechanism that is influential in the pattern formation in one disease 
predispose an individual to another IMID?
The symmetrical disease that is the exception in the above descriptions is 
degenerative arthritis. The epidemiology and aetiology of this disease is clearly 
different to that of the other symmetrical diseases. Are there different factors that 
could cause the symmetry seen in OA?
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1.5.1 Underlying mechanisms to account for symmetrical phenotype of disease 
Three hypotheses to explain bilaterally symmetrical pathology are now outlined and 
discussed.
1.5.2 The neurogenic hypothesis
The nervous system is anatomically bilaterally symmetrical. Neurons decussate 
across the midline and contain immune and inflammation modulating substances, 
including substance P (SP), calcitonin gene related peptide (CGRP), neuropeptide Y 
(NPY) and vasoactive intestinal peptide (VIP), amongst others. As will be discussed 
in Chapter 2 in more detail the physiology and distribution o f these components in 
the nervous system suggest a role for the mediation of a symmetrical phenotype. An 
autoregulatory neurogenically mediated immuno-inflammatory loop might therefore 
exist between homologous structures symmetrical to the midline.
This hypothesis was first advanced by Levine et al (1985a) as a possible mechanism 
for the symmetry seen in rheumatoid arthritis. Farber et al (1986) then applied a 
similar hypothesis to skin psoriasis. Kidd et al (1989) expanded on this basic 
hypothesis by suggesting an evolutionary advantage was to be gained by having a 
rapid contralateral upregulation of immune and inflammatory defensive mechanisms. 
This hypothesis is examined in more detail in chapters 2 and 3.
A neurogenic hypothesis is attractive to evaluate in more detail. It offers the 
possibility of a deeper understanding of the pathophysiological processes in IMIDs 
as well as suggesting the potential for new therapeutic targets. These would include 
blocking or augmenting neuropeptides and neuronal mechanisms for the induction of 
an anti-inflammatory effect.
1.5.3 The bio mechanical and anatomical hypothesis
This states that the pattern of symmetry in the observed diseases arises because o f the 
individual having bilateral anatomy and being exposed to similar external and 
internal biomechanical forces. Biomechanical stress acting as an external force and 
the intrinsic anatomy acting as the internal force are inextricably combined to give 
symmetrical structures similar environments (Chaisson et al, 1999; Niu et al, 2003). 
Even though there is a ‘handedness’ in humans defining a laterality o f function
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between the sides, it is suggested that this is either minimal in the generation o f 
excessive forces (being more restricted to fine motor movements and acts of 
coordination) or that there is a discemable break in the bilateral symmetry that can be 
detected on careful examination. One example of support for this in the literature is 
the study o f the distribution of erosions in patients with RA (Mattingley et al, 1979; 
Halla et al, 1986; Mottonen et al, 1988; Owsianik et al, 1980; Boonsaner et al, 
1992). This is a controversial finding however and as will be seen in chapter 4, the 
observation o f dominance sided erosion preference was not made in the cohort 
studied.
There is evidence to suggest that biomechanical forces are important in the 
pathophysiology o f IMID. For example, patches of psoriasis are often seen over 
pressure points and areas o f excessive skin stretching such as the buttocks, elbows 
and knees. Pressure is known to change cellular adhesion molecule and 
proinflammatory cytokine profiles in the skin (Takeuchi et al, 2003). The Koebner 
phenomenon is a direct consequence on the actions o f significant pressure on the 
subsequent manifestation o f psoriasis. Similarly immobilisation is beneficial in the 
short term (Harris and Copp, 1962; Partridge and Duthie, 1963; Gault and Spyker, 
1969) and hand splinting has also been reported to be of benefit (Ziljstra et al, 2004; 
Li-Tsang et al, 2002) to some patients with active RA.
Studies have examined the effects of immobilisation on inflammation in animal 
models (see section 3.4.1) through neural injury. There is confusion as to the cause 
of the anti-inflammatory effects of this neural injury though because, by its very 
nature, neural injury immobilises. Similarly, experiments that splint a limb are also 
confounded by the fact that the animal tends to compensate by ‘over-using’ its non­
splinted limb. Likewise, clinical observations o f neural injuries which immobilise 
(e.g. strokes, spinal and lower motor neuron lesions) might also obfuscate the causal 
effects of neuropeptides and biomechanical forces on the immuno-inflammatory 
process. This is an unresolved issue although as will be seen in Chapter 3, there are 
well designed experiments which attempt to account for this by the use of selective, 
non-immobilising nerve lesions or pharmacological agents. The results o f these 
suggest that neuropeptides are important in their anti-inflammatory effects, over and 
above that seen by immobilisation.
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The biomechanical and anatomical hypothesis fails to explain why the pattern of 
disease, whilst symmetrical, is different between individuals and for different 
diseases? Why should some individuals have predominantly a wrist distribution of 
erosive RA, and others have MCP and PIP disease? Why should individuals with 
osteoarthritis develop changes in their DIP and PIP joints, but be spared their MCP 
joints, when individuals with RA have their MCP and PIP joints more affected than 
their DIP joints? This is not difficult to explain using a neurogenic hypothesis, but is 
problematic for a biomechanical hypothesis.
1.5.4 A genetic hypothesis based on fractals
Non-linear dynamical systems (e.g. y=ax(l-x)) demonstrate important and 
unpredicted temporal and spatial biological patterns that have previously been 
missed following analysis with a linear modelling system (e.g. y=ax + b) that is 
based on proportionality and superposition properties. An example o f a useful non­
linear system is that of fractals, that is geometric shapes which are rough or irregular 
on all dimensions of scale and time. Fractals also demonstrate recurring self-similar 
shapes in all o f these dimensions and have the universal property that includes 
bifurcations, that is the ability to flip between two apparently unrelated phenotypes 
(Goldberger et al, 2000).
Examples of fractals occurring in nature include the shape of coral and branches of a 
tree. Human networks of blood vessels and bronchi have been elucidated fractally 
and interestingly several groups report that the fractal dimension of relative 
structures is 1.7. This is the same ratio as that seen in diffusion-limited growth 
processes (see section 1.1.2) and very close to <|). This suggests that mathematically 
defined processes may be important in the development o f form across a very wide 
range of biological structures (Masters, 2004).
Now, assume that joints demonstrate a fractal pattern in that there is a resonance of 
anatomy along a limited diminishing size scale as the proximal joints are compared 
with the distal joints. Certain diseases therefore have a predilection for particular 
rows of the homunculus. For example, osteoarthritis in the hands rarely affects the
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MCP row. Only when it is associated with haemachromatosis is such an anatomical 
distribution favoured. Similarly, RA has a focus on the wrist, MCP and PIP rays in 
the upper limb, although can certainly affect any other ray.
As has already been discussed, the breaking of symmetry in the embryo is associated 
with different genetic expressions. In the case of fractal patterns, symmetry is 
upheld, but the scaling is different between repeated forms. Although fractal 
arrangements appear to follow physiological principles, primarily those of 
maintaining equilibria following Murray’s principle o f minimal work, this is not a 
perfect fit according to the known parameters in an arterial branching model 
(Murray, 1926a and 1926b; Zamir, 2001). Do genetic factors account for this 
additional role in fractal phenotypes, their expression influenced by local 
environmental pressures in the developing embryo? Are different genes expressed in 
a lower fractal scale when compared to a higher one?
Many studies have expounded genetic influences on RA, but none have accounted 
for its pattern of disease. Fractal analysis o f affected joints may account for this 
pattern.
The genetic hypothesis for bilateral symmetry in disease is that the pattern is 
influenced genetically by the expression of different genes in the susceptible areas 
when compared to protected areas.
There are several problems regarding this hypothesis. To the best o f my knowledge, 
the arrangement of joints in the homunculus has not been studied using a fractal 
analysis. It is predicated on the premise that a change in scale is reflected from a 
change in genomic expression. Evidence for this however is circumstantial based on 
mathematical modelling on related systems (Zamir, 2001), i.e. circulatory compared 
to joint anatomy. There is a paucity o f evidence to suggest that genomic expression 
is different between rows of the homunculus.
The scale difference between joints in one limb is not characteristic o f many fractal 
systems that have minimal and maximal patterns expressed over many logarithms, 
even infinitely. This does not preclude such an analysis being productive however.
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Finally, non-linear dynamical modelling predicts that form can be generated from 
seemingly unrelated mechanisms to give unexpected outcomes. Using a defined set 
of genes and their associated proteins, fractal systems might predict different 
outcomes based on local environmental factors using physiological laws, such as 
those outlined by Murray in 1926. The need for a differing set of gene expression to 
generate a different scale may not be required.
For these reasons, a genetic hypothesis to account for disease symmetry appears 
unlikely.
1.6.1 Conclusion
It is possible that a varying combination of these explanatory mechanisms come to 
influence the phenotype o f the different symmetrical diseases. For example, 
osteoarthritis may be primarily influenced by genetic and biomechanical factors; RA 
by neurogenic and anatomical factors; and psoriasis by neurogenic and 
biomechanical factors. Using Ockham’s razor however, it would be more likely for 
the universal observation o f symmetry to be explained by a unifying hypothesis. The 
neurogenic hypothesis appears to be the most convincing single hypothesis for this 
purpose. Furthermore, this hypothesis is important as it may offer a deeper 
understanding o f the processes in symmetrical diseases and suggest new therapeutic 
targets.
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Chapter 2. Neurogenic hypothesis: a crossed afferent pathway to explain
the symmetrical phenotype in chronic inflammatory disease 
Summary
The neurogenic hypothesis with a crossed spinal afferent pathway is presented as a 
possible explanation for the symmetrical pattern seen in chronic immune-mediated 
inflammatory disease. Evidence from animal models using either neuronal or 
inflammatory lesions is presented to support this hypothesis through the development 
of central sensitisation and a peripheral response. Anatomical, physiological and 
pharmacological studies o f neurons and neuropeptides provide supporting evidence 
for the existence of such crossed afferent pathways. Finally, evidence is presented for 
contralateral sensitisation in man following intradermal capsaicin.
2.1.1 Spatially remote inflammatory responses
In 1978, Denko and Petricevic noted that the injection o f arthritogenic crystals into 
the hindpaws o f adult male Sprague-Dawley rats induced sympathetic or reflex 
footpad swelling in the opposite foot, a response that was augmented if the footpad 
had been ‘primed’ by a previous injection of crystals, such as urate or pyrophosphate. 
This observation was investigated in more detail by Levine et al (1985b).
They injected 150 pi of normal saline into a plantar surface o f the midfoot of male 
adult Sprague-Dawley rats on three consecutive days and then measured withdrawal 
thresholds and paw thickness in the contralateral hindpaw each day. By the third day 
they had detected a reduction in the threshold to withdraw away from pressure 
applied linearly to the hindpaw and an increase in the paw thickness judged by 
constant pressure callipers applied perpendicular to the paw with the plantar surface 
resting between the footpads. These rats were then considered ‘primed’ in that they 
had exhibited contralateral responses and these responses recrudesced with a fourth 
day o f saline injection. No tachyphylaxis was seen when the ipsilateral limb was 
stimulated 3 times over 8 hours. In fact, the contralateral responses were seen to 
augment and sustain to this increased input. This argues against a general arousal 
response that might be expected to habituate to repeated stimuli.
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Levine et al (1985b) then investigated the mechanism of this remarkable observation 
by performing a variety o f lesions on the rats. For one group of rats they exposed the 
femoral and sciatic nerves on both sides and applied capsaicin solution for 15 minutes 
to either the ipsilateral or contralateral side, using vehicle on the other side as a 
control. This treatment is relatively selective for neuropeptide containing fibres. To 
demonstrate the efficacy of this operation, they were then able to detect an increase in 
response latency to noxious heat in the paw of the treated hindlimb 3 days after 
treatment. Another group underwent chemical sympathectomy with guanethidine in 
which tissue epinephrine subsequently decreased by at least two orders of magnitude 
by radioimmunoassay compared to a control population. A third group underwent 
saphenous ligature immediately prior to the inflammatory stimulus. A fourth group 
had a section o f sciatic nerve removed either 2 days or 6 days before the stimulus. 
Finally, a fifth group underwent a local nerve block immediately after the stimulus 
that was made irreversible by removing a section o f nerve distal to the block. Control 
sham operations for all o f these groups were also performed.
The use of capsaicin, sympathectomy and nerve lesions before the stimulus all 
attenuated the contralateral responses of hyperalgesia and paw swelling. Nerve 
lesions after the stimulus partially attenuated the contralateral responses whereas 
venous ligation did not attenuate the contralateral responses. The contralateral 
responses persisted throughout all o f the sham operation groups.
Levine and colleagues (1985b) concluded by suggesting that crossed spinal reflexes 
could mediate neurogenic inflammatory responses and that their magnitude, duration 
and failure to attenuate pointed to a biological role.
There were two outstanding issues that could have thrown doubt on their 
observations. First, forepaws as a topographical control were not analysed. Did they 
too demonstrate similar responses? If they did, this might suggest a circulatory 
component not controlled by a saphenous ligature. Secondly, although the outcome 
measures were compared to baseline, the standard error of which was very small, 
these were not assessed by a blinded observer. However these issues founder on the 
reproducibility test as this experimental model has been repeated with similar results 
by several groups albeit using different techniques.
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2.2.1 Reproduction of Levine et aVs (1985b) results
A comprehensive literature review was performed to assess publications that have 
successfully repeated Levine et al's results. A Medline search (Ovid) was performed 
in October, 2001 to find relevant papers. The terms “symmetry”, “inflammation”, 
“contralateral”, and “mirror-image” were used in combinations. Abstracts were then 
scanned. Papers were included if a contralateral effect was observed in response to a 
unilateral inflammatory stimulus. Original papers were obtained and appraised. 
References were scanned to identify further papers until no more relevant papers were 
identified. Papers were excluded if the inflammatory insult caused systemic features. 
For example, high-doses (e.g. 250pg) of CFA (Complete Freund’s Adjuvant) are 
known to induce a systemic arthritis in rats, whereas 50-150pg induces only a 
monoarthritis (Donaldson et al, 1993). Papers that showed the contralateral effects 
occurring in the CNS at levels higher than the spinal cord segment of the lesion were 
also excluded. Duplicate results published in different forms were excluded. Each 
paper was appraised on the following criteria: a priori hypothesis; appropriate 
unilateral lesion; controls that were not exposed to the unilateral lesion; alternative 
explanation offered by investigators.
2.2.2 Results o f the literature search
The Medline search yielded 710 titles. From these abstracts, 31 papers were identified 
as satisfying the inclusion criteria and the original papers were obtained. References 
of these papers were scanned and a further 9 articles were identified. Of these 40 
papers, the appraisal process excluded 23. These are listed with the reason for their 
exclusion in Table 2.2. A number o f papers identified an anti-inflammatory 
contralateral response following a unilateral anti-inflammatory stimulus. These were 
excluded from this analysis because all o f these animals had pre-existing polyarthritis.
Therefore 17 papers were identified and found to fulfil the criteria applied in the 
appraisal process and support Levine et al’s original work. In all of the papers, the a 
priori hypothesis had been that an appropriate unilateral inflammatory lesion might 
cause contralateral effects and controls that had not been exposed to this lesion were 
used. These papers are presented in Table 2.1.
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Table 2.1 The contralateral effects of localised unilateral inflammation
Monoarthritis stimulus Contralateral arthritic effect with peripheral mechanism Reference
CFA (1 |xg) in knee Decrease in anabolism of cartilage for 6-72 hours Decaris
1999
Freund’s adjuvant in knee 
(0.05ml of 1 mg/ml)
Increase in SP, CGRP and NPY in knee for 2-24 h 
Increase in NK-A in knee at 2 h and at 24 h
Bileviciute
1993
Carrageenan 2% (0.05ml) 
In knee
Increase in CGRP and NPY for 2-24 h 
Increase in SP at 2 h and at 24 h; and NK-A at 24 h
Bileviciute
1993
Human recombinant IL-1 
(0.05ml of 1 mg/ml) in knee
Increase in CGRP and NPY for 2-24 h 
Increase in NK-A at 2-6 h and SP at 2 h
Bileviciute
1993
SP (0.05ml of 10'5M) in knee Increase in SP for 2-24 h; CGRP for 6-24 h; NPY for 2-6 h 
No increase in NK-A
Bileviciute
1993
SP in knee (0.2,1,2,10,20 pg 
in 50|j.l)
Decrease in anabolism of cartilage for 6-72 hours Decaris
1999
500pl of mBSA in knee pre­
immunised with 1ml CFA
Histopathological and biochemical evidence of joint 
destruction up to 80 d
Meyer
2000
500pg (50pl) mBSA in 
pre-sensitised knee
Increased proteoglycan loss and mechanical hyperalgesia 
up to 9 days
V Banchet 
2000
100 pi of 1% latex spheres 
in knee
Bradykinin-induced plasma extravasation enhanced between 
10-21 days. Macrophage infiltration noted between 3-10 days
Kidd
1995
Hindpaw stimulus Contralateral hindpaw effect with peripheral mechanism
CFA (lOOpl) TNF-alpha levels elevated up to 120 hours Woolf
1997
Carrageenan (0.1ml of 2%) CGRP levels increase in hindpaw perfusate at 3-4 hours 
Thermal and mechanical withdrawal latencies reduced at 3-4 h
Yu
1996
Urate, pyrophosphate and 
oxalate crystals (3mg/150pl)
Swelling observed, maximal at 5 hours Denko
1978
CGRP lOOpl (300pmol) Oedema induced at 5-24h Bileviciute
1998
All o f these studies were performed in rats, unless otherwise indicated 
KEY: CFA -  complete Freund’s adjuvant; SP -  substance P; NPY -  neuropeptide Y; 
CGRP -  calcitonin gene related peptide; NK-A -  neurokinin A; IL-1 -  interleukin 1; 
MBSA -  methylated bovine serum albumin; MTb -  mycobacterium tuberculosis', 
TNF -  tumour necrosis factor; NGF -  nerve growth factor; RNA -  ribonucleic acid.
Table continued overleaf
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Table 2.1 The contralateral effects of localised unilateral inflammation (continued)
Hindpaw stimulus Contralateral hindpaw with central (neural) mechanism Reference




Licking responses occur at 10-60 minutes Aloisi
1993
Bee venom lOOpl (0.2mg) Heat (not mechanical) withdrawal latency reduced for 2-48 h Chen
1999
NGF injections (3 days of 
4pg/day) in hindpaw or ear 
or forepaw.
Increased expression of preprotachykinin and preproCGRP 
mRNA in nerve (sciatic; trigeminal; or brachial plexus)
Amann
1996
IL-lbeta (lOng) B1 receptor-mediated mechanical hyperalgesia for 1-6 h Ganju
2001
Thermal stimuli (55C for 
15s)
Thermal foot withdrawal latencies reduced at 24 hours Coderre
1985
Thermal stimuli (55C for 15- 
20s)
Thermal foot withdrawal latencies reduced at 24 hours Coderre
1987
Thermal stimuli to 
decerebrate rat 
(75C for 60s)
Reduction in the flexor reflex threshold to mechanical and 
thermal stimuli at lh
Woolf
1983
Table 2.2 Papers excluded after appraisal
Hypothesis not a priori (inadequately controlled / not unilateral lesion)
Feige et al, 1989; Chandrasekhar et al, 1990; Mentzel et al, 1998
No controls
Boyle et al, 1999; Badavi et al, 2000; Ianaro et al, 2000
Polyarthritis / Pre-induced arthritis
Esselinckx et al, 1978; Bird HA et al, 1979; Bhattacharya et al, 1987; Kayser and 
Guilbaud, 1987; Kayser et al, 1988; Pinter and Szolcsanyi, 1988; Millan and Colpaert, 
1990; Millan and Colpaert, 1991; Donaldson et al, 1993; Betoin et al, 1994; Andersson et 
al, 1998; Ceccherelli et al, 1998; Koch et al, 1998; Miagkov et al, 1998; Lechman et al, 
1999; Bileviciute-Ljungar and Lundeberg, 2000; Bileviciute-Ljungar and Spetea, 2001
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Contralateral responses were seen in many different laboratories and they were 
consistently identified independent of the type o f stimulus (CFA, thermal injury, 
substance P for example) and the various strains of rats used (Wistar, Lewis and 
Sprague-Dawley) of both males and females. No alternative explanations were 
offered by the investigators to explain their findings. This suggests that these distant 
responses are not artefactual.
2.2.3 Neural mechanisms are implicated in contralateral responses 
Aside from Levine et aVs (1985b) work, several other groups provide evidence to 
support the mediating o f contralateral responses through neural mechanisms rather 
than reflecting a systemic or circulatory effect.
Coderre and Melzack (1985) abolished the contralateral hyperalgesia response to a 
noxious thermal stimulus by sectioning the sciatic nerve prior to the injury. Like 
Levine et al (1985b), they were unable to attenuate the contralateral response if they 
performed the nerve lesion after the thermal injury.
Decaris et aVs work (1999) perhaps provides the most convincing evidence for the 
distant neurogenic transmission of inflammation. They took male Wistar rats and 
induced a local degree of inflammation by injecting 1 pg of complete Freund’s 
adjuvant. There was no associated rise in temperature or serum IL-6 to indicate a 
significant systemic response but proteoglycan activity was seen to be significantly 
decreased in both knees when compared to baseline and IL-1 (3 mRNA was detected 
in both knees. IL-lp mRNA had previously been shown to be absent in the normal 
synovium. These contralateral responses were abolished when spinal cord injury was 
induced 2 days prior by an extradural balloon method. This operation did not alter 
proteoglycan synthesis nor IL-lp mRNA expression in either patella.
Bileviciute-Ljungar published two papers (2000 and 2001) demonstrating the anti­
nociceptive capacity o f contralateral stimuli on a defined inflammatory response. 
Carrageenan (1% of 50 pi) was injected into the right hindpaw of male adult albino 
Sprague-Dawley rats. The contralateral paw then received 100 pi o f 5mg/ml of 
bupivacaine. Controls were injected with saline. Hindpaw withdrawal latencies were
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seen to increase when compared to controls. No such increase was observed when the 
bupivacaine was injected systemically, suggesting a neuronal rather than a systemic 
anti-nociceptive effect (Bileviciute and Lunderberg, 2000). A similar experimental 
protocol yielded similar results with the experimental K-opioid agonist, U-50,488H, 
whereby contralateral but not systemic administration was seen to have an anti­
nociceptive effect (Bileviciute and Spetea, 2001).
Kidd et al (1995) and Donaldson et al (1995) both used capsaicin, a similar method to 
Levine et al (1985b), in disrupting neuropeptide containing nerves and interrupting 
contralateral responses. Kidd et al (1995) induced a monoarthritis using latex spheres 
injected into the right knee of male Wistar rats. Contralateral knee cellular infiltrates, 
mainly monocytes, were significantly elevated when compared to control animals and 
joints elsewhere in the affected rat. The neonatal administration of capsaicin however 
reduced this contralateral cell count whilst having no effect on the ipsilateral arthritic 
joint.
Donaldson et al (1995) induced a monoarthritis with Freund’s Complete Adjuvant in 
the left ankle of adult male Han Wistar rats that had previously been shown to spread 
to the contralateral joint. However the application of capsaicin to the sciatic nerve in a 
method similar to that of Levine et al (1985b) two weeks prior to the arthritis 
induction prevented the full expression of this contralateral arthritis.
2.2.4 Central versus peripheral contralateral responses
A distinction must be made between the central changes that occur on the 
contralateral spinal cord and can lead to hyperalgesic and allodynic sensory changes 
on the contralateral limb and those changes that are peripheral. Peripheral responses 
are polysynaptic and could only occur in the contralateral limb secondary to an 
antidromic impulse releasing neuropeptides in the periphery. This distinction is 
important when considering experimental models to test.
Including Levine et al (1985b), 10 studies were seen to manifest peripheral 
contralateral responses and 9 studies detected changes consistent with central spinal 
cord sensitisation. Some studies detected both peripheral and central spinal changes.
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For example, Yu et al (1996) detected the release of CGRP in the joint perfusate 
contralateral to a carrageenan-induced monoarthritis as well as the lowering of 
withdrawal latency to mechanical and thermal stimuli.
2.3.1 Properties of the observed contralateral responses
Taken together, these studies strongly support the hypothesis that neuronal 
mechanisms influence distant inflammation. It is tempting to speculate on properties 
that relate to these contralateral responses.
2.3.2 Magnitude of inflammatory stimulus
These contralateral responses appear to require the inflammatory stimulus to be o f a 
certain magnitude before appearing. There are several examples in the literature of 
this ‘threshold’ effect. Bileviciute et al (1998) did not demonstrate contralateral 
hindpaw oedema with low doses o f subcutaneous CGRP (75 and 150pmol), but did 
with a higher concentration (300pmol). Adjuvant arthritis in the rat induced with 
intradermal injections of small doses o f CFA around the tibiotarsal joint causes a 
contralateral arthritis if the dose is increased from 75 to 150pg (Donaldson et al, 
1993). Nociceptive behaviours towards the contralateral paw were not seen after 
0.1% formaldehyde injections, but were observed after injections o f 5% solution, and 
were even more frequent after injection with a 10% solution (Aloisi et al, 1993). 
Other papers did not examine the effects of varying the dose of the initial stimulus 
upon the contralateral responses.
2.3.3 Topographical precision
Where studied, the contralateral responses appear to be topographically precise. 
Topographically precise contralateral responses can only be mediated through the 
nervous system. Three separate studies were designed to identify this.
Kidd et al (1995) placed latex spheres within one knee joint of a rat before examining 
the inflammatory response in the contralateral knee, ankle and hip joints using 
bradykinin-induced plasma extravasation and histological examination of the joints. 
They found that only the contralateral knee exhibited enhanced plasma extravasation 
and macrophage infiltration and that these responses were not seen in the contralateral 
hip or the contralateral ankle.
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Meyer et al (2000) examined the contralateral knee and both ankles for cartilage 
metabolism and histological damage. They too found that only the contralateral knee 
showed a decrease in cartilage anabolism and signs of histological damage and that 
these were not seen in either ankle.
Amann et al (1996) used repeated injections of nerve growth factor (NGF) and 
examined the mRNA of neuropeptides in the contralateral nerves. They found 
increases only in the contralateral sciatic nerve if the hindpaw was injected, only in 
the contralateral trigeminal nerve if the ear was injected and only in the contralateral 
brachial plexus if the forepaw was injected.
2.3.4 Stimulus specificity
The contralateral responses are broadly stimulus specific. If  a pro-inflammatory 
stimulus is induced unilaterally, the contralateral response is pro-inflammatory, as 
evidenced by the identified papers, all o f which show contralateral pro-inflammatory 
responses. However, if the unilateral response is neurological in nature, such as the 
sectioning of a peripheral nerve, then the contralateral response is also appropriately 
neurological: the corresponding neuromuscular junction exhibits nerve sprouting. 
Also, if the insult is anti-inflammatory, such as detailed in some o f the papers in 
Table 2.2, the contralateral response is anti-inflammatory.
2.3.5 Reduced response
The contralateral responses are only a ‘shadow’ o f the original lesion both in 
magnitude and temporally. In all of the identified papers, the contralateral findings 
were less than the ipsilateral changes. The withdrawal latencies were more greatly 
reduced on the side of the lesion than the contralateral side; the magnitude o f the 
biochemical or histopathological abnormalities was greater on the side of the lesion; 
and the macroscopic changes such as oedema were also greater on the side o f the 
lesion.
2.3.6 Sensitisation and the lack of tachyphylaxis
As described above (section 2.1.1), Levine et al (1985b) performed experiments to 
test the property o f tachyphylaxis in this system and they did not find any evidence of 
its existence. They found instead that the contralateral side had been sensitised and
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this priming could be augmented by increasing the frequency o f the stimulus. No 
other group has tested these properties, although, as will be discussed later, this fits 
well into the sensitisation of the contralateral spinal horn and the release o f 
neuropeptides contralaterally.
2.4.1 Does the right side know what the left is doing?
In 1999, Koltzenburg, Wall and McMahon reviewed a wide range o f examples of 
unilateral neural interventions that produced bilateral effects. While acknowledging 
that many o f these examples could be readily understood within existing frameworks 
of knowledge they too proposed the existence of a new signalling system across the 
midline of the body. They were focussed on unilateral neural lesions rather than 
inflammatory insults. However remarkably similar observations were made between 
the literature that they summarised (Table 2.3) and those that have been identified in 
Table 2.1 above.
The results of the experiments are not the provenance o f but a few laboratories and 
the diversity o f the results range from gene expression through to anatomical 
remodelling and physiology. These contralateral responses were also noted to be 
stimulus-specific, delayed temporally and smaller in magnitude.
Focussing on Rotshenker and Tal’s (1985) experiments they note the occurrence of 
the degeneration of the ipsilateral neuromuscular junction distal to the nerve lesion 
and the new sprouting that is seen in the contralateral intact neuromuscular junction. 
Appropriate controls of sprouting neuromuscular junctions were obtained from 
normal muscles. Interestingly the sprouting contralateral to the sectioned nerve was 
first seen 5 days after a proximal lesion in the sciatic nerve, but it took 12 days to 
occur when similar numbers of axons were cut more distally.
They suggest several mechanisms for such contralateral responses, rejecting systemic 
and circulatory causes due to a variety o f experimental parameters that were 
controlled. They favour the passing of a slow messenger through the dorsal 
commissural system, probably a neurotrophin, although acknowledge that electrical 
and direct trans-median signalling could occur.
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Table 2.3 Does the right side know what the left side is doing? 
(Koltzenburg et aU 1999)
Lesioned nerve Species Effect in contralateral homonymous neurones
Motoneurones
Facial, hypoglossal Rat Chromatolysis, changes in RNA levels
nerve
Facial, hypoglossal Rat Increase in acid phosphatase succinoxidase
nerve
Hypoglossal nerve Rat Proliferation of microglia, invasion of the nucleus by
leukocytes
Sciatic nerve Rat, mouse Increase in mRNA for tubulin, CGRP, CCK, GAP-43
Sciatic nerve Rat Increase in CGRP, pro-opiomelanocortin derived
peptides, B-endorphin and a-melanotropin levels
Muscle nerves Frog, rat, Sprouting of endplates
mouse
Muscle nerves Frog Increased release of ACh





















Decrease in ACh levels
Transmedian sprouting, upregulation of the 
neurotrophin receptor p75
Transmedian sprouting of fibres; increase of cell size 
Sprouting into DRG or spinal roots
Transmedian sprouting
Increase of mRNA for B-tubulin and decrease in 
mRNA for the low-molecular-weight neurofilament 
Change of expression of genes for SP, CGRP, 
neuropeptide Y and galanin 
Upregulation of bradykinin receptors 
Downregulation of the mRNA for the tetrodotoxin- 
resistant sodium channel 
Macrophage invasion of the DRG 
Increased expression of the neurotrophin receptor, p75, 
on satellite cells of the DRG 
Intraplantar injection of NGF increases CGRP, SP, 
preprotachykinin and prepro-CGRP content 
Reduced cutaneous plasma extravasation
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The following sections go on to describe the anatomical, physiological and 
biochemical mechanisms that outline a crossed afferent spinal pathway and that could 
account for the contralateral observations and associated properties.
2.5.1 The anatomy of crossed spinal afferent fibres
Cajal and von Lenhossek separately hypothesised at the end of the 19th Century that a 
significant part of the dorsal commissure is comprised o f fibres from one substantia 
gelatinosa travelling to the contralateral dorsal horn through posterior decussation. 
The first experimental demonstration of crossed afferents came in the 1930s (Ranson 
et al, 1932) and was quickly followed by other groups.
Szentagothai described in great detail the anatomy o f the dorsal horn. He depicted 
rich connections between the two opposite gelatinous substances (Rexed’s laminae I, 
II and III) through the dorsal most bundle of the posterior gray commissure 
(Szentagothai, 1964). He studied young cats and dogs and, as well as using Golgi 
analysis and experimentally induced degeneration, he pioneered the method of 
‘persisting elements’ thus permitting whole neuronal architecture to be preserved by 
securing the local blood supply. He found that most crossed fibres are secondary and 
higher order neurons, although direct primary sensory collaterals are occasionally 
seen in degeneration studies.
His findings explain those of Culberson et al who revisited this subject in 1979. They 
studied opossums, possums and bushbabies as well as cats and stained alternate 
sections with the Fink-Heimer method (silver impregnation) and cresyl violet acetate. 
Crossed afferent projections were a constant feature of all the animals at the sacral 
and higher cervical levels o f the spinal cord. However there were much fewer crossed 
projections between C5 -  T12. Most fibres diverged to reach laminae III and IV in the 
contralateral dorsal horn. The caveat to this study was that the methodology 
employed differed from that of Szentagothai (1964) and not all afferents were 
identified due to differing degeneration times, and intemeurons were not specifically 
studied.
In the same year, Light and Perl (1979) also published their observations on the 
primary afferent projections o f several mammals, including cats, rats and macaque
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monkeys. They used a tool that was novel at the time, horseradish peroxidase to 
anterogradely stain neuronal projections. They noted that small fibres streamed 
through the posterior commissure on a regular basis running along the base o f the 
dorsal horn (lamina V in the cat) or the marginal zone (lamina I). In the monkey, the 
highest density o f contralateral fibres occurred in the thoracic, sacral and caudal 
sections. Many fibres were also seen to terminate just dorsal to the central canal in the 
midline. Again, the intemeurons were not stained using this method.
In summary, several groups have looked and found somatosensory afferent 
projections crossing the dorsal commissure in a number o f mammalian species. This 
provides anatomical evidence that crossed spinal afferent pathways exist to transmit 
signals across the midline. Figure 2.1 summarises this data in a cartoon.
Figure 2.1 Scheme demonstrating identified routes through the dorsal 
commissure of sensory fibres entering the dorsal horn 
(Culberson et al, 1979: Light and Perk 1979: Szentagothai, 1961)
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2.5.2 Function of the crossed afferent pathway
Spinal reflexes that cross the midline have long been reported. The oldest and most 
commonly recognised are those of the crossed extensor and adductor reflexes, 
recognised at the end of 19th Century. Recent studies have demonstrated that this 
pathway involves both short and medium latencies and are therefore both 
monosynaptic and polysynaptic in nature (Coma et al, 1996; Alexander and Harrison, 
2002).
However these reflexes necessitate synaptic interface with the ventral hom to 
stimulate the contralateral motor command. This is incongruent with the anatomical 
studies that rarely find such connections through the posterior decussation, although 
Light and Perl (1979) did describe ventral decussations synapsing in the ventral hom. 
It seems unlikely therefore that the observed fibres are mediating motor spinal 
reflexes.
Culberson et al (1979) suggested that the afferents innervated dermal tissue that was 
near the ventral and dorsal midlines. The mammals that they studied had tails and this 
correlated well with the predominant decussating neurons being located sacrally and 
caudally. However, Szentagothai (1964) described interconnections between the two 
sides of the spinal cord at all levels in cats and dogs. Light and Perl’s study (1979) of 
macaque monkeys demonstrated decussations occurred prominently in the thoracic 
spinal cord. It would seem unlikely therefore that all decussations would be 
innervating midline structures. Indeed this is bom out by neurophysio logical studies.
2.6.1 The neurophvsiology of crossed afferent pathways in the dorsal hom 
The observation that some neurons in the dorsal hom have bilateral receptive fields is 
of significance in the neurophysiology o f contralateral pathways. This is not a new 
observation. Taub (1964) described the inhibitory effects of C-fibre stimulation either 
by electrical or noxious stimulation on the contralateral dorsal hom as had Wagman 
and Price (1969). Fitzgerald (1982b) demonstrated that this inhibitory effect could be 
modulated by capsaicin treatment. The following sections break down the findings 
into spinal and supra-spinal effects.
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2.6.2 Crossed afferent neurophvsiologv at the spinal level
Fitzgerald (1982a) best illustrates this in her studies on decerebrate and spinalised 
rats, used to investigate this phenomenon in more detail at the segmental spinal level. 
She studied the deeper laminae IV, V and VI o f the spinal cord and stimulated the 
contralateral limb with a functional stimulus such as a small paint brush, fine toothed 
forceps or noxious heat (45-50°C), as well as C-fibre or A-fibre electrical stimulation 
o f the contralateral sciatic nerve. 53 separate neurons were identified, 90% of the 
cells having ipsilateral fields on the toes or foot and the other 10% of cells having 
large ipsilateral fields involving most of the leg. Most cells responded to all of the 
stimuli (Wide Dynamic Range (WDR) cells) but others were more Nociceptive 
Specific (NS). 5 Long Term Memory cells were identified and none of these had 
contralateral inhibitory fields, although one had a contralateral excitatory field.
When the contralateral leg and tail were noxiously (heat or pinch) stimulated 29 / 53 
cells were found to have inhibitory contralateral fields, whereas there were some cells 
(3) with excitatory contralateral fields. The contralateral inhibitory field was in the 
‘mirror-image’ distribution of the ipsilateral excitatory field for the majority o f the 
cells, although 5 cells had contralateral inhibitory fields throughout the whole 
contralateral leg and tail. The contralateral inhibition was invariably related to 
noxious stimuli and could be quite profound. The inhibited cells received A- and A/C 
stimulation electrically, but no cell was inhibited by receiving only C-fibre input. 
Electrical stimulation of the sciatic nerve produced excitation in 22 / 53 contralateral 
cells followed by a period o f inhibition. These were not necessarily the same cells 
affected by the contralateral functional stimuli.
This demonstrates the physiological existence at the spinal segmental level o f cross­
midline afferent pathways, the majority o f which appear to be inhibitory and 
mediated by A-fibres.
Fitzgerald went on (1982b) to describe the effects of capsaicin, applied directly to the 
exposed sciatic nerve for 15 minutes 7-21 days prior to the experiment, on the 
contralateral fields. Reproducing the above results in control (sham-operated) and 
normal rats, she found that the contralateral fields had turned from being 
predominantly inhibitory in the control rates to being predominantly excitatory in the
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capsaicin treated group. This contralateral field was never larger than the ipsilateral 
field with again the majority occurring on the foot and toes. The contralateral 
excitation was never as strong as ipsilateral excitation.
Interestingly, the dorsal horns on both sides of the spinal cord changed their
contralateral fields from inhibitory to more excitatory following unilateral capsaicin 
treatment. Several explanations may account for this including the removal of the 
inhibitory C-fibre effect modulating the A-fibre input from an inhibitory to a 
stimulatory signal; the changing role o f intemeurons following capsaicin treatment; 
and the role o f neuropeptides as neuromodulating agents. These are yet to be 
explored.
Expanding on these observations, Neugebauer and Schaible (1990) examined a 
spinalised cat model before and after the introduction of a kaolin and carrageenan 
knee monoarthritis. They noted that 1 8 / 3 2  neurons located in laminae VI, VII and 
VIII of the lumbar spinal cord had bilateral receptive fields. Following the arthritis, 
more neurons exhibited contralateral fields and the contralateral fields that had 
previously been detected in some neurons became expanded and their thresholds 
lowered. They acknowledged that the global effect o f such changes may be masked 
by supraspinal influences, but the ‘bottom-up’ effect of an inflammatory stimulus on 
the physiological properties of both sides o f the spinal cord is undeniable. As can be 
seen in Table 2.1 and has previously been discussed, it is likely that these changes are 
transmitted to the behaviour of the animal.
2.6.3 Crossed afferent neurophvsiologv in intact animals
The influence o f supraspinal pathways can be studied by examining intact animals.
Grubb et al (1993) examined the dorsal horns o f male Wistar rats following the 
induction o f a chronic arthritis by Freund’s complete adjuvant. Rats were examined 
between 2 and 20 days post induction. Similar to Fitzgerald (1982a and b) they found 
42/82 spinal neurons exhibited contralateral limb fields, the majority o f these cells 
were WDR (36/42) and that the fields were mainly inhibitory (28/36). Also similar to 
Fitzgerald’s study using capsaicin (1982b), the numbers o f cells expressing excitatory 
contralateral fields increased significantly at day 20, but not prior. This increase was 
mainly due to an increase in activity of the ventral hom cells. Little change was seen
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in the number of neurons expressing inhibitory contralateral fields at any time point. 
They concluded by suggesting that these changes were indicative o f central spinal 
processing.
It is noteworthy that the changes in these rats were minimal compared to Fitzgerald’s 
studies (1982a and b) and that the role o f a significant inhibitory role for supraspinal 
influences maybe large (Eccles and Sherrington, 1931).
This pathway has recently been further explored by Sotgui et al (2004). They 
recognise that WDR neurones are not functionally altered by normal pre-synaptic 
input from the contralateral side in intact animals based on experimental evidence 
such as Grubb et aVs (1993). However augmenting the contralateral pre-synaptic 
signal, by either infusing an excitatory neurotransmitter (NMDA) or inhibiting the 
inhibitory neurotransmitter glycine with strychnine, recruited 50% more of the post- 
synaptic dorsal hom WDR neurons and their global activity was more spontaneous 
and sustained following a noxious stimuli applied contralaterally than when compared 
to that recorded before the pre-synaptic augmentation. It therefore appears that 
supraspinal influences may be overcome.
Perhaps relevant to this is that substance P appears to have modulating properties on 
the post-synaptic membrane potential resembling long term potentiation in 
neurokinin-1 receptor positive neurons, a population that is less than 5% of the total 
neuronal population in the dorsal hom (Carrasquillo and Gereau, 2004). These fibres 
are required for central sensitisation following capsaicin injection and perceptual 
wind-up following repeated non-traumatic stimulus.
2.6.4 The metabolism of the spinal cord to a unilateral inflammatory stimulus. 
Metabolic studies suggest that neuronal activity is bilateral in the spinal cord 
following a unilateral stimulus. This provides further evidence that the crossed spinal 
afferent pathway is physiological in intact animals.
The uptake of 2-deoxyglucose (2-DG) has been used as a marker of neuronal 
activation to study cellular activity in the rat spinal cord. Increases in metabolism 
have been measured in the contralateral regions o f the spinal cord following unilateral
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hindpaw inflammation caused by formalin, thermal injury or complete Freund’s 
adjuvant.
Porro et al (1991) and Aloisi et al (1993) studied the cervical spinal cord uptake of 
[14C] 2-deoxyglucose in adult male Sprague-Dawley rats at 2 and 60 minutes 
following the injection of 5% formalin compared with control groups o f saline 
injected or uninjected rats. They found bilateral increases in the dorsal horns, 
predominantly on the ipsilateral side at 2 minutes in a broadly symmetrical fashion 
whereas activation was only in the medial part of the contralateral dorsal hom at 60 
minutes.
Coghill et al (1991) used a similar technique to study the effects of non-noxious and 
noxious heat stimuli applied to one hindpaw of adult male Sprague-Dawley rats. They 
found contralateral spinal changes in the level of 2-DG uptake, mainly in the deeper 
layers (laminae V-X) and the medial ventral hom.
Similarly, Schadrack et al (1999) studied the effects of complete Freund’s adjuvant 
injection into the ankle of Sprague-Dawley rats on spinal cord metabolism between 2 
and 14 days. They too found bilateral increases in 2-DG uptake, initially within all 
laminae, but then focussing more on laminae V-VII. There was more uptake in the 
cord ipsilateral to the arthritis.
The conclusion is that the metabolic and neurophysio logical potential for the 
contralateral spinal cord to be influenced by, and affect the process o f  a unilateral 
lesion is supported by the presented evidence.
2.7.1 Pharmacology of crossed afferent spinal pathways
Certain populations of afferent unmyelinated sensory fibres are remarkable in 
containing neuropeptides within their nerve terminals. The commonest of these 
peptides are the co-localised substance P (SP) and calcitonin gene-related peptide 
(CGRP). It is these neuropeptide containing fibres that are affected by capsaicin 
(Caterina et al, 1997) and they are heavily implicated in all o f the pain pathways. SP 
and CGRP both have effects on local inflammatory processes and 
immunomodulation. It is therefore of interest to note that the contralateral effects can
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be abrogated by the use o f capsaicin (see section 2.2.3), further implicating the role o f 
these neuropeptides in putative contralateral pathways. Of particular relevance would 
be the expression of neuropeptides and their receptors centrally.
Increases in substance P, CGRP and their receptors appear to be consistent findings 
whether the stimulus is mBSA, latex spheres or CFA. These increases have been seen 
in the spinal cord (Kantner et al, 1985; Galeazza et al, 1992; Mapp et al, 1993; 
Stucky et al, 1993) as well as the contralateral dorsal root ganglion (Kidd et al, 1995; 
Mapp et al, 1995; von Banchet et al, 2000). Only de Ceballos et al (1990) found 
substance P levels to be decreased at 24 hours in the contralateral spinal cord 
following a thermal injury.
For example, Mapp et al (1993) took male Wistar rats and induced an arthritis using 
methylated bovine serum albumin following sensitisation with Freund’s complete 
adjuvant 21 days prior. They used controls of unsensitised and sensitised animals 
with normal saline. Increases in the number of cells expressing CGRP and SP were 
observed at day 3 in the contralateral dorsal hom when compared with the control 
groups. These differences disappeared at day 28 post inoculation. Interestingly, on the 
ipsilateral side to the inflammation, only CGRP immunoreactivity was seen to 
increase at day 3 and both CGRP and SP were seen to decrease at day 28.
The ability to block neuropeptides pharmacologically reduces the expression of 
contralateral responses. Yu et al (1996) demonstrated that a unilateral injection of 
carrageenan into the plantar region o f the hindpaw was sufficient to produce bilateral 
changes in the withdrawal latencies to thermal and pressure stimulation and increase 
the concentrations o f CGRP in the spinal cord and the contralateral joint. However, 
following the administration of intrathecal CGRP8'37, a selective antagonist of CGRP, 
the central sensitisation was significantly abrogated. The effects of CGRP8'37 were 
only partially reversed by the application o f naloxone.
Similarly Decaris et al (1999) were able to block the contralateral effects (see section 
2.2.3) with the prior administration of a neurokinin-1 antagonist into the spinal canal.
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2.8.1 Molecular and genetic mechanisms o f crossed afferent pathways
The proteins of immediate-early genes and transcription factors in dorsal horn cells 
are rapidly expressed in response to many peripheral stimuli. Such products include 
fos, jun and krox-24. The expression of these genes and their products has been seen 
contralaterally in the spinal cord.
After CFA was placed into either the hindpaw (Menetrey et al, 1989) or the ankle 
(Leah et al, 1996), c-fos was expressed in lamina VIII contralaterally. After thermal 
stimulation immediate-early genes and their products were also seen in the deep 
laminae contralaterally (Williams et al, 1990; Herdegen et al, 1991a). After electrical 
stimulation of unmyelinated sensory afferents (Herdegen et al, 1990 and 1991b) early 
gene products were expressed in laminae IV and VI. After carrageenan was used to 
cause hindpaw oedema, fos-like immunoreactivity was seen in laminae V and VI 
(Noguchi et al, 1991). All o f these studies would support the hypothesis that there is 
significant activation of contralateral neurons.
2.9.1 Evolutionary role for contralateral responses through crossed afferent pathways 
For any biological pathway to be teleologically conserved there should be clear 
physiological advantages. One hypothesised role for a crossed afferent pathway is 
that it can rapidly upregulate protective pro-inflammatory responses in the 
contralateral limb in preparation for an insult that has already occurred to the 
organism on the ipsilateral side (Kidd et al, 1995). Biologically this could be 
protective and appropriate. The inflammatory response could be focally upregulated 
and should a similar noxious insult appear on the contralateral side, perhaps it could 
be dealt with more effectively. The advantage that this precise response has over a 
systemic response to inflammation is that it is economic with the energy expended 
and limits widespread self-damage caused by inappropriate inflammation. Similarly, 
pain withdrawal reflexes are centrally primed so that the contralateral limb can be 
withdrawn more quickly. There is more chance o f damage limitation from a 
dangerous environment if such responses existed and it could be argued that survival 
is enhanced through the use of such pathways.
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That these pathways may now be disadvantageous, propagating chronic inflammatory 
diseases, is a reflection of a change in environmental conditions. The symmetrical 
diseases do not on the whole affect the ability to procreate and hence the genetic basis 
for these responses could be conserved.
2.10.1 Contralateral responses in man
Although many groups have been able to establish the existence o f contralateral 
responses in the laboratory in a variety o f different species, evidence has yet to be 
provided for such pathways to exist in man.
Haigh (personal communication) investigated this possibility and was able to 
determine that a central sensitisation could be induced contralaterally in a 
topographically precise manner following the intradermal injection of capsaicin.
2.10.2 Protocol for demonstrating contralateral central sensitisation to capsaicin 
Volunteers were seated in a quiet temperature-controlled room (23-24°C) for 30 
minutes. The exact contralateral site was identified. 100pi o f 1% capsaicin (Sigma, 
80% Tween solution) was then injected intradermally into one forearm. The capsaicin 
had been made up on site and stored at 4°C throughout the study. Allodynia and 
hyperalgesia were then mapped every 10 minutes over the following hour (Image 
2.1). This was done both ipsi- and contralaterally using Semmes-Weinstein 
monofilaments and standard quantitative techniques (Simone et al, 1989; Pedersen 
and Kehlet, 1998). Due to possible suggestion bias the volunteers were not told of the 
study objective and both arms were mapped. Volunteers were told to avoid smoking, 
caffeine, strenuous exercise and alcohol on the day of the study.
2.10.3 Sensory detection o f hyperalgesia and allodvnia.
Pinprick hyperalgesia was detected using a stiff Semmes Weinstein monofilament 
(6.45; 1500mN) (Finnerup et al, 2003). This was first tested on an area of skin 
(anterior chest wall) that was not anatomically related to the capsaicin injection or the 
contralateral side. Most volunteers reported that this felt like a pinprick but was not 
very painful. Volunteers were asked to rate whether the 6.45 monofilament felt 
different on the forearm compared to the sensation felt over the anterior chest wall.
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Responses were positive for hyperalgesia if the volunteer reported that the sensation 
was different to the surrounding skin and was more painful than previously 
experienced.
Allodynia was detected using a 4.74 (51.9mN) monofilament, and again the anterior 
chest wall was used prior to the experiment as a reference. This force is not normally 
perceived as painful (Brennum et al, 1989), but is well above the sensory threshold. 
Reponses were positive for allodynia if  the volunteer reported that the sensation was 
different to the surrounding skin and painful.
Points referring to positive responses to allodynia and hyperalgesia were then 
transferred using transparent acetate onto blank paper. Free drawn areas were 
described by connecting these points and the surface area was measured using image 
analysis (MAVIS, Plassman and Jones, 1998).
Image 2.1 Capsaicin injection is given into the left arm (white arrow). 
Hyperalgesia (lines) and allodynia (crosses) are mapped every ten minutes in 
different colours to both arms over 1 hour
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Figure 2.2 The percentage of responders to intradermal capsaicin over time
(n=32)
Purple and magenta bars are ipsilateral hyperalgesia and allodynia respectively. 
Yellow and turquoise are contralateral hyperalgesia and allodynia respectively. The 
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2.10.4 Volunteers for the protocol and controls
Volunteers were recruited at the Royal National Hospital for Rheumatic Diseases and 
the University o f Bath. Two groups were recruited, healthy volunteers and patients 
with RA.
Because skin differs in the density o f nociceptors and thresholds to sensory stimuli 
vary within the same individual depending upon the location, comparing forearm 
responses to anterior chest wall responses might be misleading and generate false 
positive responses. To help control such bias, and also control for suggestion bias, the 
control group o f healthy volunteers was recruited. They had not been exposed to the 
intradermal capsaicin. Areas o f hyperalgesia and allodynia were mapped as outlined 
above on the forearm.
Recruitment was over 9 months at the RNHRD Trust. Bath Local Research and 
Ethics Committee approved the protocol (BA 110). Baseline characteristics including
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disease duration, medication and disease activity were collected. All volunteers gave 
their informed consent.
2.10.5 Outcomes and statistical analysis
A non-parametric signed rank test was used to compare the frequency o f contralateral 
hyperalgesia and allodynia in the group exposed to capsaicin to the frequency of such 
response in the healthy control group not exposed to capsaicin.
The secondary outcome was to compare the contralateral responses between the 
rheumatoid and healthy groups.
2.10.6 Contralateral sensitisation following intradermal capsaicin
In the control (non-capsaicin) group, 23 volunteers (mean age 27 years, 43% male) 
were recruited. 3 of these volunteers also had a diagnosis of rheumatoid arthritis (all 
female). 2/23 (8.7%) volunteers demonstrated areas of hyperalgesia and allodynia that 
both felt different and was more painful than the surrounding tissue. Both volunteers 
were healthy. One of these volunteers had a very large area of hyperalgesia with ill- 
defined boundaries. The other had a small area.
In the group who were administered capsaicin 9/14 (64.3%) healthy controls 
demonstrated contralateral hyperalgesia or allodynia within an hour. 12/18 (66.7%) 
patients with RA demonstrated contralateral sensory changes. Both groups 
demonstrated statistically significant differences in the frequency o f contralateral 
responses when compared to the control group at (p<0.05) (Figure 2.2). In the healthy 
group, this achieved significance for hyperalgesia at 5, 15 and 25 minutes and for 
allodynia at 15, 25, 35 and 45 minutes. In the rheumatoid arthritis group, this 
achieved significance for hyperalgesia at 15, 25, 35 and 45 minutes but did not 
achieve significance for allodynia at any time point.
The area o f the contralateral responses varied in magnitude between 5-50% of the 
ipsilateral response to capsaicin (Figure 2.2) in both groups.
The mean mechanical hyperalgesia area in the contralateral arm in both groups was 
18 cm2 (SEM +/-5 .3). The mean mechanical allodynia area was 14 cm2 (SEM +/-
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4.7). Both of these were significant (p<0.05) when compared to the control group’s 
mechanical hyperalgesia and allodynia, 4 cm2 (SEM +/- 3) and 3 cm2 (SEM +/- 2.7) 
respectively.
There were no significant differences between the proportions o f healthy volunteers 
and patients with rheumatoid arthritis who described contralateral sensations. There 
was no difference in the temporal pattern of the responses between these two groups. 
There was no correlation between the baseline characteristics o f the volunteer groups 
and the presence a contralateral response.
In summary, contralateral sensitisation to a stimulus of intradermal capsaicin is robust 
and topographically precise in this group of volunteers. This is the first demonstration 
o f a neurogenic contralateral responses occurring in man and provides evidence of a 
central sensitisation pathway’s existence.
2.11.1 Conclusion
The neurogenic hypothesis has been advanced. Both central and peripheral 
mechanisms can be induced contralaterally following unilateral inflammatory 
stimulus. Multiple examples appear in the literature using a variety of inflammatory 
stimuli in different experimental models. There are clear anatomical pathways that 
have been described in the literature to account for these contralateral responses. 
Neurophysiological and morphological molecular studies also support the implication 
o f the contralateral dorsal horn in the response to an acute inflammatory stimulus. 
Finally, central sensitisation has been shown to occur in man following intradermal 
capsaicin injection.
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Chapter 3. Neurogenic influences on inflammation and symmetrical
diseases
Summary
This chapter summarises the effects that nerves, and specifically neuropeptides, have 
on inflammation with particular reference to the possible peripheral modulation of 
inflammatory and immune processes. The distribution of nerves is briefly 
summarised in normal joints and those of patients with rheumatoid arthritis, as well as 
the skin of patients with psoriasis. The role of neuropeptides is then discussed and it 
can be seen that they can significantly influence local inflammatory and more 
systemic immune processes. Evidence is given for the effects of neural lesions on the 
course of inflammatory and immune processes in animal models of arthritis. Finally, 
clinical observations of the effects of neural lesions, both upper and lower, on the 
phenotypic manifestation o f symmetrical diseases are summarised. All of this 
evidence supports the hypothesis that an autoregulatory neurogenic loop can 
peripherally influence the course of diseases such as RA and can therefore account 
for the symmetry seen in these diseases.
3.1.1 Introduction
The possible role of a neurogenic autoregulatory loop to explain the symmetry 
observed in bilaterally symmetrical diseases has been outlined. If  this hypothesis is 
correct, then nerves and in particular neuropeptides should be appositely positioned to 
influence this process. Furthermore, disease development should be slowed, arrested 
or ameliorated by interrupting the nerve supply to the affected areas. The following 
sections pay particular attention to rheumatoid arthritis, although other diseases such 
as skin psoriasis are considered. The innervation of the joint is outlined, the influence 
of neuropeptides on immune and inflammatory mechanisms is considered, and 
observations of the interruption of the neural supply are summarised.
3.2.1 The anatomical distribution o f nerves in joints
Although previously thought to be poorly innervated, the joint in fact has a rich and 
varied nerve supply, both in terms of large fibres mediating mainly proprioception
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and small unmyelinated fibres mediating mainly * nociception. The neurally dense 
areas are located in the joint capsule, at the insertion of ligaments and tendons, and in 
the synovium (Kellgren and Samuel, 1950; Dye et al, 1998).
Mapp (1995) described the histological innervation of the normal synovium. Most 
joints derive their neural supply from at least one spinal level. About 50% of articular 
nerves are small in diameter and sympathetic or nociceptive in nature. Sympathetic 
fibres generally follow the larger blood vessels within the joint and their role appears 
suited to controlling the local blood supply. Unmyelinated C fibres not only surround 
the blood vessels but end freely in the synovium unrelated to any blood supply. These 
fibres are nociceptive and are generally quiescent to normal physiological stimuli and 
range o f movements. They are sensitised in the presence of inflammatory mediators 
or painful stimuli and, upon being sensitised, can induce a discharge following a 
normal stimuli.
3.2.2 The distribution of nerves in rheumatoid arthritis
Mapp (1995) went on to describe the innervation o f the synovium in rheumatoid 
arthritis and noted that this is markedly different to that of the normal synovium. 
Using immunohistochemical studies, deep vessels appear to maintain their 
innervation, which is confirmed to be sympathetic in origin on specific staining. 
However, smaller vessels more superficial to the joint cavity are apparently denuded 
and the number of free fibres is greatly reduced in the synovium, especially in the 
intimal layer. No staining was seen in intensely inflamed and ‘lymphoid’ areas of the 
diseased synovium.
The destruction, or overgrowth, of nerve fibres in RA and OA is supported by 
observations from other groups (Gronblad et al, 1988; da Silva and Carmo-Fonseca, 
1990) and implicates the nervous system in the pathophysiology of such diseases.
3.2.3 The distribution of nerves in skin o f patients with psoriasis
Pergolizzi et al (1998) examined the epidermal nerves from 10 patients with skin 
psoriasis. They took biopsies from three areas; long-standing lesions; mature, but not 
long-standing lesions; and apparently uninvolved skin. They found that both of the 
psoriatic lesions had significantly decreased expression of neural fibres and there was
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almost a complete lack of epidermal nerve fibres in long-standing psoriatic lesions. 
Johansson et al (1991) also found a profound reduction in the expression o f protein 
gene product (PGP 9.5), a pan-neuronal marker, in the lesions o f mature psoriatic 
plaques when compared to non-lesional skin.
However, these results are in counterpoint to Chan et al (1997) and Al’Abadie et al 
(1995) both of whom noted that the expression of substance P (SP) and calcitonin 
gene-related peptide (CGRP) are increased in the lesions with psoriasis. Little detail 
was available however on the temporal history o f these biopsies and the conflicting 
results may therefore not be incongruent.
The early involvement of neuropeptides in the developing psoriatic plaque is 
provided by Naukkarinen et al (1993) who studied plaques induced by the Koebner 
phenomenon, non-lesional skin and skin from healthy volunteers. They found a 
steady increase in levels of SP and vasoactive intestinal peptide (VIP) in the 
developing lesions. There was a clear increased density o f these neuropeptides in the 
mature psoriatic lesion.
From histological studies, nerves are clearly involved in the pathophysiology of both 
RA and skin psoriasis. The role of various neuropeptides in the immune and 
inflammatory processes will now be discussed.
3.3.1 Neuropeptides
Histochemical and immunological studies have revealed the presence o f a variety of 
peptides in neurons. A summary of these peptides to date is provided in Table 3.1. 
The role for these peptides outside the traditional neurotransmitter and 
neuromodulation roles for neuronally stored substances is wide and varied. Many o f 
these neuropeptides are located in neurons found in synovium. These include 
substance P, calcitonin gene-related peptide, neuropeptide Y, vasoactive intestinal 
peptide, somatostatin and dynorphin. It should be noted that the production o f these 
peptides is not limited to the nervous system, but monocytes, dendritic cells, 
eosinophils and mast cells are all capable of their production.
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Table 3.1 Some Mammalian Neuropeptides and Neuropeptide Families 
(adapted from Hokfelt et ah 2004)
Hypothalamic hormones
Oxytocin; Vasopressin
Hypothalamic releasing and inhibiting hormones
Corticotropin releasing hormone (CRH); Growth hormone releasing hormone 
(GHRH); Luteinizing hormone releasing hormone (LHRH); Somatostatin growth 
hormone release inhibiting hormone; Thyrotropin releasing hormone (TRH) 
Tachykinins
Neurokinin a ; Neurokinin (3; Neuropeptide K; Substance P 
Opioid peptides
(3-endorphin; Dynorphin; Met- and leu-enkephalin 
NPY and related peptides
Neuropeptide tyrosine (NPY); Pancreatic polypeptide; Peptide tyrosine-tyrosine 
(PYY)
VIP-glucagon family
Glucagon-like peptide-1 (GLP-1); Peptide histidine iso leucine (PHI); Pituitary 
adenylate cyclase activating peptide (PACAP); Vasoactive intestinal polypeptide 
(VIP)
Other peptides
Brain natriuretic peptide; Calcitonin gene-related peptide (CGRP) (a- and (3-form); 
Cholecystokinin (CCK); Galanin; Islet amyloid polypeptide (LAPP) or amylin; 
Melanin concentrating hormone (MCH); Melanocortins (ACTH, a-MSH and others); 
Neuropeptide FF (F8Fa); Neurotensin; Parathyroid hormone related protein 
‘Novel’ neuropeptides
Agouti gene-related protein (AGRP); Cocaine and amphetamine regulated transcript 
(CART)/peptide; Endomorphin-1 and -2; 5-HT-moduline; Hypocretins/orexins; 
Nociceptin/orphanin FQ; Nocistatin; Prolactin releasing peptide; Secretoneurin; 
Urocortin
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As will be seen the physiological effects in vitro and in vivo of these neuropeptides 
support the view that they can influence the immune-mediated inflammatory 
processes present in bilaterally symmetrical diseases. Pharmacological evidence is 
given by their actions, either through agonists or antagonists, in the development and 
maintenance of experimentally-induced animal models o f arthritis. The generalised 
central effect o f neuropeptides appears to be more of a modulating, rather than 
transmitting, nature. The peripheral effects o f the relevant neuropeptides are more 
relevant to the contralateral responses of crossed afferent pathways. Some of these 
neuropeptides will now be briefly summarised. This review is not intended to be 
exhaustive, merely reflect the influence that these neuropeptides might have upon the 
periphery.
3.3.2 Substance P fSP)
Substance P (Powderable) was first discovered by von Euler and Gaddum in 1931. 
Although they isolated a heterogeneous collection o f substances, they immediately 
demonstrated powerful vasodilatory actions and effects on gastric motility that have 
been confirmed in studies using the synthetic peptide performed after SP was finally 
isolated in the 1970s. Vascular effects include the margination of neutrophils and, in 
synergy with chemotactic peptides and complement, the migration and cytotoxic 
activation of these neutrophils.
Local inflammatory properties occurring at physiological concentrations of SP 
include the degranulation of mast cells (many unmyelinated nerve endings are seen to 
interact closely with mast cells); secretion o f prostaglandins and thromboxane from 
macrophages; and the modulation of immunoglobulin production from lymphoid 
tissue (Holzer, 1988; Garrett et al, 1992; Mapp, 1995; Lotz, 1997).
Lymphocytes have specific receptors for SP and, when stimulated, proliferate more in 
its presence. It is considered to be immunostimulatory. Lymphocytes also have 
receptors for CGRP, somatostatin and various amines which are considered to have 
more suppressive activities (see below, Lambrecht, 2001). Anatomical studies 
demonstrate the interaction between the SP neuropeptide containing neurons and the 
high endothelial venules in lymph nodes. This is the putative interface between the 
draining antigen presenting cells and circulating lymphocytes’ access to the inner
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cytoarchitecture of the lymph gland. Interestingly, the local application of capsaicin 
into these draining lymph nodes attenuates adjuvant-induced arthritis (Lorton et al, 
2000).
An interesting effect of various neuropeptides has been described by Levite (1998) 
Whilst naive T-helper cells (THO) are driven by antigenic stimulation to induce rather 
fixed patterns of cytokine secretion characterised by the ‘pro-inflammatory’ TH1 (e.g. 
IL-2, IFNy) and the ‘anti-inflammatory’ TH2 (e.g. IL-4, IL10) cytokine profiles, 
neuropeptides cause these THO cells to produce a rather different and distinctive 
pattern described as ‘forbidden’. This forbidden pattern combines both the 
characteristic TH1 responses with the additional secretion of IL4 and IL10, and the 
characteristic TH2 responses with the additional secretion of IL2 and IFNy. These 
effects seem to be not only a property of SP, but also CGRP, somatostatin and VIP.
In patients with inflammatory arthritis there are several reports of elevated 
concentrations o f SP in the synovial fluid (reviewed by Garrett et al, 1992). These 
levels are far in excess of those found in paired plasma levels suggesting a joint 
origin. Similarly there is an increased expression in the joints of patients with RA 
when compared to healthy controls of the enzyme neutral endopeptidase which is an 
important catabolic enzyme of SP. Finally it has also been shown that there is a large 
increase in the number o f SP receptors in the rheumatoid synovium when compared 
to a healthy population (Garrett et al, 1992).
Levine et al (1984) demonstrated that SP infusion into the knees o f rats increased the 
severity o f adjuvant induced arthritis and that the administration of a putative receptor 
antagonist reduced this arthritis to the level of moderate soft tissue swelling and 
osteoporosis, findings corroborated by Lam and Ferrell (1989) with a carrageenan 
model o f tissue inflammation.
In conclusion, the pro-inflammatory peripheral effects of substance P and its role in 
rheumatoid arthritis are well described.
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3.3.3 Calcitonin gene-related peptide (CGRP)
CGRP is colocalised with SP in vesicles contained in the synaptic terminals of 
unmyelinated and thinly myelinated neurons. The actions o f CGRP are synergistic 
with those of SP (Lotz, 2000). It is recognised that CGRP is more potent as a 
vasodilator than SP (Brain et al, 1985) but has a similar action on microvascular 
permeability and neutrophil accumulation. CGRP however has immunomodulatory 
activities that are more suppressive including the suppression of the proliferation of 
murine T cells and dendritic cell activation (Lambrecht, 2001).
3.3.4 Somatostatin (SS)
Somatostatin’s activities as an inhibitory neuropeptide were described in 1968 
(Hokfelt et al, 2004). However it wasn’t until 1973, when SS was isolated and 
structurally characterised that it was realised to be identical to the gut hormone 
described in 1969. SS is considered to be more of an anti-inflammatory neuropeptide. 
It too is released from capsaicin-sensitive nerve endings and it has a tendency for 
suppressive effects on the immune system, specifically on the proliferation of T-cells 
and in causing a reduction of IFN-y production from both murine and human T 
lymphocytes (Hokfelt et al, 2004).
Somatostatin has been studied in the setting o f arthritis induced by complete Freund’s 
adjuvant. An agonist has been found to ameliorate the course of the arthritis whereas 
an antagonist exacerbates the histological and clinical picture (Helyes et al, 2004).
3.3.5 Vasoactive intestinal peptide (VIP)
VIP was isolated in the 1970s from the duodenum and its chemical structure 
elucidated a short time later (Delgado et al, 2004). VIP has a mixed effect on 
inflammation and the immune system. Several studies demonstrated an 
immunosuppressive effect of VIP on T-lymphocytes by reducing their proliferation 
and cytokine expression of IL-2. However more recent studies have suggested 
augmented immune and inflammatory actions of VIP with the activation o f dendritic 
cells and the generation of IL-12.
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)Promising experimental data has come from the administration of intraperitoneal 
injections of VIP after the development of an arthritis induced by sensitisation to 
collagen type II in complete Freund’s adjuvant in DBA/1 mice. Mice treated with VIP 
showed delayed onset, lower incidence and decreased severity of their collagen- 
induced arthritis when compared to the control groups, and these responses were 
dose-related (Delgado et al, 2001).
3.3.6 Neuropeptide Y
Neuropeptide Y is part of the ‘pancreatic polypeptide family’ and is peripherally 
widely located in the sympathetic nervous system. Although more studied in relation 
to anxiety, obesity and cardiovascular disease, there is evidence to suggest a role for it 
in the interface between the immune and sympathetic nervous systems. It is 
recognised to be a messenger and a modulator of the immune system by its functions 
on the differentiation o f T helper cells, monokine release, NK cell activation and 
immune cell redistribution (Bedoui et al, 2003).
3.3.7 Nerve Growth Factor (NGF)
Although not strictly a neuropeptide, neuropeptide-containing nerves are dependent 
upon the neurotrophin Nerve Growth Factor (NGF). Its effects have been studied in 
skin psoriasis models as well as arthritis. Epidermal keratinocytes are known to 
synthesise and release nerve growth factor (NGF) and express its low affinity (p75) 
and high affinity (trkA) receptors (Pincelli, 2000). NGF is known to stimulate 
keratinocyte proliferation and induce apoptosis in its absence. NGF is also expressed 
in higher levels in psoriatic skin when compared to non-lesional skin from the same 
patients and skin from healthy controls (Pincelli, 2000). Moreover, NGF blockade 
through a specific trkA receptor antagonist ameliorated psoriatic plaques transplanted 
onto the severe combined immunodeficient mouse in a double-blinded placebo- 
controlled study (Raychaudhuri et al, 2004).
It should be noted that synovial cells also release NGF and that this is augmented by 
inflammatory cytokines. Elevated levels o f NGF have been found in the synovial 
fluid o f patients with inflammatory joint disease when compared with normal healthy 
volunteers and plasma NGF is increased in patients with juvenile chronic arthritis.
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NGF levels are higher in active rheumatoid disease when compared to quiescent. 
(Falcini et al, 1996; Halliday et al, 1998).
Agonists and antagonists have not directly been studied in experimental arthritis. 
However, one study did suggest that an indirect method to reduce the amount of NGF 
in a carrageenan model of active joint inflammation using cholecystokinin 
antagonism resulted in an increase in joint swelling, suggesting that NGF has an 
ameliorating influence in this model (Manni et al, 2002).
3.4.1 Denervation and arthritis in animal models
Hood et al (2001) induced a monoarthritis in male Dunkin-Hartley guinea pigs using 
a suspension of heat-killed M. tuberculosis in paraffin oil (CFA). She had pre-treated 
a group of 10 guinea pigs with systemic capsaicin. This group had significantly 
attenuated disease after day 1 of arthritis induction. Initial macrophage infiltration 
was followed by a lymphocyte population at day 3, which was again significantly 
attenuated in the capsaicin-treated group.
Courtright and Kuzell (1965) showed that sectioning one sciatic nerve 7 days before 
the induction of adjuvant arthritis delayed the onset and reduced the severity o f 
disease in that limb.
As noted in chapter 1 (section 1.5.3) a criticism of this manipulation for studying the 
neurogenic effect on the development of arthritis is the accompanying paralysis 
induced by the neural lesion. Kane et al (2005) have recently circumvented this 
criticism by severing only the sensory afferent nerves, leaving the motor neurons 
intact. That they found similar results to the other groups strongly supports a 
neurogenic role in the development o f acute arthritis.
Levine et al (1986) used a variety o f neural lesions and concluded that not one single 
lesion could consistently account for the improvement or accentuation o f adjuvant- 
induced arthritis. He used groups o f rats that were genetically bred to have a high 
sympathetic tone or had been exposed to neonatal capsaicin or had a unilateral dorsal 
rhizotomy performed or underwent peripheral sympathectomy. Deafferented rats had 
a worsening o f their arthritis whilst with those treated with neonatal capsaicin had a
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less severe arthritis. Rats with a high sympathetic tone also had a more severe arthritis 
and the sympathectomised rats had less severe disease.
These animal models provide several different illustrations o f the effects of neural 
depletion on the course of arthritis. Most, but not all, have beneficial effects. Another 
way to examine this issue is to assess the effects o f neural injuries on IMID by 
clinical observations.
3.5.1 Denervation and the attenuation of inflammation in clinical disease
The appropriate innervation of normal tissue is essential for the development of 
inflammation. In a striking clinical case report, Schade Willis et al (2001) reported 
the sparing of a limb affected by a brachial plexus injury secondary to birth trauma 
from necrotic skin rash due to N. meningitidis infection in a young boy. Tarkowski et 
al (1996) demonstrated a lateralisation of the tuberculin response favouring the non­
paralysed side in patients with poliomyelitis affecting one of their upper limbs.
It is therefore of no surprise to see sparing of disease progression in the diseases that 
have so far been described. A selection of these is summarised in Table 3.2.
These examples are self explanatory, but the effect of denervation to a lesion of 
psoriasis is shown in Image 3.1. The superior part of a chronic plaque of psoriasis has 
demonstrably improved following denervation whereas the innervated lower half is 
still chronically inflamed.
3.6.1 Conclusion
From the review o f the evidence in these first three introductory chapters, it seems 
plausible, if not likely, that a neurogenic loop affecting the peripheral contralateral 
side in a topographically precise manner exists and should therefore be demonstrable 
in man.
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Table 3.2 Reports in the literature of the development of arthritic diseases in
partially paralysed patients (Dixon. 1989)
Disease Nerve lesion Outcome suppressed Reference
OA Hemiplegia Heberden’s nodes Forestier (1935)
OA Hemiplegia Heberden’s nodes Coste (1935)
OA Hemiplegia Heberden’s nodes Winter (1952)
OA Poliomyelitis OA knee or hip Glyn (1966)
OA Nerve injury OA and Heberden’s nodes Stecher (1947)
OA Hemiparalysis OA Segal (1998)
RA All nerve lesions Erosions Yaighmai (1977)
RA Hemiplegia Arthritis Bland (1968)
RA Hemiplegia Digital vasculitis, arthritis 
and RA nodules
Nava (1953)
RA Hemiplegia Arthritis Jacqueline (1953)
RA Hand dominance Radiological changes of 
arthritis
Soila (1963)
RA Disuse caused by 
elbow trauma
Arthritis Kamerman (1966)




Nerve injury in 
one finger
Arthritis mutilans in one 
finger
Kane(2005)
PsA Hemiplegia Arthritis Veale (1993)
PsA Denervation DIP arthritis and nail 
pitting
Mulherin (1995)
Psoriasis Lower motor Plaque amelioration Raines (2002)
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Image 3.1 Partially denervated psoriatic plaque (Raines and Cox, 2002)
This gentleman had undergone an oesophagectomy (scar arrowed) and the intercostal 
nerves were severed. These supplied the skin that included the superior aspect o f the 
chronic psoriatic plaque and it can be seen that this has greatly improved.
Reproduced with permission from BMJ Publishing Group Ltd.
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Chapter 4. Symmetry o f early erosions in patients with rheumatoid
arthritis
Summary
Erosive disease in patients with rheumatoid arthritis (RA) is classically described as 
symmetrical in nature. In this chapter, this symmetry is described in the erosions of 
patients with RA with 6 months o f symptoms. The progression o f this symmetry is 
described 17 months later and compared to the baseline reading. It can be seen that 
not only is early RA symmetrical, but that this symmetry increases as time passes. 
Either a neurogenic or anatomical hypothesis may explain the symmetry of these 
erosions. There was no dominant side predilection at any time point however and this 
does not support a biomechanical hypothesis. A neurogenic hypothesis would best fit 
these observations.
4.1.1 Symmetry of disease in rheumatoid arthritis
Rheumatoid arthritis affects the joints in many different dimensions and these can be 
measured. Measurements can be made clinically or through a variety o f imaging 
techniques. For example, clinical assessments can be made of pain, tenderness, 
stiffness, swelling, range o f movement, and function. Imaging assessments include 
radiography, ultrasonography, scintigraphy, thermography, magnetic resonance 
imaging (MRI) and computed topography (CT). Many studies have been conducted 
into examining the effects o f RA on patients’ joints using these assessments. 
However, few studies have looked specifically at the distribution of the disease. 
Studies that have been performed have mainly used radiographic techniques. These 
will now be briefly summarised and discussed.
4.1.2 Previous radiographic studies o f the symmetrical distribution of erosions in RA 
Halla et aVs study (1986) exemplifies a number o f problems that occurred in previous 
studies when examining the symmetrical distribution o f erosions in patients with RA. 
Other studies with similar methodological weaknesses include those of Martel et al 
(1965), Mattingley et al (1979), and Owsianik et al (1980). Halla et al (1986) 
examined radiographs for marginal erosions in 200 consecutive patients attending an
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outpatient clinic using 3 independent examiners. They found only 21% of the 
erosions in the metacarpophalangeal (MCP) and metatarsophalangeal (MTP) joints 
were classified as asymmetrical, with nearly 80% having symmetry. However, this 
study used radiographs which are a relatively insensitive means of detecting erosions. 
Several joints were grouped together rather than being analysed individually thus 
exaggerating the symmetry finding. They also failed to take into account the 
temporally dynamic nature o f RA by only analysing their cohort at one point in time 
thus potentially underestimating any symmetry.
Zangger et al (2005) identified asymmetry to occur between 9.7-14.4% of joints in 
patients with RA, slowly increasing dependent upon disease duration. They found 
that the wrist, when divided into quadrants, and the MCPs exhibited more asymmetry 
than the PIPs. Furthermore, by studying 77 erosions, they found that the overall 
probability o f small joints in the foot and hand becoming symmetrical over two years 
was 28.5% and this symmetry was predicted by rheumatoid factor. This study is 
limited not only in its imaging methodology but also by its analysis. By not 
determining the background rate of erosion development in these patients it is 
difficult to predict the significance of the number o f symmetrical erosions. For 
example, 28.5% of erosions may be very significant if the rate of joints being affected 
is small (say 5% per year), but not very significant if the rates o f new erosions are 
higher (say 20% per year).
Mottonen et al (1988) commented upon the symmetry of erosive disease by using a 
relatively more sensitive combination o f scintigraphic and radiological assessment 
and following up a group of 13 patients for the following 2 years. They noted 4 
erosions at baseline and the development of 47 new erosions in 387 joints (13.2%). 
Although noting a relative asymmetry in the distribution o f these erosions, the small 
numbers o f patients and erosions meant that there was a lack o f power to detect 
significant differences.
Boonsaner et al (1992) specifically tested the hypothesis that there is a discrepancy 
between the dominant and non-dominant sides. They studied the radiographs of 93 
patients with RA. They found significant differences between the two sides (dominant 
and non-dominant) in both joint space narrowing and erosions. However in their
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analysis they did not make joint-to joint comparisons, preferring to use a total load of 
erosions when comparing both sides. This may introduce bias into their results should 
one side develop an erosion prior to the contralateral. This could have been obviated 
if they had undertaken a longitudinal study.
Brook and Corbett (1977) examined the hands and feet of 94 patients with early RA 
radiographically and followed them up for 5 years. They found symmetrical changes 
occurring in the joints. However they did not specifically design their study for this 
analysis and their inclusion criteria could be questioned as nearly 30% of their cohort 
did not develop any erosions.
A more sensitive technique to standard radiography is that of micro focal radiography.
4.2.1 Microfocal Radiography
The advantage of microfocal radiography is that it increases the radiographic 
magnification without losing any spatial resolution thereby allowing better 
identification of the imaged structures. Magnifying standard radiographs loses 
resolution dependent primarily on the focal length of the X-ray spot source, typically 
more than 0.3mm. With very small X-ray sources however (<20pm) this loss o f 
resolution is overcome (Figure 4.1). The development of fast rare-earth screen-film 
systems in the late 1980s permitted the development of these microfocal imaging 
systems. High magnification (up to 10 times) and the retained resolution of 
microfocal radiography permit measurements of structures as small as 40\)m 
(Buckland-Wright et al, 1986; Buckland-Wright and Bradshaw, 1989). 
Macroradiographs are produced from microfocal radiography (Figure 4.2).
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Microfocal X-ray unit showing cathode, electromagnetic lens and target assembly
Figure 4.2 Microfocal radiography
Film processor Gantry Microfocal
The microfocal radiographic unit arrangement demonstrates the juxtaposition o f the 
patient gantry with the microfocal unit. Magnification o f the image occurs by 
removing the film processor from the gantry.
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4.2.2 The use of microfocal radiography to assess erosions in RA
Erosions on macroradiographs of the wrist and hand in patients with RA can be seen 
within 3 months of symptom onset (Buckland-Wright, 1984) and these measurements 
have previously been shown to be both accurate and reproducible (Buckland-Wright 
and Walker, 1987).
Buckland-Wright (1984) used this technique to assess the presence o f erosions in the 
hand and wrist joints of 26 patients with early and moderately advanced disease. He 
found that this technique was more sensitive than standard radiography and he was 
able to discern erosions that were unidentifiable on standard films. He described the 
earliest erosions occurring in the medial (radial) side o f the carpus; the 2nd and 3rd 
MCPs; and the 3rd and 4th PIPs. He noted that the erosions appeared to be 
symmetrical although this study was not primarily powered nor structured to assess 
this in more detail.
4.2.3 The use of microfocal radiography to assess the symmetry of erosions in RA 
Clarke et al (1994) assessed the distribution o f symmetry in the joints o f patients with 
early RA using microfocal radiography longitudinally at four separate time points 
over 18 months. They took 51 patients with a mean disease duration o f 36 months 
(range 3-276 months) and analysed the erosion area at 142 sites and the joint space 
width in 25 sites in the wrist and hand of each side. They analysed the erosion scores 
in three ways. Firstly, they summed the areas for each hand to give a total erosion 
area load per hand. Secondly, they summed the areas for each of the 142 sites to give 
an erosion area per site. Thirdly, they compared the size of the erosion with the 
contralateral side in individual patients using the signed rank test. They compared 
differences for the first outcome (total erosion area per hand) at all 4 time points, and 
the other two outcomes at baseline and 18 months.
They found no difference between the dominant and non-dominant hands in total 
erosion load per hand at three of the four time points. At the 12 month assessment 
visit they noted that the dominant hand had a smaller total erosion load when 
compared to the non-dominant hand.
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They found two of the 142 sites demonstrated significant differences at baseline 
between the two extremities and six o f the sites demonstrated differences at 18 
months. There was an equal split in which side the erosion area was larger. Neither of 
the sites demonstrating asymmetry at baseline did so at 18 months.
They also found that 6 patients had significant differences in the number of sites 
exhibiting larger erosions at baseline, and 5 patients exhibited significant differences 
at 18 months. Again, there was an equal split between dominant and non-dominant (5 
and 6 respectively) and none of the patients demonstrating asymmetry at baseline did 
so at 18 months.
They concluded by stating that over the 18 month study there was almost no evidence 
of the group progressing asymmetrically.
This study addressed many of the criticisms outlined towards studies in section 4.1.2, 
namely the use of a sensitive method longitudinally, but it did study a heterogeneous 
group of patients with different disease durations and treatments.
Interestingly, they chose to analyse the erosions by using a measure of area rather 
than frequency. Previous publications had shown that erosion area is more useful 
measure o f disease progression than frequency due to its increased ability to detect 
disease progression in disease longer than 48 months duration. The number o f 
erosions as an outcome measure for the assessment of symmetry is probably more 
appropriate. This is because biomechanical forces are important in the size o f an 
erosion although not in their initiation (Jayson et al, 1970). Clarke et aVs (1994) 
methodology will therefore confound a study designed to test the hypothesis of 
neurogenic symmetry or biomechanical.
It was felt that this study could therefore be repeated in a different cohort and using 
different outcome and analytical methods.
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4.3.1 A macroradio graphic study o f the distribution and progression of erosions in
the hand and wrist joints of patients with early rheumatoid arthritis 
From the evidence above, it was decided to study the presence of erosions in the 
joints o f a group of patients with very early rheumatoid arthritis longitudinally. Such 
a cohort existed in Professor Buckland-Wright’s X-ray library at the Department of 
Clinical Anatomy, School of Biomedical Sciences at the Guy’s Hospital campus in 
King’s College, London. This cohort provided the bulk of the patients for a 
randomised controlled trial into the effects o f myocrisin (Buckland-Wright et al, 
1993).
4.3.2 Cohort of RA patients
The X-rays o f hands and wrists from 42 patients with RA were identified. Their 
average age was 55.3 (range 29-79, SD 13.5) and they had had symptoms for a mean 
of 6.4 months (range 2-15, SD 3.6). 25/42 (59.5%) were women; 20/42 (47.6%) had a 
positive rheumatoid factor; and 15/42 (35.7%) smoked. The mean number o f joints 
involved at recruitment on a 28-joint count was 6.4 (range 1-18, SD 3.6), ESR 31.9 
(range 1-110, SD 28.0), and morning stiffness 528 minutes (range 0-1440, SD 652.2). 
Patients rated themselves as 23.1 on a 100-point visual analogue scale (range 0-95, 
SD 23.5) and their average uncorrected Health Assessment Questionnaire (HAQ) 
score was 16.0 (range 4-32, SD 10.9). None of the patients had commenced a Disease 
Modifying Anti-Rheumatic Drug (DMARD). 34/42 (81.0%) were taking non­
steroidal anti-inflammatory drugs. 7 patients were taking other medications. These 
included atenolol (2 patients); thyroxine (2); dyazide (2); amitriptylline (2); nifedipine 
(2); ranitidine; ferrous sulphate; dothiepin; uniphyllin; timolol eye drops; ventolin and 
becotide inhalers.
In summary, this appeared to be a slightly older group of patients than classically 
described with mild-to-moderate disease. This cohort had early disease with more 
than 90% having symptoms of less than 12 months duration.
Only patients with definite Rheumatoid Arthritis (ARA Criteria) were included into 
the trial. Patients had been excluded if they had been treated with DMARDs; they had 
severe systemic, renal, or hepatic disease; significant laboratory findings; a history of 
blood disease, exfoliative dermatitis or SLE; an allergy to gold; a history of urticaria,
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eczema or colitis. Patients had also been excluded if they were currently taking 
phenylbutazone or oxyphenbutazone; or were pregnant or nursing.
The trial necessitated obtaining macroradiographs at 6-monthly intervals for 18 
months. Of the 42 patients studied, 10 did not have X-rays at 18 months, and 
therefore their X-rays at 12 months were used instead. One other patient had films at 
24 months rather than 18. The average difference between the baseline and follow-up 
X-rays (time 1: T l) was for all 42 patients was 16.7 months.
4.3.3 Protocol o f the study
The presence of an erosion, no erosion, or other X-ray pattern was classified from 142 
sites on each hand and wrist at two time points: baseline (TO) and follow-up 
macroradiographs (Tl). Each film was read twice and only if an erosion was seen at 
both viewings was it determined to be present (see sections 4.3.4 and 4.3.5). The 
thumb was excluded from the macroradiographs.
For an erosion to be included for the purposes o f the study, all three of the following 
features must exist. There must be a clear disruption of the cortical line and there 
must be loss o f trabeculation in the underlying bone, and both of these changes must 
be seen on both reviews of the microradiograph.
A database in Microsoft Excel was compiled for analysis. Expected numbers of 
symmetrical erosions were determined depending on the prevalence of erosions and 
compared with observed values with the Z-test, a generalised version of the Chi- 
squared test. Progression of the erosions was then assessed.
In brief, normal bone, erosions and abnormalities that were not erosions were coded 
0, 2 and 3 respectively. Because each macroradiograph was assessed twice the 
possible scores were 0, 2, 3, 4, 5 and 6. Only a score of 4 represents an erosion to be 
included in the count. Using combinations of Excel functions, data could be extracted 
to provide details on the symmetry of erosions and their progression.
Baseline values (TO) reflected an average o f 6 months from the start of the patient’s 
symptoms and the follow-up film to assess progression (T l) was taken 17 months
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later. Two different levels o f analysis were performed on the database: ‘point-to- 
point’ (142 points per side) and ‘joint-to-joint’ (22 joints per side). The wrist was 
divided on anatomical grounds into 10 separate regions (see Figure 4.3), and there 
were 4 MCPs, 4 PIPs and 4 DIPs on each side making a total o f 22 joints.
Figure 4.3 Division of the wrist joint into 10 regions
The regions were formed on anatomical grounds for the analysis o f  the wrist:
1 Stylo id-pisiform-triquetrum 1, 14, 15, 16, 17
2 Radio-ulnar-lunate 2, 3, 5, 11, 12, 13
3 Radio-scaphoid flexor 7 ,9
4 Radio-scaphoid-trapezium 4, 6, 8, 26
5 Scaphoid-capitate-trapezoid 10, 22, 24
6 Carpo-metacarpal (CMC) 1 25, 27, 28, 29, 30
7 CMC 2 3 1 ,3 2 ,3 3 ,3 4
8 CMC 3 2 3 ,3 5 ,3 6 ,3 7 ,3 8
9 CMC 4 1 9 ,2 0 ,2 1 ,3 9 ,4 0 ,4 1 ,4 2
10 CMC 5 1 8 ,4 3 ,4 4 ,4 5 ,4 6
75
4.4.1 Measuring the reproducibility o f micro focal radiography 
Reproducibility o f the scoring is paramount to the use of microfocal radiographic 
techniques being useful in the study o f erosions in RA. Both interobserver and 
intraobserver scores were therefore obtained in a blinded fashion. Blinding was 
achieved by covering any identifying features on the macroradiographs. For the 
purposes of intraobserver readings, these were obtained more than 3 months apart. 
Both observers were blinded to the original results.
The unweighted kappa score is an appropriate test to use to assess the consistency 
between two observers of radiographic readings organised into categorical data (i.e. 
coded values of 0, 1,2 etc...) (Landis and Koch, 1977; Ruckman et al, 1995; Zangger 
et al, 2004).
4.4.2 Intraobserver kappa value
For intraobserver values, 1111 separate points were analysed on 10 different 
macroradiographs. The overall erosion prevalence for this cohort was 7.8%, 
representative of that in the overall sample (6.8 -  13% dependent upon whether the 
sample was from TO or Tl). The interobserver kappa value was 0.71 (0.62-0.80 95% 
confidence intervals) (GraphPad). This is a substantial agreement according to Landis 
and Koch’s (1977) scale.
Table 4.1 2x2 table for intraobserver reliability score (n = l l l l )
Reading 2
Reading 1
No erosion Erosion Total
No erosion 1019 13 1032
Erosion 26 53 79
Total 1045 66 1111
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Table 4.2 Kappa values and their strengths of agreement (Landis and
Koch. 1977)
Kappa value Strength of agreement.
<0 Poor
Slight0 - 0.2
0.21 - 0.4 Fair





From this kappa value, the minimum detectable difference can be calculated (Lassere 
et al, 1999). This was found to be 30 erosions to an alpha o f 0.05. This means that 
any difference between groups that was more than 30 erosions was unlikely to be due 
to the observer error.
4.4.3 Interobserver kappa value
The interobserver scoring was performed by Ms. Elizabeth Messent, a doctoral 
student working with Professor Buckland-Wright and experienced in evaluating 
macroradiographs. A random selection of 20 different points was used on 5 separate 
macroradiographs producing a series o f 100 points for analysis. The criteria for 
erosion identification were identical and training had occurred prior to the scoring 
cohort. The erosion prevalence for this cohort was 5%, slightly lower than in the 
intraobserver sample. The kappa value for her interobserver score was found to be 
0.59 (0.28-0.91 95% confidence intervals). This agreement is moderate on the Landis 
and Koch scale (1977).
4.5.1 Results: Distribution of the erosions
There were equal numbers of erosions on both left and right sides at both time points. 
Table 4.3 details the frequency of the points where the erosions were most prevalent. 
Table 4.4 details the joints where these were seen the most. This is represented 
pictorially at and between the different time points in Figures 4.4-6.
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Table 4.3 Distribution of the 12 most frequently eroded points
Rank ND side Dom * New ND side at New Dom TOTAL
At TO (n) at TO (n) T l (n) at Tl (n) (n)
1 8 24) 8 (26) 44 (28) 8 (36) 8 (112)
2 44 20) 4 (19) 1 (26) 11 (21) 44 (85)
3 6 20) 44 (17) 8 (24) 44 (20) 4 (75)
4 18 18) 6 (15) 18 (23) 1 (20) 6 (74)
5 4 18) 1 (14) 19 (20) 7 (19) 1 (72)
6 7 18) 18 (13) 6 (20) 6 (19) 18 (71)
7 26 16) 51 (11)* 4 (20) 26 (18) 7 (64)
8 1 14) 39 (11) 11 (19) 19 (18) 26 (60)
9 17 13) 19 (11) 39 (18) 4 (18) 19 (60)
10 52 11)* 11 (10) 26 (18) 18 (17) 11 (59)
11 19 11) 26 (9) 7 (18) 27 (16) 39 (52)
12 39 10) 7 (9) 21 (17) 14 and 21 21 (48)
(14)
The figures represent the region (142 in total) with the frequency o f the erosions in 
brackets. All o f these points are in the wrist apart from points 51 and 52, marked *. 
These are respectively on the medial and lateral 2nd metacarpal head, closest to the 
joint space. Please see Figure 4.3 to identify the wrist regions.
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Table 4.4 Distribution of the most frequently eroded joints (not including wrist)
Rank ND side Dom New ND side New Dom TOTAL
at TO (n) at TO (n) at T l (n) At Tl (n) (n)
1 DIP 3 (6) MCP 2 (11) PIP 4 (9) DIP 4 (7) MCP 2 (24)
2 MCP 3 (5) PIP 2 (4) MCP 2 (7) PIP 5 (6) PIP 2 (18)
3 MCP 4 (5) MCP 3 (3) MCP 4 (6) DIP 5 (5) PIP 4 (18)
4 MCP 5 (5) DIP 2 (3) PIP 2 (6) MCP 3 (4) MCP 3 (17)
5 PIP 2 (5) MCP 4 (2) DIP 4 (6) DIP 2 (4) PIP 5 (17)
6 PIP 3 (5) DIP 3 (2) DIP 5 (6) PIP 4 (4) DIP 2 (16)
7 PIP 5 (5) PIP 3 (2) MCP 3 (5) PIP 2 (3) DIP 4 (16)
8 MCP 2 (4) PIP 4 (2) PIP 3 (5) MCP 2 (2) MCP 4 (15)
9 DIP 2 (4) MCP 5 (1) PIP 5 (5) MCP 4 (2) PIP 3 (14)
10 PIP 4 (3) PIP 5 (1) DIP 2 (5) MCP 5 (2) DIP 5 (12)
11 DIP 4 (3) DIP 4 (0) MCP 5 (3) PIP 3 (2) MCP 5 (11)
12 DIP 5 (1) DIP 5 (0) DIP 3 (0) DIP 3 (2) DIP 3 (10)
It can be seen that the majority of erosions occur in the wrist, then in the MCPs, PIPs 
and DIPs respectively. In the digits, the concentration of erosions is focussed on the 
second MCP and then radially fans out both across the row of MCPs and the distally 
along the columns.
The points that have the most numbers o f erosions are the scaphoid, trapezium, hook 
of hamate and lunate; the distal end of the radius; the ulnar styloid; and the bases of 
the 4th and 5th metacarpals. All o f these concur with previous publications on the 
distribution of erosions early in course of RA both using microfocal radiography 
(Buckland-Wright and Walker, 1987; Clarke et al, 1994) which are mentioned above 
and standard radiographic techniques (Leak et al, 2003). Leak et al (2003) found that 
the radioulnar, radiolunate, scaphoid, styloid process and the heads o f the 2nd and 3rd 
MCPs were all affected early and relatively more in frequency than other joints. 
Interestingly, they found that the fourth finger was relatively spared irrespective of 
dominance - not a finding repeated here.
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Figure 4.4 Colour-coded distribution of the points affected by erosions in the
digits and wrists at baseline (TO)
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Figure 4.5 Colour-coded distribution of the points affected by new erosions in
the digits and wrists at between the time points (Tl - TO)
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Figure 4.6 Colour-coded distribution of the points affected by erosions in the









4.5.2 Distribution of erosions at TO
There were no differences between the numbers of erosions on the dominant (369 
(6.61%)) and non-dominant (384 (6.79%)) sides. This was less than the smallest 
detectable change (30 erosions).
With respect to the digits, the frequency o f erosions per row in decreasing order was 
MCPs followed by PIPs and then DIPs. The frequency o f erosions per digit in 
decreasing order was 2nd, 3rd, 4th and then 5th. The highest frequency of erosions 
occurred in the 2nd MCP and the distribution fanned out in a radial form in decreasingthorder so that the joint with the fewest number of erosions was the 5 DIP.
The erosions have a predilection for the joint surfaces rather than the capsular 
insertion. This was highly significant when tested with a Chi-squared test (p<0.001). 
The erosions predominate on the radial side of the 2nd and 3rd MCP where they occur 
around the capsular insertion. This however was not significant when tested. There 
was a suggestion that the erosions in the DIPs occurred on the distal portion of the 
joint surface; the erosions o f the PIPs were equally distributed; and the erosions in the 
MCPs occurred on the proximal side of the joint surface.
With respect to the wrist, there was a greater prevalence of erosions in these bones 
than in the digits. The erosions occurred in regions with large supporting ligaments 
attached. They occurred in high numbers on both the radial side o f the carpus
th th(trapezium; scaphoid and radial head) and the ulnar side (base o f 4 and 5 
metacarpals; hook of hamate; and ulnar styloid). These findings were very similar to 
those of Buckland-Wright’s (1984) who noted that the erosions in RA occurred 
around the ligamentous insertions.
4.5.3 Distribution o f new erosions in the intervening 17 months (T1-T0!
There were again equal numbers o f new erosions occurring on the dominant (355 
(6.29%)) and the non-dominant sides (335 (5.93%)). This was again less than the 
smallest detectable change.
In the digits, the distribution was identical to that seen at baseline, namely centred 
around the 2nd MCP and fanning out. There was a slight preponderance of erosions
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towards the dominant side at this point, although this was non-significant on a Chi- 
squared test.
In the wrist the distribution was again reflected from the baseline image with both the 
radial and ulnar sides equally affected and the erosions predominated in those areas 
with ligamentous insertions. There was a preponderance of erosions towards the non­
dominant side, again non-significant. Overall there was no difference in the number 
o f new erosions in the hands and wrists between the sides.
4.5.4 Distribution of erosions at Tl
The total number of erosions on the dominant side was 607 (10.7%). The total 
number of erosions on the non-dominant side was 592 (10.5%). This was again less 
than the smallest detectable difference. It should be noted that the total seen at Tl did 
not represent the sum of erosions seen at TO and new erosions. This was because 
there was some healing o f erosions seen in this cohort (Buckland-Wright et al, 1993) 
and there was a degree error in the observation process.
The picture seen at TO was accentuated with replicable findings. At Tl however the 
Chi-squared test reached significance for both the radial distribution of erosions in the 
capsular regions of the 2nd and 3rd MCPs (p<0.05) as well as the proximal prevalence 
o f erosions in the DIPs (p<0.05).
4.5.5 Summary of the erosion distribution
The distribution of erosions found in this study was in agreement with other 
descriptions of the erosion development in patients with early rheumatoid arthritis, 
namely that both radial and ulnar sides of the wrist were involved and that the MCPs 
and the radial columns were more affected than the DIPs and ulnar columns in the 
digits.
Certain points within these areas, mainly in the wrists, were much more likely to 
develop an erosion than any other. Understanding why certain areas were predisposed 
to developing erosions may help in understanding the pathophysiology o f rheumatoid 
arthritis (see section 4.8.1).
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At neither time point was there a difference in the total number o f erosions between 
the non-dominant and dominant sides. This was also true in the distribution o f new 
erosions between the two time points.
4.6.1 Results of the symmetry analysis
Two different levels of analysis were performed on the database: ‘point-to-point’ 
(142 points per side) and ‘joint-to-joint’ (22 joints per side). Baseline values (TO) 
reflected an average of 6 months from the start of the patient’s symptoms and the 
follow-up film to assess progression (Tl) was taken 17 months later.
4.6.2 Point-to-point analysis
There were a maximum of 5964 available points on Non-Dominant (ND) side and 
5964 available points on Dominant (D) side. The number o f excluded points for each 
side at each time point were 305 (ND, TO), 380 (D, TO), 288 (ND, Tl), and 282 (D, 
Tl). Points were excluded if they could not be assessed because of either overlapping 
bone or had not been imaged.
Table 4.5 The total number of points available for analysis
MAX ND TO D TO ND Tl D T I
5964 5659 5584 5674 5682
DIPs 1344 1312 1289 1316 1306
PIPs 1344 1288 1281 1301 1303
MCPs 1344 1298 1287 1312 1317
Wrist 1932 1761 1727 1745 1756
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4.6.3 Point-to-point symmetry at baseline (TO)
I f  one point has an erosion at TO, what were the odds o f  an erosion occurring in 
exactly the same point on the other side compared to any other contralateral point?
At baseline there were 384 / 5659 erosions on the ND side (6.79%)
And 369 / 5584 erosions on the D side (6.61%)
O f which 150 were bilateral
Odds ratio = 6.1 ** (95%CI: 5.1 -  7.1)
Therefore the number of symmetrical erosions was 6 times greater than by chance. 
Table 4.7 Regional subgroup analysis for point-to-point analysis at TO



















The symmetry o f the erosions was therefore not a mathematical quirk and was present 
at baseline. It appeared to be more accentuated distally, although the PIP and DIP 
odds ratios did not reach significance. Therefore, as the prevalence of erosions 
diminished, the chance of symmetry increased.
4.6.4 Potential confounding variables in the point-to-point analysis 
The above calculations were based on the assumptions that the erosions were 
distributed equally between the 142 points on each side and that each individual was 
equally likely to develop an erosion. As described above, the erosions have a 
predilection for particular points, especially around the wrist. This predilection 
distorts the assumption that erosions were randomly scattered. Furthermore, different 
individuals have different numbers of erosions. Correction factors for both of these 
assumptions are now detailed. After using these correction factors, it can still be seen 
that the observed symmetry was significantly higher than expected.
Firstly, the symmetry for each o f the 142 points was calculated separately, based on 
the number of erosions that were present at that point. The expected numbers of 
symmetrical erosions were then summed for each point. When this was done, the 
corrected number of expected bilaterally symmetrical erosions rose from 25 to 70.1, 
and the new odds ratio reduced to 2.1 (1.7-2.5 95% Cl). This was still highly 
significant on the Z test (p<0.01).
Secondly, the expected number o f symmetrical points per individual patient was 
calculated in a similar fashion and summed. When this was done, the expected 
number o f total erosions rose from 70.1 to 109.8. This individual influence on the 
expected erosions was less important than the anatomical preference o f the erosions 
(1.6 versus 2.8 times the expected rate respectively).
This revised expected number of 109.8 erosions was still significantly short of the 
150 observed with an odds ratio of 1.4 (1.1 -  1.6 95% Cl). Although it can be seen 
that most of the observed symmetry was accounted for by the anatomical 
predisposition and the differential expression o f erosions between individuals, there 
was still a significant influence on the expression of symmetry that was unaccounted
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for. This is discussed further in section 4.7.1 when a symmetry score is calculated for 
each individual patient and compared to the total number of erosions (Figure 4.7).
These findings were reproduced at the Tl time interval and the details have not been 
listed here.
4.6.5 Point-to-point symmetry over the intervening 17 months (Tl-TO)
I f  one point has an erosion unilaterally at TO what were the odds o f  an erosion 
occurring in exactly the same point on the other side 17 months later compared to 
any other contralateral point?
145 erosions that were previously unilateral at TO became bilateral at T l. Of these 
145, 57 erosions developed on the ND side following a unilateral erosion on the D 
side at TO; whereas 88 erosions developed on the D side following a unilateral 
erosion on the ND side at TO. Furthermore, 85 de novo erosions occurred bilaterally. 
Overall at T l, there were 335 erosions new to the ND side and 355 erosions new to 
the D side
New symmetrical erosions occurred at 142 / 335 on ND side (42.4%)
And 173 / 355 on D side (48.7%)
The number o f available points for an erosion occurring on ND side to be opposite an 
erosion on the D side was 219 / 5292 = 4.14%
OR =10.2** (8.6-11.9)
Therefore a non-eroded point on the ND side was 10 times more likely to develop an 
erosion at Tl if it was opposite an erosion at TO than if it was not opposite an erosion.
The number of available points for an erosion occurring on the D side to be opposite 
an erosion on the ND side was 234 / 5313 = 4.40%
OR = 11.1** (9.41-12.72)
Therefore a non-eroded point on the D side was 11 times more likely to develop an 
erosion at T l if it was opposite an erosion at TO than if it was not opposite an erosion.
88
Table 4.8 Regional subgroup analysis expressed as odds ratios for the point-to-

















There was more symmetry expressed distally than proximally. As the frequency of 
the erosions decreased they were more likely to display symmetry.
4.6.6 Joint-to-ioint analysis
There were 924 joints available for analysis on both sides. No joints were excluded 
from this analysis, although several joints did not have all o f their points included.
4.6.7 Joint-to-ioint symmetry at baseline
I f  one joint has an erosion what was the likelihood o f another erosion occurring in 
exactly the same joint on the other side at baseline (TO)?
924 joints
At baseline (TO) there were 219 / 924 erosions on the ND side (23.7%)
And 219 / 924 erosions on the D side (23.7%)
Of which 124 bilateral
Odds ratio = 2.4 ** (95% Cl: 2.0-2.8)
Therefore the number of symmetrically eroded joints was 2.4 times greater than by 
chance.
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Table 4.9 Regional subgroup analysis for ioint-to-ioint analysis at TO
ND side (%) D side (%) Bilateral OR (95% Cl)
Wrist 147/420 (35) 167/420 (39.8) 103 1.8 (1.5-2.1)**
MCP 33/168(19.6) 31/168(18.5) 14 2.3(1.1-3.5)*
PIP 21/168(12.5) 12/168 (7.1) 3 2.0 (-0.3-9.4)
DIP 18/168(10.7) 9/168 (5.4) 4 4.2 (0.0-8.3)
* p <0.05
** p<0.01
There was more symmetry expressed distally than proximally. As the frequency of 
the erosions in the joints decreased they were more likely to display symmetry.
4.6.8 Progression of erosions in joints over 17 months
I f  a joint has an erosion unilaterally at TO what were the odds o f  an erosion 
occurring in exactly the same joint on the other side 17 months later compared to any 
other contralateral joint?
64 erosions that were unilateral at TO became bilateral at T l. Of these 64, 29 erosions 
developed on the ND side when there was a unilateral erosion on the D side at TO; 
whereas 35 erosions developed on the D side when there was a unilateral erosion on 
the ND side at TO. Furthermore, 48 de novo erosions occurred bilaterally.
Overall at T l, there were
136 new erosions on the ND side 
145 new erosions on the D side
New symmetrical erosions occurred at 77 / 136 erosions on the ND side (56.6%) 
And 83 / 145 erosions on the D side (57.2%)
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The number o f available points for an erosion occurring on the ND side to be 
opposite an erosion on the D side was 95/705 = 13.48%
OR = 4.22 ** (3.30-5.10)
Therefore a non-eroded joint on the ND side was 4 times more likely to develop an 
erosion at Tl if it was opposite an erosion at TO than if it was not opposite an erosion.
The number of available points where an erosion occurring on the ND side was 
opposite an erosion on the D side was 95/705 = 13.48%
OR = 4.25 ** (3.15-5.34)
Therefore a non-eroded point on the D side was 4 times more likely to develop an 
erosion at Tl if it was opposite an erosion at TO than if it was not opposite an erosion.
** p<0.01
Table 4.10 Regional subgroup analysis expressed as odds ratios for the ioint-to- 
ioint analysis for expression of symmetry in the intervening 17 months between
TO and T l
ND side (OR, Cl) D side (OR, Cl)
Wrist 5.6 (4.2-6.9)** 3.5 (2.5-4.4)**
MCP 5.1 (2.5-7.6)** 3.8 (1.8-5.8)**
PIP 3.9 (1.0-6.7)* 7.8(2.5-13.2)**
DIP 3.3 (0.0-6.6) 12.8(1.5-24.1)*
*p<0.05
**p<0.01
The TO baseline data can be considered to represent the erosive process over the 
previous 6 months. The Tl data has been corrected by subtracting the TO data so that 
it can be considered to represent the erosive process over the following 17 months. 
The Tl data has also been analysed to represent the total erosive process over the 
previous 23 months.
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From the TO data, it can be seen that symmetry exists early in the course of the 
disease. This symmetry appears to be accentuated distally even though the frequency 
of the erosions in these regions decreased. However the odds ratios were not 
significant at this time point. The symmetry was more accentuated at a point-to-point 
level when compared to the joint-to-joint analysis.
Over the next 17 months, the symmetry was seen to accentuate, again more at the 
point-to-point level. Perhaps this accentuation does not represent a different rate of 
symmetry development secondary to an increase in the number of erosions, but was 
merely reflective of the longer time interval (17 months) of this analysis compared to 
that o f TO (6 months). Again, the erosive frequency diminished distally and the 
symmetry was more pronounced distally. This time, this reaches clear significance.
4.7.1 Univariate analysis on a symmetry score
A ‘symmetry score’ was given for each patient. This was calculated by expressing the 
ratio of the number o f observed symmetrical joints to the number o f expected. 
Symmetry scores ranged from 0 -  57.6 (median 7.5, SD 10.3).
Patient factors (age, sex, handedness, medications, NSAID use, smoking status, 
alcohol intake) as well as disease status (symptom duration, rheumatoid factor, hours 
of stiffness, number o f joints affected, ESR and Health Assessment Questionnaire 
(HAQ)) had been recorded at baseline for the purposes of the study. These were 
coded and then modelled against the dependent variable (symmetry score) using a 
univariate analysis (SPSS 12.0). Secondary analyses tested for correlations between 
these variables and the student’s t-test was used where appropriate to compare means. 
The level of significance for this secondary analysis was set as p<0.01 because 
multiple tests were performed.
The symmetry score was seen to correlate negatively with the total number of 
erosions in an exponential pattern. Figure 4.7 illustrates this using the log o f the 
symmetry score. This result is counterintuitive. It might be expected that the degree 
of symmetry should rise as the number o f erosions increases as there are fewer 
available sites for non-symmetrical erosions. However it can be seen that an 
individual who develops a single erosion was more likely to develop a second erosion
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in the exact contralateral point than any other area, even the predisposed areas. This 
suggests that a symmetrical erosion was more likely to develop very early on in the 
disease process than later.






This demonstrates that the fewer the number o f  erosions that a patient has the more 
likely it was that these were to be symmetrical. (p=0.018)
To investigate this finding further the distribution o f  the erosions in those patients 
with 10 or fewer total erosions (n=17) was analysed. 8 patients in this group had no 
symmetrical erosions (total o f  33 erosions) leaving 9 patients with a total o f  13 
symmetrical erosions from a total o f  66 erosions. The following areas were affected 
with the associated frequencies in brackets: 6 (3); 44 (3); 8(2); 4, 11, 18, 22 and 26. 
All o f  these areas were in the wrist and at high risk o f developing an erosion (Table 
4.3). Looking at the anatomical distribution o f these areas, they appear to be 
predominantly on the radial side o f the wrist (4, 6, 8, 11 and 26) with 44 occurring on 
the ulnar side and 22 in the middle. It appears that another process occurred when the 
patient has few erosions to induce a symmetrical pattern.
♦ ♦
♦
10 20 30 40 50 60
Erosion number
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The symmetry score did not correlate with any o f the other patient nor disease factors. 
The numbers of joints affected predicted the HAQ score in a positive relationship 
(p<0.001), but no other relationships were significant. The lack of positive findings in 
relation to previously well described factors (e.g. rheumatoid factor and number o f 
erosions) could have been due to the relatively small numbers (n=42) of patients that 
were analysed in this way.
4.8.1 Discussion of the study methods
This was a single observer retrospective study of 42 patients with the onset of 
rheumatoid arthritis within the past 6 months at two cross sectional times 17 months 
apart using the sensitive technique o f microfocal radiography to identify erosions. 
The technique was validated using a blinded observer with moderate to good 
interobserver values.
The threshold for erosion detection was set high. Positive identification of an erosion 
in two viewings was required. For example, ‘en face’ erosions were obviously 
detectable but difficult to fulfil the above criteria due to any obvious lack of cortical 
disruption. This reduced sensitivity may have missed erosions and makes it more 
likely that any expressed symmetry was a reflection of those areas which were most 
likely to yield a positive erosion reading.
This study could now be repeated prospectively using a larger cohort and perhaps a 
different technique such as MRI to reduce any systematic mistakes from the detection 
strategy. Pierre-Jerome et al (1997) studied the wrists of 31 females with rheumatoid 
arthritis using MRI fast field echo sequences. They found that the symmetry of the 
carpal bone lesions also dissipated over time with patients who had symmetrical 
lesions having had RA for significantly less time than those patients with 
asymmetrical lesions (12 versus 6 years). The erosions predominated over the radial 
force-bearing column of the wrist and they also noted that more lesions occurred on 
the right. This group of patients however had had the disease for a significant time 
and very few patients had early disease. Furthermore the symmetrical analysis was 
cross sectional and did not take into account the evolution of erosions over time.
94
4.8.2 Discussion of the symmetry analysis
In section 4.6.3 it was seen that the symmetry at baseline was pronounced with an 
odds ratio of more than 6 (p<0.01).
It was then seen (section 4.6.4) that this was mainly accounted for by the predilection 
for erosions to occur in particular places. This distribution restriction could be seen to 
account for the higher than expected numbers of symmetrical erosions but only 
explained about half of the increased odds ratio.
The individual’s number o f erosions was another confounder, but this again only 
explained about half of the remaining increased symmetry. There was still a 
significant level of symmetry (p<0.01) seen in the distribution of the erosions that 
was unaccounted.
Finally (section 4.7.1), this remaining symmetry was seen to be accounted for by an 
interesting finding. The fewer the number of erosions that an individual had, the more 
likely those erosions were to be symmetrical. This influence was small because the 
total number of erosions that patients with a few erosions contribute towards the total 
number of erosions in the population was small. This effect was significant however 
and needs to be explained.
The implication is that in the early stages of the disease, the erosions’ distribution is 
more likely to be symmetrical than later on in the disease. This however is 
counterintuitive to the finding that the erosions become more symmetrical as time 
progresses. This contraindication can be understood by identifying two processes as 
being important at different stages of the development of erosions. One process 
produces symmetry in the erosions (S) whereas the other produces damage in the 
predisposed areas (P). The ‘symmetricising’ process (S) is focal, transient and 
dominant in the early part of the disease although only affects a small number of 
areas. The damage caused in the predisposed areas by a more general slower process 
takes time to accumulate but tends to increase symmetry because of the restriction of 
the number of available predisposed points. It is possible that process S is an artefact 
of the analysing system but this is unlikely given that it is not one or two patients that
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skew the results, but a general trend in the data. Identifying the different processes 
may enlighten the pathophysiology o f rheumatoid arthritis.
The places where these erosions occurred were in exactly the same places as the 
commonest areas affected. By understanding why these areas were affected, and not 
others, an important insight into the mechanism may be realised.
4.8.3 Neurogenic hypothesis
A neurogenic hypothesis should have several predictions concerning the distribution 
of these erosions. Erosions should be seen to occur in areas with a high prevalence o f 
nerves and likewise erosions should not occur in areas of low neuropeptide 
concentration. Neuropeptide containing nerves within joints were mainly 
concentrated in perivascular locations or as free nerve endings (section 3.2.1). The 
blood supply from the joint is derived mainly from a rich network of pericapsular 
arterioles feeding into finer capillary networks. The anatomical subdivision o f the 
hand and wrist templates did not take these into account and little insight can be 
gained from this.
However, another area of high neuropeptide concentration occurs in the ligamentous 
insertions into the bone, otherwise known as the enthesis (Benjamin and McGonagle, 
2001). It can be seen that the areas of highest concentrations of erosions were around 
the entheses of the wrists. It is attractive to consider that the neurogenic mechanism 
may be mediating the high expression o f symmetry seen in these areas. Perhaps the 
neurogenic mechanism represents process S described above?
The erosions occurred on the bare areas immediately adjacent to the perimeter o f the 
cartilage (see Image 4.1, Figures 4.4-6). In the knee, this area too has a rich blood 
supply with associated neuropeptide containing nerves (Mine et al, 2000), although 
this has not been studied in the finger joints.
The distribution of the erosions seen in this study supports a neurogenic hypothesis 
and suggests that further investigation into contralateral changes following unilateral 
inflammatory stimulus is warranted.
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Image 4.1 The erosions occurred in the bare areas adjacent to the cartilaginous 
perimeter. Evidence from a DIP joint
4.8.4 Anatomical and biomechanical hypotheses
The biomechanical forces applied through the whole hand are very complicated and 
vary depending on the hand’s position and the force applied to the extent that whole 
hand models have not yet been developed. However, individual joint kinetics and 
relative ligament influence on force dissipation and joint stabilisation is well 
developed and instructive for the hand surgeon’s clinical management and 
pathological understanding.
Biomechanical forces have been best studied in osteoarthritis. The distribution o f 
osteoarthritis with its bias for the PIPs, DIPs and carpotrapezium joint (1st 
carpometacarpal) with a sparing o f  the MCPs is very different to that o f  rheumatoid 
arthritis. This in itself might suggest that the role o f biomechanical forces in the 
development o f the pattern o f  erosions in rheumatoid arthritis is small.
There is evidence from both the literature and this study to suggest that load bearing 
is important. In the rheumatoid patient this load bearing wrist shifts more to the ulnar 
side whereas normal load bearing occurs through the radial columns in the wrist 
(Manal et al, 2002). There is support for this switch from radial to ulnar sides from 
this study by looking at the relative number o f new erosions between TO and T l when 
compared to baseline. It can be seen that the new erosions occurred preferentially on
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the ulnar side whereas the development of new erosions on the radial side is greatly 
decreased when compared to baseline distributions. The fan distribution of the 
erosions could fit with force vectors applied to the hand being channelled through the 
radial side. The development of proportionally more erosions in the ulnar MCPs over 
the following 17 months when compared to the first 6 months might also reflect this 
change in biomechanical loading emphasis. Perhaps the biomechanical hypothesis 
may contribute to process P described above?
The full expression of the pattern described (distal PIP and proximal MCP 
involvement) is not explained however, and the experience from OA would suggest 
that the hand is particular well designed to avoid undue load being expressed at the 
MCP.
The anatomical part of this hypothesis suggests that there are intrinsic anatomical 
abnormalities that predispose areas to an erosions. This might include a ‘bear’ area 
denuded from cartilage that exposes underlying bone to an erosion. Or it might 
include an area o f very thin cortex, such as those that might occur next to entheses. 
There are, however, many entheses in the carpus, only some of which have been 
highlighted in the above schema.
4.9.1 Conclusion
It can be seen that the distribution of erosions in patients with early RA is 
symmetrical. It can also be seen that the odds ratio for this symmetry increases over 
time. Most of this symmetry is accounted for by two mathematical confounders: the 
number of erosions affecting a predisposed site, and the number o f erosions an 
individual develops. However the remaining amount of symmetry appears to be 
related to a process that occurs when a patient has very few erosions. It is unclear 
whether this process is an accentuated predisposition of particular sites to anatomical 
and biomechanical factors, or a separate process that could be neurogenic in nature.
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Chapter 5. Establishing the experimental model to investigate skin 
blood flow responses to an active immunisation
Summary
An experiment to investigate putative contralateral responses should have an 
appropriate stimulus; a sufficiently sensitive detection strategy and be adequately 
controlled. This chapter outlines the approach used to satisfy these conditions. Pilot 
studies are then summarised to demonstrate the reliability o f the techniques selected 
and the development of the experimental protocol.
5.1.1 Stimulus properties
The stimulus should be local and not induce significant systemic changes that might 
confound any results. Adequate controls are therefore paramount. The stimulus 
should generate a significant response to maximise any contralateral changes. From 
the review of the literature, the stimulus should be either sustained over time or of 
sufficient magnitude in order to overcome the threshold effect and generate a 
contralateral response (Shenker et al, 2003; see Chapter 2). The stimulus should 
also be acceptable to sufficient numbers of subjects to allow the adequate powering 
of the experiment.
5.1.2 The stimulus: An active immunisation
An active immunisation was selected to be the stimulus o f choice for the following 
reasons.
Symmetrical diseases tend to be o f the Immune-Mediated Inflammatory Disease 
(IMID) classification. An active immunisation has persistent local inflammatory 
reactions (see below) as well as obvious immune stimulating actions. The 
combination o f these is attractive when looking for a stimulus as the temporal 
persistence may overcome any threshold effect. Active immunisations are both 
common and well-tolerated in all populations and this is liable to improve 
recruitment.
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Active immunisations that were considered for the purposes of the investigation 
were mumps-measles-rubella (MMR), influenza (inactivated virus), typhoid (Vi 
capsular polysaccharide) and hepatitis B (hepatitis B surface antigen). These 
immunisations were selected on the basis of their common use.
For a list of other possible local stimuli that have been used in publications 
involving human volunteers and reasons why these were not considered, please see 
Table 5.1.












Reason fo r  exclusion
Inflammatory-only response 
Mild and transient stimulus
Mild and transient stimulus
Mild and transient stimulus
Mild and transient stimulus 
Poor anticipated recruitment
Reference
Day et al, 2001 
Mohammadian et al, 
1998
Skaare etal, 1997
Turner et al, 2000
Borum etal, 1998 





Specialised equipment required 
Poor anticipated recruitment 
Difficult to standardise 
Poor anticipated recruitment
Pedersen et aL 2000
Pitzalis et al, 1996
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5.1.3 Literature review of local and systemic responses following an MMR.
influenza, typhoid or hepatitis B immunisation
For the purposes of the experimental model, it is desirable for the active 
immunisation to have a persisting local inflammatory response with a minimal 
systemic response. Prominent systemic (circulatory) effects would confound any 
topographically-precise contralateral response (neurological). A brief literature 
review was therefore conducted.
To summarise the results, self-reported local reactions are prevalent in a significant 
proportion o f patients (20-30%) who had been given one of these active 
immunisations. In a minority of subjects (1-10%) there is some systemic activation, 
although this is seen to subside using laboratory measures within 24 hours in the 
majority o f cases.
Controlling for this confounding systemic response is important and can be 
achieved by taking a control region that is not topographically related to the 
immunisation and to perform the experiment at least 24 hours following the 
immunisation.
Influenza
Wongsurakiat et al (2004) studied local and systemic effects of a split-virion 
attenuated influenza immunisation in 62 patients with chronic obstructive airways 
diseases compared with a placebo injection (63 patients). Local reactions occurred 
more in the influenza group (27% versus 6%) but there were no differences in 
systemic reactions (76% versus 81%) suggesting no significant systemic effects 
were occurring. A similar study was performed in Liverpool in healthy subjects 
aged between 65-74 years old by Allsup et al (2001). They also found an increased 
reporting of local symptoms when compared with placebo injection (11% vs. 5%) 
with no evidence o f a systemic effect (35% vs. 42%). Less than 1% of 2150 Italian 
subjects immunised with either an inactivated influenza virus or subunit vaccine 




Using lab measures, typhoid (Vi capsular polysaccharide) immunisation induced a 
rise at 8 hours in the serum levels of tumour necrosis factor-a, interleukin-6 and 
interleukin-1 receptor antagonist. There was also a reduction in the endothelial 
responses to bradykinin with no effect on the response to glyceryl trinitrate and 
norepinephrine. Endothelial reactivity to sublingual nitroglycerin or 5-minutes of 
occlusion as measured by plethysmography and conduit vessel response using high- 
resolution ultrasound was altered 8 hours post-immunisation. This dysfunction had 
normalised by 32 hours post-immunisation (Hingorani et al, 2000; Kharbanda et al, 
2002; Clapp et al, 2004). Sabitha et al (2004) obtained questionnaires from 153 
healthy subjects aged between 12-25 years old who had been given typhoid Vi 
capsular polysaccharide immunisation. 29 (19%) reported local skin reactions of 
pain, redness or swelling and 5 (3%) reported symptoms o f fever, headache or 
chills. Panchanathan (2001) obtained questionnaires from 125 Malaysian Air Force 
recruits who had also been immunised with a typhoid Vi polysaccharide. 28% 
reported local symptoms such as pain, erythema and induration and 1% self- 
reported systemic symptoms
Hepatitis B
Clarke et al (1989) studied 92 medical students following repeated intradermal 
Heptavax B (plasma-isolated hepatitis B surface antigen). They documented that 
more than 85% of subjects reported symptoms o f pain, erythema or induration at 6 
months following 3 immunisations. No systemic symptoms were reported. They 
also took skin biopsies from the injection site two months after immunisation. These 
skin biopsies (n=7) demonstrated a superficial and deep perivascular lympho- 
plasma-histiocytic inflitrations with a preponderance of T-cells over B-cells.
MMR
Gotherfors et al (2001) reported an incidence of between 20-30% of local skin 
reactions following a second MMR injection given to a population of healthy 12 
year olds.
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5.2.1 Detection strategy properties
The contralateral responses that have been reported in the literature are small and 
transient (see chapter 2). The detection system should therefore be of sufficient 
sensitivity to identify very small changes. The timing of the experiment is also 
paramount in order to maximise the contralateral response. The detection strategy 
should be feasible in the available setting and acceptable to sufficient numbers of 
subjects to allow the adequate powering of the experiment.
5.2.2 The detection strategy: a non-invasive scanning laser Doppler Imager to study 
microvascular skin blood flow
The velocities of moving particles can be determined from the resultant frequency 
shift o f reflected light following its contact with a moving object according to the 
Doppler principle. Blood flow can therefore be semi-quantified by extrapolating 
from the frequency shift detected when low-power, fixed-wavelength laser light is 
reflected from moving red blood cells. Laser Doppler measurements are specific to 
the blood flow in the skin and not influenced by underlying muscle blood flow 
because the laser light does not penetrate more than a few millimetres (Wardell, 
1993; Grossman et al, 1995).
Fixed laser Doppler flowmeters (LDF) have been in use for several years using 
these principles. However, the localised nature of the perfusion signal coupled with 
the gross anatomical variability o f the microvasculature prohibits its use in 
meaningful comparisons o f absolute blood perfusion measurements across different 
individuals. This caveat also applies when comparing readings from different sites 
within the same individual. LDF therefore is strictly site-specific and should be 
limited to monitoring dynamic responses to physiological stimuli at a single site 
(Grossman et al, 1995).
The recent development of scanning laser Doppler imaging (LDI) devices obviates 
some of these problems. LDI reduces the variability o f single-point measurements 
caused by the skin’s natural heterogeneity in blood vessel density. It gives an 
average skin blood flux for an area that can be compared more accurately over time, 
or across different regions, than LDF (Stucker et al, 1995; Morris and Shore, 1996).
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Measurements obtained by laser Doppler are intrinsically o f a relative nature 
because the factor of proportionality will be different for different tissues so an 
absolute, quantitative index of perfusion (e.g. number of blood cells moving through 
1 g o f tissue per second) can not be derived using LDF or LDI. ‘Absolute’ values 
can be derived however if the experimental conditions are carefully controlled and 
LDI has been successfully used experimentally to assess vascular skin responses 
over two experimental times and between two separate sites (Clough et al, 2001; 
Ramsay et al, 2003).
5.2.3 The use of capsaicin-induced vascular responses as a surrogate for 
neuropeptide availability
The sensitivity of any detection method can be hugely improved by using a 
surrogate marker. Capsaicin (8-methyl-N-vanillyl-6-noneamide) has been used as a 
tool for assessing neuropeptide availability, an important system in the regulation of 
skin blood flow. Many o f the published contralateral responses in animals are 
directly related to or downstream from neuropeptide discharge (see Chapter 3). This 
would therefore be a highly relevant system to investigate as neuropeptides have 
properties that are functionally and anatomically appropriate to mediate 
contralateral responses. Furthermore, topical capsaicin is safe and in regular clinical 
and experimental use.
Capsaicin has separate outcomes on both the nervous and the vascular systems. In 
the nervous system an area of primary sensitisation is generated from the actions on 
the peripheral nerves. Central sensitisation occurs in the spinal cord to generate a 
larger area of secondary hyperalgesia surrounding the area of primary hyperalgesia 
(LaMotte et al, 1992).
Capsaicin opens the non-selective cation channel TRPV1 receptor (transient 
receptor potential channel vanilloid receptor 1), located on fine sensory afferent 
nerve fibres, to allow an influx o f calcium and effect the release o f substance P (SP) 
and calcitonin gene-related peptide (CGRP) from dense-core vesicles through an 
exocytotic mechanism (Merighi et al, 1988; Bevan and Szolcsanyi, 1990; Oh et al, 
1996; Caterina et al, 1997). These neuropeptides then act as vasodilators through 
both endothelial-dependent and endothelial-independent mechanisms (Brizzolara
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and Bumstock 1991; Lippe and Holzer, 1992). Skin blood flow responses to the 
application o f capsaicin have therefore been used as an indirect measure of 
neuropeptide release.
Several techniques have been used for evaluating the skin blood flow responses to 
topical capsaicin. These usually include mapping out the area o f flare (planimetry); 
colorimetry; and fixed laser Doppler flowmetry (LDF) (Helme and McKeman 1985; 
Jolliffe et al, 1995; Morris et al, 1995; Fang et al, 1997; Harding et al, 2001). A 
lack o f sensitivity is seen when comparing planimetry to LDI or colorimetry 
(Stucker et al, 1995 & 1996). As mentioned above, comparably sensitive techniques 
such, as colorimetry and LDF, are not as reproducible as LDI (Stucker et al, 1995).
5.3.1 Controlling for confounding variables
Skin blood flow and vascular reactivity is dependent upon several variables. These 
include the region of the body that is to be studied, age, vasoactive medications, 
room temperature, skin temperature, posture and the time within the menstrual cycle 
(Charkoudian 2003). An experimental protocol should take into account these 
factors.
Pilot studies were undertaken to assess the variability of skin blood flow in the same 
region on two separate occasions. For females, the second scan was timed to be 
approximately at the same point within the menstrual cycle as the first. Each subject 
was acclimatised in a temperature-controlled room (25-27°C) for 30 minutes. This 
was deliberately warm to encourage a slight vasodilatation. Subjects were advised 
to avoid caffeine, nicotine and alcohol on the day of the study and excluded if any 
vasoactive medication had changed between visits. A colour thermographic camera 
(ThermoVision, Flir Systems, Sweden) monitored the skin temperature, and a 
digital thermometer (Digitron Instrumentation Ltd, Model 2751-K) monitored the 
room temperature. Adjustments to the temperature control were made throughout 




Four regions of interest (ROI) were identified, two on each arm. These were 
carefully marked and recorded on the first visit so that they could be used again on 
the second visit. The ROI were the outer upper and ulnar lower regions on each arm. 
The upper ROI was approximately 15cm along a line measured from the mid­
acromion point in the shoulder to the lateral epicondyle in the elbow. The lower 
ROI was approximately 12cm along a line measured from the lateral epicondyle in 
the elbow to the ulnar styloid in the wrist. Each ROI was identified to a digital 
camera in the LDI by using a hollow plastic circular template and a semi-permanent 
marker pen to circumscribe a 2.8cm region. The mark used to identify the ROI was 
the centre o f this circle.
The LDI (LDI-2, Moor Instruments Ltd, Devon, UK) was used approximately 
perpendicular to the skin surface at a distance of 75cm using a flux gain value of 2; 
scan speed o f 4 pixels/ms; and a bandwidth of 250Hz -  15kHz. Scanning time was 
approximately 3 minutes. All four ROI were scanned simultaneously. The 
calibrating procedure for the LDI was conducted at monthly intervals using the 
manufacturer’s standard and in-built software.
The LDI was used to obtain two baseline images before the topical capsaicin cream 
(0.075%, Axsain) was applied using the hollow template to define the contact 
surface area as outlined above. The cream was left on the skin for 30 minutes. The 
cream was completely removed with a soft tissue and care was taken to avoid a 
mechanically-induced flare reaction. Seven further LDI scans were then obtained 
over the next 21 minutes.
5.4.1 Data analysis
In addition to using the peak skin blood flow, the vasodilatory response expressed 
by LDI values has been corrected by different methods in the literature. Values for a 
pre-defined region of interest such as that used in this protocol can be expressed 
using the area under the curve (AUC) (Ramsay et al, 2003) or corrected for the 
baseline by either division (Newton et al, 2001) or subtraction (Zhelev and 
Bakalova, 2002). The total area of vasodilation can also be calculated (Clough et al, 
2001).
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The pilot study assessed all five o f these methods. ROI were identified from the pre­
drawn felt-tip pen mark on a digital camera image that had been simultaneously 
acquired during the flux scan. This free-drawn ROI was automatically copied onto 
the flux image and the average flux for that ROI calculated using the accompanying 
software (Moor Instruments Ltd, Version 3.11).
The five separate analyses outlined above were carried out on the same data (in 
addition to using the peak values) in order to establish which method would be the 
most reproducible for this protocol. Three analyses focussed on the increase in skin 
blood flow within the ROI defined by the template and the fourth analysis 
concerned the total area of the flare. The four methods of correcting the peak skin 
blood flow were:
1 Uncorrected peak flux values (in PU).
2 Subtracting the baseline blood flux from the peak flux (in PU) (Zhelev and 
Bakalova, 2002).
3 Expressing the peak flux as a ratio to baseline (Newton et al, 2001).
4 Calculating the AUC (in PU, without subtracting baseline) (Ramsay et al, 2003).
5 Total area (baseline areas subtracted from average of maximum 2 areas)
(Clough et al, 2001). To identify the total area o f flare a threshold value of 150
perfusion units was set and the number of pixels with values above this counted 
using the software.
Biological zero
The biological zero (the laser Doppler signal when arterial flow is arrested) was not 
measured as this was assumed to be constant at a given location in a given 
individual over time. Other groups have not measured the biological zero because 
their experience was that it makes only a small contribution to the total signal and 
does not change significantly under different conditions (Morris and Shore, 1996; 
Newton et al, 2001). Furthermore, subtracting the biological zero from flux readings 
leads to an underestimation of the net flux (Zhong et al, 1998).
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5.4.2 Study aims
For the purposes o f the initial pilot study, the primary aim o f  the study was to assess 
the reproducibility o f  the increase in skin blood flow following topical capsaicin 
over the two separate experiments using the five different methods. Reproducibility 
was expressed in terms o f  the coefficient o f variation. Secondary outcome measures 
were to correlate the effects o f  skin temperature, room temperature, age, region, 
baseline blood flow and inter-subject variability on the response to capsaicin. This 
analysis was performed using univariate modelling. This fully factorial balanced, 
type III model had no a priori contrasts and a Tukey’s post-hoc test was used. All 
analyses were performed using SPSS 12.0.
5.4.3 Reproducibility o f  LDI measurements
The reproducibility o f  the data collection was performed by using an observer who 
was blinded to the original data and also independent o f the study. The independent 
observer followed the protocol for identifying the ROI from the digital camera 
image as outlined above and the results are displayed in Figure 5.1. 343 regions 
were analysed with the mean difference being 2.9 PU (SD 10.2 PU). This analysis 
therefore introduced only a small amount o f variation into the data.
Figure 5.1 Bland-Altman plot of interobserver differences (PU) from free 
drawing around digital camera image of region of interest fROI)
PU
Diff
50 100 150 200 250 300 350 400
Average o f two readings (PU)
The red lines indicate 95% confidence intervals.
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5.4.4 Testing the adequacy o f  the acclimatisation time
A period o f  acclimatisation is needed to give a steady state o f skin blood flow. To 
determine whether 30 minutes was adequate, 14 subjects who had undergone pilot 
studies had regions identified that were not involved in the study. These were 
monitored over the course o f the experiment and the data are summarised in Figure 
5.2. Skin blood flow is seen to vary very little after 60 minutes o f  acclimatisation. 
The difference between this steady state and skin blood flow after 30 minutes was 
seen to be between 2-4 PU (SEM 2). 30 minutes therefore was thought to be 
adequate.
Figure 5.2 The role of acclimatisation in skin blood flow variability (n=14) 
showing mean flux at baseline and for 30 minutes following the removal of 
capsaicin in control regions distant to the capsaicin application
30 33 60 63 66 69 72 75 78
Time (minutes).
Note: non-linear scale
5.5.1 Measuring increases in skin blood flow in response to topical capsaicin in 14 
healthy subjects on two separate occasions
14 subjects were recruited (7 males; mean age 41 (21-72) yrs). All were healthy and 
taking no medication. Two subjects smoked. Informed, written consent was 
obtained from every subject. The Local Research and Ethics Committee approved 
this study (BA172). One subject was excluded because o f  a skin flare reaction to 
mechanical abrasion prior to the experiment that had not subsided by the time of 
recording. Each subject had four ROI. Therefore, 52 separate areas were analysed.
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Table 5.2 summarises these results and displays the mean coefficients o f variation. 
The analytical methods with the best reproducibility over time were the AUC and 
subtraction of the baseline. The methods with the worst reproducibility were the the 
uncorrected data and the area of flare. The coefficients o f variation ranged from 
27.8-49.4%.
Table 5.2 Coefficients of variation of increased skin blood flow in response to 
topical capsaicin over time and according to the analytical method






Uncorrected 197.0(155.2) 193.2 (149.5) 49.4%
Subtraction 270.4(121.0) 275.6(104.2) 29.8%
Ratio 5.9 (3.0) 6.4 (3.3 ) 37.6%
AUC 2390.9(1143.8) 2918.2(1392.0) 27.8%
Total Area 400.8(185.1) 474.7 (216.4) 43.8%
5.5.2 Baseline skin blood flow measurement over time in the control group
In the control group the skin blood flow at baseline was seen to vary by an average 
mean of 1.5 PU (2.9%), (SD 14.5 PU, SEM 3.9 PU), over two measurements. There 
were no significant differences in skin blood flow over time in any of the regions 
(Wilcoxon signed-rank test), nor any differences over time between the regions 
(ANOVA).
5.5.3 Secondary analysis in the control group
Univariate modelling showed that the increase in skin blood flow following 
capsaicin administration was significantly correlated with age (Figure 5.3). This 
increase in skin blood flow was not related to skin temperature, room temperature, 
region, subject, baseline skin blood flow, or time of the experiment.
In addition, there was no relationship between either the skin or room temperature 
and skin blood flow (Table 5.3). As expected skin temperature was significantly
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correlated with room temperature (p=0.021) although r2=0.05 meaning that this was 
a weak relationship at the studied temperatures. There were no significant inter­
regional differences between the skin temperatures.
Figure 5.3 Secondary analysis: Increase in skin blood flow following topical 
capsaicin is correlated negatively with age







10 20 30 40 50 60 70 80
Age
Each subject has 8 readings
Highly significant correlation with age (P<0.01)
Table 5.3 Baseline skin and room temperatures as measured by quantitative colour 
thermography for all ROI o f each subject on the two separate occasions
RT 1 Time 1 RT 2 Time 2
Area LU RU LL RL LU RU LL RL
Mean 25.1 32.1 32.1 32.2 32.6 25.9 32.2 32.1 32.9 33.0
SD 0.3 1.3 1.5 1.4 1.1 0.7 1.4 1.4 1.1 1.0
RT -  Room Temperature; LU -  Left upper ROI; RU -  Right upper ROI; LL -  Left 
lower ROI; RL -  Right lower ROI
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5.5.4 Delaved responses to capsaicin as a possible confounding factor
It was estimated that 21 minutes of scanning would be adequate to capture the peak 
skin blood flow response to topical capsaicin based on pilot studies. However, 12 
out of 104 regions had the maximal skin blood flow response at the measurement 
taken at 21 minutes. It was possible therefore that the skin blood flow in these 12 
had not peaked and this would confound any reproducibility studies. Taking these 
regions out of the analysis, 42 regions were left for analysis. No significant 
differences were seen in the revised coefficients of variation with the range being 
25.2-41.4% and the AUC and subtraction data still being the most reproducible.
5.6.1 Differences in skin blood flow in response to capsaicin following 
immunisation
15 immunised subjects were recruited (6 males; mean age 55 (25-81) yrs). Each 
subject was studied according to the protocol outline above. Informed, written 
consent was obtained from every subject. The Local Research and Ethics 
Committee approved this study (BA172). All were included in the analysis o f data. 
The subjects had been immunised a median of 3 days prior to the study (range 2-10 
days).
The primary outcome assessed was the response to capsaicin measured by 
subtracting the baseline from the average of the two maximal readings using 
absolute perfusion units (PU) (see section 3.5.1). This measurement was then 
subtracted from the measurement 2 months later. All 4 regions were analysed and 
then compared (figure 5.4). There were no differences in the increase in skin blood 
flow over time in response to capsaicin following an immunisation. There were no 
significant differences either within each region (Wilcoxon signed rank test) or 
between regions (ANOVA).
The value o f capsaicin in detecting differences between a group of subjects who had 
been immunised compared to a group that had not was therefore thought to be 
minimal. This surrogate outcome measure was therefore dropped from the protocol.
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Figure 5.4 Differences over time between the regions following immunisation.
Maximal LDI values after capsaicin corrected by subtracting the baseline (n=15) 
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5.6.2 Differences in skin blood flow following immunisation prior to capsaicin 
Figure 5.5 demonstrates the skin blood flow following an immunisation. This 
difference is significant when compared to the internal control two months later 
(Wilcoxon sign-rank test; two-sided p=0.013). This difference in skin blood flow 
was also significant (p=0.044) when compared to the control regions in the lower 
arms using a one-way ANOVA.
However, the increase in blood flow in the immunised region was not significant 
(p>0.05) in a one-way ANOVA comparison with the exact contralateral region. This 
suggests that there could have been increases in the skin blood flow occurring there 
that were not occurring in the control group. These differences must have been 
small however as there was no significant difference between the contralateral 
group and the control groups using this outcome.
Taken together, this pilot data does not support the null hypothesis and suggested 
that further studies be undertaken to investigate whether immunisation leads to an 












Figure 5.5 Changes in skin blood flow following immunisation in the different
regions
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immunised region over the two time points (Wilcoxon signed-rank test).
Changes were therefore made to this protocol in an effort to increase sensitivity. 
Recruitment was restricted to before 4 days following an immunisation and the 
distance at which the LDI scanned was reduced allowing the gain to be increased.
5.1.1 Timing o f  the study in relation to the immunisation
This pilot study recruited subjects who had been immunised a median o f 3 days 
prior to the study (range 2-10 days). Figure 5.6 demonstrates that the skin blood 
flow response following immunisation is greatest following recruitment before day 
4. It was decided that further studies should concentrate on recruiting before day 4.
♦
★
Immunised Contralateral Control (lower arms)
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Figure 5.6. Differences in skin blood flow over time since immunisation in the 4
different regions of interest
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LU -  Vaccinated left upper ROI; RU -  Right upper ROI; LL -  Left lower ROI; RL 
-  Right lower ROI
5.7.2 Increasing the sensitivity o f  the LDI
An attempt was made to increase the sensitivity o f  the LDI to small changes in skin 
blood flow. This was done by reducing the distance between the LDI and subject 
from 80 to 20cm thereby decreasing background noise. The LDI flux gain was 
changed from 2 to 0 whilst all other parameters were kept constant. 8 new control 
subjects were scanned using these parameters to obtain new control data for the 
baseline skin blood flow responses.
5.8.1 Testing the variability o f  the new protocol on a control group (n=8)
This modified protocol was tested on a group o f healthy subjects who were taking 
no medication at the time (n=8; 4 males; mean age 35 years (range 22-88)) over two 
months (see Figure 5.7). The skin blood flow over time was seen to vary by a mean 
o f 2.1 PU (1.4%) (SD 39.2 PU, SEM 13.9 PU). There were no significant 
differences in skin blood flow over time controlled for region tested by Wilcoxon 
signed rank test; nor between the regions tested by one-way ANOVA. 95% o f the 
data was between + / - 77 PU (50.3%) o f the first scan.
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5.9.1 Calculating sample size based on the pilot data
Using the pilot data from the original protocol (n=15), the baseline skin blood flow 
in the contralateral region (right upper) at the follow up time (i.e. when there had 
been no previous immunisation) was 35.5 PU (SD 14.8). Following an 
immunisation, this increased to 40.3 PU (SD 13.6), an increase o f  4.8 PU (SD 13.5). 
Using these values a sample size o f  57 subjects would be required with an a=0.05 
(one-sided) and (3=0.8 (GraphPad Stat).
Figure 5.7 Bland Altman plot of the differences over time for all four scanned
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Red lines indicate 95% confidence intervals (n=8).
116
Chapter 6. Skin blood flow responses following active immunisation
Summary
The experimental model was tested. The null hypothesis was supported. Skin blood 
was seen to increase in the vaccinated region but not in either the experimental 
(contralateral) nor the control (lower arms) regions. Reasons for the lack of support 
for the hypothesis are discussed including the possibilities that the magnitude of the 
stimulus was insufficient to overcome the threshold required to generate a 
contralateral response and the timing of the experiment was not sufficient to capture a 
contralateral response.
6.1.1 Hypothesis
The hypothesis is that the skin blood flow  in the area o f the contralateral arm, 
precisely topographical to an active immunisation given 2-4 days prior, will be 
different to that o f control areas in a group o f healthy volunteers.
The null hypothesis is that the skin blood flow  in the area o f  the contralateral arm, 
precisely topographical to an active immunisation given 2-4 days prior, will be no 
different to that o f control areas in a group o f healthy volunteers.
6.2.1 Methods
The background for this chapter has been laid out in Chapter 5.
Healthy individuals were recruited and studied on two separate occasions. 
Recruitment came from three sources:
1 Students at the University of Bath following mumps, measles and rubella 
(MMR) immunisation (32 volunteers)
2 Staff at the Royal National Hospital for Rheumatic Diseases following annual 
influenza immunisation (25 volunteers)
3 Patients recruited through local general practices (3 volunteers).
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A £30 stipend was given to each volunteer to compensate for the time given to this 
study.
Anatomical landmarks were used to define four regions of interest (ROI) two in the 
upper and two in the lower arms. These were carefully marked and recorded on the 
first visit so that they could be used again on the second visit. The upper arm ROI was 
identified in a similar way to that in Chapter 5. It was located with reference to the 
anatomical line drawn from the midpoint on the lateral aspect of the acromion in the 
shoulder to the lateral epicondyle in the elbow. The lower arm ROI differed from that 
marked before as it was located with reference to the anatomical line drawn from the 
lateral epicondyle in elbow to the ulnar styloid in the wrist on the hairy dorsal aspect 
of the forearm. Each ROI was identified with a circular template (2.83 cm2) using a 
semi-permanent marker pen. Each subject was then acclimatised in a warm 
temperature-controlled room (25-27°C) for 30 minutes.
6.2.2 Correcting for confounders
To correct for possible confounders (see Chapter 5), subjects were advised to avoid 
caffeine, nicotine and alcohol on the day o f the study and excluded if any medication 
thought to affect the microcirculation had been given or changed between visits. Each 
subject was given a questionnaire to assess possible confounding variables to skin 
blood flow and microvascular assessment. The following data was collected: time 
since the vaccine; age; past medical history; medication; creams applied to their upper 
arms; smoking history; and allergies. This data is presented in Tables 6.1 and 6.2.
The second scan was timed to be 1 to 3 months later (mean 2 months), and for 
females this was scheduled to be approximately the same point within their menstrual 
cycle. A digital thermometer (Digitron Instrumentation Ltd, Model 2751-K) 
monitored the room temperature. The skin temperature was not monitored as it was 
thought irrelevant due to the shorter time course of this experiment (12 minutes) 
compared to the pilot studies (more than 60 minutes).
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6.2.3 The Laser Doppler Imager
The LDI (LDI-2, Moor Instruments Ltd, Devon, UK) was used at a distance o f 20cm 
perpendicular to the skin surface using a gain value of 0 for the flux; scan speed o f 4 
pixels/ms; and a bandwidth of 250Hz -  15kHz. Scanning time was approximately 1 
minute. Each ROI was scanned individually. Two scans were taken from each ROI. 
Capsaicin was not used. The LDI was calibrated on each day o f scanning as necessary 
according to calibration software.
6.2.4 Data analysis
The primary outcome was to detect whether there were any differences between the 
exact contralateral area and the control groups. The differences between these regions 
were analysed using a one-way ANOVA with a Bonferroni correction. The second 
primary outcome was to detect whether there was any difference in the contralateral 
area following immunisation compared to 2 months later.
Secondary analysis involved examining the data at the different time points using a 
one-way ANOVA with a Bonferroni correction and examining the effects of the 
recorded variables on the skin blood flow and each other using univariate modelling. 
SPSS 12.0 was used for all statistical analysis. Graphical data is presented using MS 
Excel.
6.3.1 Results: The characteristics o f the studied population
60 subjects were recruited and their baseline characteristics are listed in Table 6.1. 
One subject did not attend for his second scan and was excluded from the analysis. 
His data did not significantly differ from the group data in any significant way (see 
Table 6.4). The results to the questionnaires are detailed in Tables 6.1 and 6.2. One 
student had unfortunately contracted mumps and attended his first (post­
immunisation) session during his prodromal illness. His data did not vary from the 
mean significantly and was not excluded from the final analysis (see Table 6.4).
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Table 6.2 Details of past medical history and medication
Previous illness Medication Cream Allergies
Asthma (4) Mini-pill (4) Aqueous (3) Dust mite
Hayfever (3) Becotide (2) Vitamin E Opioids
Cured breast cancer Salbutamol (2) Moisturiser Penicillin
Diabetes Insulin 50/50 paraffin Septrin
Chronic otitis media Oral contraceptive Papaya body butter
Osteoporosis Anti-histamine





6.3.2 Primary outcomes: The skin blood flow after immunisation
Table 6.3 presents the skin blood flow immediately after the immunisation; 2 months 
later; and the differences between the two. Figure 6.1 represents this graphically. 
Table 6.4 presents the data from both the volunteer who did not return for follow-up 
and the volunteer with mumps.
Table 6.3 The mean skin blood flow from the different regions on the arms 
immediately following the immunisation: 2 months later (control): and the
differences between the two
Mean SD SEM Median
Immunisation
Vaccine 258.1** 143.1 13.2 244.7**
Experimental 190.5 63.4 5.8 181.6
Lower (V) 167.4 46.5 4.3 159.3
Lower (E) 175.4 53.9 5.0 165.6
Control
Vaccine 188.9 74.1 6.9 180.1
Experimental 186.2 66.4 6.1 177.9
Lower (V) 166.9 41.5 3.8 158.6
Lower (E) 169.5 48.6 4.5 161.2
Difference
Vaccine 70.0** 150.8 14.0 65.4**
Experimental 4.3 58.2 5.4 3.7
Lower (V) 0.5 47.6 4.4 0.7
Lower (E) 5.8 56.9 5.2 3.7
** p<0.01 compared to other regions using ANOVA
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Figure 6.1 Mean skin blood flow values (standard errors shown) of the four 
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(Contralateral) (Contralateral)
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Table 6.4 Values of the subject who did not return (DNR) and the subject who
Region Mean (DNR)
had mumns (M)
Median (DNR) Mean (M) Median (M)
Immunisation
Vaccine 156.7 146.5 168.4 162.2
Experimental 130.3 124.0 189.4 181.4
Lower (V) 138.0 132.0 148.4 143.3
Lower (E) 137.8 128.0 155.4 147.9
Control
Vaccine - - 156.6 151.4
Experimental - - 187.9 173.8
Lower (V) - - 174.7 162.9
Lower (E) - - 164.9 157.2
Difference
Vaccine - - 11.8 10.8
Experimental - - 1.5 7.6
Lower (V) - - -26.3 -19.6
Lower (E) - - -9.5 -9.3
From Table 6.3 and Figure 6.2, it is clear that the introduction of an immunisation 
causes an increase in skin blood flow in that region compared to any o f the other 
regions (p<0.01). None of the other regions differed significantly between each other 
on a one-way ANOVA with a Bonferroni correction. It was also noted that the skin 
blood flow differed significantly from that recorded 2 months later only in the 
immunised region and not in any o f the other regions using a Wilcoxon signed-rank 
test.
As can also be seen, after the immunisation the skin blood flow in the contralateral 
exact area (Experimental) is non-signficantly higher than the control areas. However 
this apparent increase is not due to the introduction o f the vaccine because when the 
control skin blood flow is seen 2 months later, the same difference is evident. It 
appears that the anatomical area scanned in the upper arms has a higher skin blood
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flow than the control areas in the lower arms. This is significant (PO.OOl) when the 
upper arms are compared to the lower arms using a two-way paired t-test. Possible 
reasons for this are detailed in the discussion. When the skin blood flow from the two 
time points are subtracted then the differences between the skin blood flow in the 
regions disappears (Table 6.3).
There are no significant differences in the contralateral arm when compared to that in 
the control areas. This result supports the null hypothesis.
6.3.3 Skin blood flow after immunisation over time in the different regions 
Figure 6.2 illustrates the differences in blood flow in each region against the time 
since the immunisation was given. Table 6.5 describes these results numerically.
As can be seen skin blood flow in the immunised region is increased for at least four 
days. None of the other time points in any o f the other regions (experimental and 
control) were seen to change over the corresponding four days. This data supports the 
data previously presented. There was no detectable significant rise in skin blood flow 
following immunisation in regions distant to that of the immunisation region itself.
It is interesting to note that the range o f data on the first day post-immunisation was 
significantly different to the ranges seen on the volunteers attending 2-4 days post­
immunisation. This increased spread of data was a consistent finding across all o f the 
regions. This variability however was not dependent upon the timing of the 
immunisation and is a reflection of volunteers with more variable skin blood flow 
being recruited 1 day following immunisation.
The skin blood flow in the experimental group one day following an immunisation 
was raised compared to the same region 2 months later, although this was not 
significant. Due to the large standard deviation o f the data more than 200 more 
volunteers would need to be recruited to find this value significant using an alpha o f 
0.05 and a beta of 0.8 (see section 6.5.1).
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Figure 6.2 Blood flow in the different regions over four days since immunisation
PU Immunised region (note different range ony-axis)














PU Lower regions combined (control)
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Table 6.5 The blood flow differences between immunisation and control times
plotted against time since immunisation (SEMI
Day 1 Day 2 Day 3 Day 4
Vaccine 56.5 (22.1)* 122 (52.3)* 81.7 (32.1)* 49.8 (13.8)**
Experimental 11.5(12.0) -2.5 (13.7) -4.3(11.4) 4.3 (5.6)
Lower (V) 0.1 (9.7) 0.0 (7.3) 3.7(10.1) 0.0 (6.6)
Lower (E) 4.3 (12.7) 6.4 (10.5) 1.8(10.2) 8.8 (5.8)
* p<0.05 Wilcoxon signed-rank test 
** p<0.01 Wilcoxon signed-rank test.
6.3.4 Secondary analysis: Effects of other variables on skin blood flow 
An analysis using univariate modelling (SPSS 12.0) was performed to assess whether 
there appeared to be any impact on skin blood flow from the variables described 
above. There appeared to be significant relationships between skin blood flow and the 
type of immunisation received; age; smoking status; and the presence o f an allergy.
Type o f immunisation
The 2 individuals who had the typhoid immunisation had significantly higher blood 
flow values in the region that was immunised, and significantly lower values in all of 
the other regions after the immunisation when compared to the volunteers who had 
received either influenza or MMR immunisations (pO.OOl using one-way ANOVA 
with a Bonferroni correction). 2 months later, these 2 individuals had significantly 
lower blood flows in all regions than the other groups (p<0.001). These findings were 
not explained by the presence of any other variable, but may be a reflection o f very 
low numbers in this group.
Volunteers who received the MMR had significantly higher blood flows than those 
who received influenza immunisation (p<0.01). This was seen in the upper arms only, 
and occurred both after immunisation and 2 months later, suggesting that this was an 
intrinsic difference between the two groups rather than caused by the immunisation.
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The MMR group was significantly younger than the influenza group (p<0.01) 
although there was no significant relationship between the skin blood flow in the 
upper arms and age (p=0.18). There were no other differences between the MMR and 
influenza groups and it is difficult to explain the observed difference using the data 
collected.
Age
The relationship between age, blood flow, region and immunisation was interesting 
(Figure 6.3). Across all of the regions, age was seen to be associated with a slight but 
highly significant (p<0.001) decrease in the skin blood flow at two months following 
immunisation i.e. the control time. It was seen to have a slightly negative non­
significant relationship with skin blood flow after immunisation. When the differences 
between the two times was taken age was seen to have a significant positive 
relationship with differences in skin blood flow (p<0.01). It appears that the increase 
in skin blood flow following immunisation increases as age increases.
When this relationship was explored with regards to region specificity the following 
results were seen (Figures 6.4, 6.5, and 6.6). Skin blood flow was seen to decrease 
with age in all of the regions at time 2 (Figure 6.4). This was a highly significant 
relationship in both of the upper arms (p<0.001) whereas it was not significant in the 
lower arms.
Skin blood flow was seen to increase with age following immunisation (time 1) in all 
of the regions apart from the contralateral region to the immunisation site (Figure 6.5). 
The negative relationship with skin blood flow and age following immunisation was 
highly significant in this contralateral (experimental) region (pO.OOl). The positive 
relationship was significant only in the lower arm on the immunised side (p=0.028).
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Figure 6.3 Blood flow plotted against age and its relationship with immunisation
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The top graph is control data (no immunisation). The middle graph is post­
immunisation (experimental data). The bottom graph is the difference between the 
two. As can be seen there is a negative correlation o f  age with no immunisation that is 
negated after an immunisation. This means that there is a positive relationship with 
age if the differences are examined. (Note differing range on y-axis)
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Figure 6.6 Age against skin blood flow at each region. Skin blood flow from 2 
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When the two time points are subtracted from each other (Figure 6.6) skin blood flow 
is seen to increase in all o f the regions with respect to age apart from the exact region 
contralateral to the immunisation. This increase in skin blood flow with respect to age 
is significant in all of these three regions. There is no significant change in the 
contralateral region. These results are discussed in section 6.5.2.
When the older age group (over 50 years old, n=9) are analysed as a subgroup, skin 
blood flow is seen to differ significantly between the regions (Table 6.6). Both the 
vaccinated region and the contralateral region are seen to differ significantly from the 
control regions both following immunisation and when corrected for the skin blood 
flow 2 months following immunisation. Here it can be seen that these significant 
differences arise because of an increase in the skin blood flow after immunisation in 
the control lower arm regions. The skin blood flow does not change in the 
contralateral region exactly opposite to the immunisation.
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Table 6.6 The mean skin blood flow from the different regions on the arms 
immediately following the immunisation: 2 months later (control): and the 
differences between the two in the over 50 age group (n=9)
Mean SD SEM Median
Immunisation
Vaccine 275.9** 157.0 39.2 252.9
Experimental 149.8** 37.3 8.8 142.1
Lower (V) 194.3 82.2 19.4 181.4
Lower (E) 188.9 113.4 26.7 178.6
Control
Vaccine 145.4 22.7 5.7 138.8
Experimental 150.6 27.5 6.5 152.4
Lower (V) 160.8 26.0 6.1 152.4
Lower (E) 162.0 44.9 10.6 144.7
Difference
Vaccine 130.5** 142.4 35.6 121.928.9
Experimental -0.8** 36.9 8.7 -2.6
Lower (V) 33.5 69.9 16.5 28.9
Lower (E) 26.9 75.6 17.8 26.1
** p<0.01 compared to control regions using ANOVA 
Smoking
The 6 volunteers who smoked had significantly higher blood flow (p<0.01) after they 
had been immunised when compared to non-smokers. There were no significant 
differences in this smoking group 2 months later. On further analysis, this increased 
blood flow arises in all regions apart from the experimental (exact contralateral) 
region.
Allergies
The 3 volunteers with allergies had higher skin blood flow than those with no 
allergies. This was only at the control time point, 2 months after immunisation, and
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was only seen in the upper arms, not the lower. This was unaccounted for by another 
variable.
In summary, several variables were seen to have an impact on the skin blood flow 
over and above the region and the immunisation.
6.4.1 Findings from the protocol
The main findings from this protocol are that an immunisation increases the skin 
blood flow in that region significantly for at least the following 4 days. There are no 
concomitant differences in the skin blood flows in any of the other regions. There are 
no differences in the skin blood flow in the exact contralateral region when compared 
to a control region taken at the same time; nor when compared to the same region 2 
months later. These results support the null hypothesis.
Further findings are that age is correlated negatively with skin blood flow 2 months 
following immunisation and has a significant relationship with region and 
immunisation time as well. The type of immunisation also has a complex relationship 
with region and skin blood flow. Smoking and the presence of allergies also 
demonstrate significant differences in skin blood flow following immunisation when 
compared to volunteers who do not smoke and have no allergies respectively.
6.5.1 Discussion of the primary outcome findings
These findings are not consistent with the evidence that has been published and 
summarised in Chapter 2. Aside from the bias in the literature for the publication of 
positive results, there may be several other reasons for this.
As has been detailed in Chapters 2 and 5 the stimulus has to overcome the threshold 
properties set for the crossed afferent pathway by either being of sufficient magnitude 
or duration. Animal models all used very different stimuli to that used in this protocol. 
They were more severe and sustained (e.g. chronic monoarthritis; neural lesion; 
hindpaw oedema etc.) than the immunisation that the volunteers received. It would 
not be ethically permissible to apply a more powerful stimuli to human volunteers. It 
may be that the immunisation did not surmount the ‘gating’ of the central nervous 
system.
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Another property of the crossed afferent pathway is that the contralateral effects that 
are seen are reduced in magnitude and temporally delayed, sometimes up to days 
following the original insult. This led Koltzenburg, Wall and MacMahon (1999) to 
comment that the contralateral responses might be mediated by slow signalling 
pathways that occur centrally. In this study the contralateral responses were not 
detected for 4 days following the immunisation. It may be that this time period was 
not long enough to capture the putative contralateral effect. The ipsilateral response to 
the immunisation had not subsided as there were still significant differences between 
the skin blood flow recorded 4 days after the immunisation compared to that of the 
control 2 months later. Perhaps any contralateral response could manifest itself at least 
4 days after the immunisation, even after the immunisation has subsided.
It is possible that the study was not adequately powered to detect a very small and 
subtle contralateral effect occurring at day 1. This is the time that the skin blood flow 
corrected for the control 2 months later was noted to be slightly higher than the 
control regions (Table 6.5) to a p=0.202 with a Wilcoxon signed rank test. Using these 
results as the basis for powering a new study (mean 212, SD 72.7) more than 200 
more volunteers would need to be recruited. This was clearly impractical in the time 
available.
It is possible that the contralateral responses were actually occurring but failed to be 
detected. A different detection technique (immunohistochemistry) is detailed in the 
next chapter.
Is it possible that crossed afferent pathways do not have a role to play in man? This 
may be so, but unlikely to be plausible. Crossed pathways are histologically 
detectable in species that bear a close relationship to man, such as the apes (Culberson 
et al, 1979). These decussating fibres are not related to any existing
neurophysiological framework although appear to have a physiological role 
(Fitzgerald, 1982 a and b). Contralateral responses are ablated following disruption of 
the peripheral or central nervous system, but not o f the circulatory system (see 
Chapter 2). The circumstantial evidence for crossed afferent pathways to have a
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meaningful role in species related to man is considerable and there would be no 
reason for thinking that these pathways would not be active in man.
6.5.2 Discussion of age and regional differences in skin blood flow 
Skin blood flow is known to reduce as people grow older. Tsuchida et al (1991) 
examined the skin blood flow in the deltoid region of 55 volunteers ranging from 20- 
72 years old and found significant decreases in the clearance of radioactive Xenon 
from the skin correlated with increasing age. In a related study Tsuchida (1990) noted 
that this decrease was about 30-40%. This study supports both the quality and 
quantity of that observation (Figure 6.4, top graph).
The relationship with age, region, immunisation and skin blood flow is interesting. 
Significant differences were seen in the skin blood flow responses in the control 
regions following immunisation that was not seen in the contralateral region opposite 
to the immunisation (Figures 6.4-6). These significant differences in the older age 
group arise due to the increase in skin blood flow in the control lower arm regions 
following immunisation (Table 6.6). There is no increase in skin blood flow in the 
topographically precise contralateral region following immunisation. Therefore, 
although there are significant differences between the control and experimental 
groups in this post-hoc analysis there were no significant differences between the skin 
blood flow in this region following immunisation when compared to 2 months later 
using a Wilcoxon signed-rank test. This does not invalidate the null hypothesis and 
further investigation is required to test this association before any firm conclusions 
can be drawn. Furthermore, the numbers were small in the over 50 years age group 
(n=9) compared to the younger age group and this could have skewed the slope at this 
point.
The relationship between the skin blood flow in the upper arms when compared to the 
lower arms is also interesting. It is possible that proximal body regions will have 
relatively higher vascular pressures, relatively larger blood vessels and hence 
relatively higher blood flows. There is some evidence in support of this from Helme 
and McKernan (1985) who investigated the skin flare following the application o f a 
defined amount of topical capsaicin in various regions of the body. They found that 
the more proximal sites generated larger flare reactions. Similarly, Tsuchida (1979)
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examined the skin blood flow using a [133]Xenon clearance method and found that the 
anterior chest wall and face had higher blood flow than the deltoid region which 
consequently had higher blood flow than posterior cervical, lateral thoracic, lateral 
abdominal, and gluteal sites. He did not use sites on the forearms as comparators.
6.5.3 Developing this model further
Further work to detect contralateral responses might include changing the protocol to 
address all o f the above factors discussed in section 6.5.1. For example, the timing of 
the recruitment could be extended to ensure that in all cases the increased blood flow 
caused by the immunisation had been captured. A different stimulus could be 
included. Some o f these have been considered in Chapter 5 (Table 6.1). Most of these 
stimuli suffer from the same perceived problem as an immunisation. Larger stimuli 
would not ethically be permissible but could be recruited from patients with 
appropriate local inflammatory lesions. Such examples might be abscesses, unilateral 
trauma and local tumours. Recruitment would be limited however and it would be 
difficult to compare cases due to the uncontrolled variability o f the different insults.
It was thought that a different method for detecting changes in a given outcome could 
be considered. Radio-isotopic labelling and clearance methods, high resolution 
Doppler ultrasound, and microangiography were thought not to be sufficient to 
provide enough sensitivity to detect small changes. More sophisticated scanning 
techniques such as functional Magnetic Resonance Imaging or Positron Emission 
Topography might have the ability to detect small changes in skin blood flow in the 
deeper tissues, but these were not available. A different line of investigation was 
therefore chosen to attempt to capture contralateral changes. This was 
immunohistochemical in nature and this will now be discussed in Chapter 7.
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Chapter 7. Dilutional immunohistochemistrv to semi-quantifV E-selectin
staining density contralateral to MMR immunisation
Summary
In this chapter, the hypothesis that topographically precise contralateral inflammatory 
changes occur following an immunisation is tested at the microscopic level. Skin 
biopsies were taken from the upper (experimental) and lower (control) arm 
contralateral to an MMR immunisation. An immunohistochemical technique, using 
supraoptimal dilutions of the primary antibody, was used to semi-quantify the 
amounts of the protein E-selectin expressed on the dermal endothelium. No 
differences between the experimental and control groups were found in any o f the 
outcome measures. The null hypothesis is again supported.
7.1.1 Hypothesis
The hypothesis is that there is greater expression o f  endothelial E-selectin in skin 
biopsies taken from the exact contralateral area to an MMR immunisation (given one 
to three days prior) when compared to the control contralateral skin biopsy taken 
from a different dermatomal area.
The null hypothesis is that there is no difference in the expression o f endothelial E- 
selectin in skin biopsies taken from the exact contralateral area to an MMR 
immunisation (given one to three days prior) when compared to the control 
contralateral skin biopsy taken from a different dermatomal area.
7.2.1 Rationale for using an immunisation as the stimulus
It was decided to use the same stimulus (active immunisation) as had previously been 
used as this was still felt to be the best available stimulus to induce contralateral 
responses due to its immuno-inflammatory properties and longevity (see Chapters 2 
& 5). As previously discussed this stimulus also allowed adequate recruitment of 
volunteers. It is unknown however whether an immunisation induces inflammation in 
distant tissues even though there are short-lived systemic effects (see Chapter 5).
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7.3.1 E-selectin in normal human skin
E-selectin is not expressed in large quantities in normal human skin. Some studies 
have indicated the presence o f small amounts (Groves et al, 1991 and 1992; Smith et 
al, 1993; Terajima et al, 1998; Chong et al, 2004), whereas others have not detected 
any presence of E-selectin (Cotran et al, 1986; Sepp et al, 1994; Sais et al, 1997; 
Strickland et al, 1997; Sigurdsson et al, 2000; van der Laan, 2001) in normal skin 
from healthy human volunteers.
For example, Chong et al (2004) readily demonstrated the presence of E-selectin in 
all 12 skin biopsies taken from non-inflamed skin. This skin had been removed in 
cosmetic plastic surgery to the face, breast and abdomen in patients with no known 
inflammatory condition. They used a monoclonal antibody and the ABC method (see 
below) stained with the NovaRed substrate kit. The distribution o f E-selectin was 
patchy in these samples. Some biopsies were positive in one section and negative in 
an adjacent section and, even within one vessel, E-selectin expression could be seen 
to vary from one area of the lumen to another.
For another example, Van der Laan (2001) obtained 6 skin biopsies from patients 
(average age 60 years old) about to undergo elective surgery and could not 
demonstrate the presence of E-selectin protein. Again a monoclonal antibody (HI 8/7) 
was used, this time with a peroxidase conjugated secondary antibody visualised with 
amino-ethylcarbazole. This is a relatively insensitive method compared with the ABC 
method. Interestingly, human endothelial cells studied from these biopsies under 
electron microscopy showed a variety of different stages of ‘activation’, possibly 
corroborating Chong et aVs (2004) findings.
The patchy expression of E-selectin and different staining protocols may explain the 
different results seen between studies that examine the dermal endothelia o f healthy 
human volunteers.
7.3.2 E-selectin expression is induced following inflammatory stimulation 
E-selectin is upregulated rapidly following inflammatory stimuli and this process is 
linked to transcriptional up-regulation via the NF-#cB pathway (Barnes and Karin,
1997). Although some studies have induced E-selectin using the pro-inflammatory
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cytokines TNFa and IL-1, some other inflammatory stimuli may be quite mild. For 
example, E-selectin mRNA is demonstrable 4 hours after human forearm skin has 
been rubbed with an eraser for two minutes (Takeuchi et al, 2003).
E-selectin protein expression is detectable following neuropeptide release after 24 
hours, either through capsaicin (Egan et al, 1998), or direct injection of substance P 
(Smith et al, 1993). Egan et al (1998) explored the histological relationship between 
unmyelinated nerves and mast cells in the skin o f mice and applied topical capsaicin 
to the skin of human volunteers. They found an intimate relationship between the 
nerves and mast cells in mice and an upregulation of E-selectin from 
immunohistochemical techniques in the volunteers. Smith et al (1993) injected SP, 
CGRP and VIP into the skin o f volunteers and compared the numbers o f neutrophils, 
eosinophils and E-selectin expression over the following 24 hours. There were 
significant increases in both types of cell and E-selectin expression between 1-8 hours 
following injection of each o f these neuropeptides.
7.4.1 Rationale for immunohistochemistrv
There are many laboratory investigational techniques to detect inflammatory 
responses. Immunohistochemistry is used to demonstrate the presence of an antigen 
within tissue. First described by Albert H Coons and colleagues in 1941 (Polak and 
van Noorden, 1997), there are now many different techniques available. Its 
advantages are that it is relatively cheap, reliable and quick to use compared to other 
techniques such as in situ hybridisation or the polymerase chain reaction. A 
disadvantage of immunohistochemistry compared to these other techniques is that it 
can not be used to gain absolutely quantitative measurements. However it can be used 
qualitatively and semi-quantitatively in a comparative manner, using techniques such 
as the supra-optimal dilution method.
For the purposes of this study, the immunohistochemical technique used is the avidin- 
biotin-peroxidase complex (ABC) method (Hsu et al, 1981). This three-layer 
technique exploits the strong and specific attraction of avidin and biotin. Avidin has 
four binding sites per molecule for the low molecular weight vitamin, biotin. Biotin
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has just one binding site for avidin and can be conjugated to many other 
macromolecules, such as fluorophores or enzymes.
First, the primary antibody is added to the section, after the standard preparation and 
blocking techniques. The second layer is the biotinylated secondary antibody which 
binds specifically to the primary antibody. The third layer is a suspension of avidin 
and biotinylated peroxidase. This complex can be visualised under light microscopy 
after adding diaminobenzidine tetrahydrochloride which is oxidised by the 
peroxidase. The following reaction product is intensified with copper to give a dark- 
brown stain.
7.4.2 Supraoptimal dilution
First described in 1985 by Vacca-Galloway, this technique is useful in semi- 
quantifying the amount of antigen in one sample relative to another, or one structure 
relative to another within the same sample. This technique has been used by several 
groups in order to semi-quantify tissue antigens (Springall et al, 1988; Bhatia et al, 
1998; Arantes and Nogueira, 2001).
The principle is dependent upon the varying interaction between the fixed 
concentration of antigen in the section with the different antibody concentrations. The 
antibody is first titrated in a series of dilutions to find the optimal dilution that gives 
strong staining and a low background as well as the ‘supra-optimal’ dilution at which 
staining is weak but still reliably demonstrates all the positive structures. The end­
point occurs at the dilution where no reliable staining o f the antigen occurs. 
‘Titration’ curves can then be drawn from the semi-quantified staining that occurs at 
each antibody dilution. There are three relevant outcome measures that have been 
used with this technique to compare the amount o f tissue antigen between two 
samples. These are the end-point dilution, the slope of the titration curve, and the 
amount of staining at a supra-optimal dilution compared to the optimal dilution 
(Vacca-Galloway, 1985; Arantes and Nogueira, 2001).
The constraints to this technique are that a rigid protocol must be adhered for all 
samples to be compared. For example, tissue on separate slides must be as 
contiguous as possible to allow reliable counts. Traditionally, the relatively
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insensitive peroxidase-anti-peroxidase (PAP) method has been used for supraoptimal 
dilution methods because o f the difficulty in identifying high and low amounts of 
antigen using the more sensitive ABC method (Stemberger and Stemberger, 1986). 
As will be seen, this has not proved to be a problem in the following protocols, 
presumably due to the very low concentrations of primary antibody that were used. 
Finally, good image analysis techniques should be available with adequate 
reproducibility measures.
The following sections describe the establishment of the immunohistochemical 
techniques: the protocol; the image analysis; and the reproducibility o f this technique.
7.5.1 Detecting E-selectin in the laboratory using immunohistochemistry 
To determine whether E-selectin could be detected using standard ABC 
immunohistochemical techniques (see section 7.6.3), and to assess the effects of an 
inflammatory stimulus on its expression, three skin biopsies (see section 7.6.2) were 
taken from one subject. The sites were: a control site that had not been exposed to any 
stimulus; an immunisation site that had been injected with an influenza immunisation 
24 hours prior; and a capsaicin site that had been injected with 0.1% capsaicin 
solution 8 hours prior. The intradermal capsaicin site was used as a positive control 
for the technique as capsaicin is known to induce E-selectin expression (Egan et al,
1998).
The results are shown in Image 7.1 with negative controls from the protocol shown in 
Image 7.2. Consecutive sections were stained with either human E-selectin antibodies 
or human CD31 antibodies (endothelial marker) so that co-localised staining patterns 
could be ascertained. As can be seen, the distribution of the E-selectin staining pattern 
co-localises with that of the CD31 pattern, suggesting that this positive stain is very 
likely to represent true E-selectin staining. There is very little E-selectin in the control 
section although normal amounts of endothelial CD31 are seen. E-selectin is heavily 
expressed in the capsaicin exposed skin. The skin exposed to immunisation also 
demonstrates the up-regulation of E-selectin.
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The stimulus (immunisation) and detection technique (immunohistochemistry) are 
therefore adequate for detecting an inflammatory response and would be appropriate 
to use in a model to test the hypothesis.
7.5.2 Supraoptimal dilution technique in the three samples
Supraoptimal dilutions were then carried out using these samples and the following 
fold dilutions of the primary antibody: 20 50 100 200 800 1,600 5,000 15,000
50,000 and 150,000. Images were captured at low power using Zeiss KS300 
microscope and Image Capture software. Images were then processed using 
interactive software that identified regions of interest and automatically calculated a 
pixel count. By simultaneously using high power microscopy, a consecutive section 
stained for the endothelial marker CD31, and the image analysis, non-specific 
staining could be identified. Hence areas o f true endothelial staining representative o f 
E-selectin staining were more likely to be counted. The amount of staining correlates 
with the distribution o f the antigen and, at low doses of primary antibody, its 
concentration in the tissues. As can be seen in Image 7.3 the staining o f endothelium 
with the E-selectin antibody vanishes at a dilution of 150,000.
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Image 7.1 E-selectin and CD31 staining in consecutive sections from skin






Images a, c, e stained for E-selectin at 1:50 dilution for one hour. Images b, d, f 
stained for CD-31 at 1:400 dilution for one hour (endothelial stain). All images are 
xlO magnification. All skin biopsies were taken from the same individual.
Images a and b were taken from a control site and demonstrate little or no E-selectin 
staining. Images c and d were taken 8 hours following a capsaicin injection and 
demonstrate a large amount o f E-selectin staining co-localised with CD-31 staining. 
Images e and f were taken 24 hours following an influenza immunisation and 
demonstrate E-selectin staining co-localised with CD-31 staining.
144
Image7.2 Negative control sections for E-selectin immunohistochemistry
Image a obtained after primary antibody had been omitted. Image b obtained after 
secondary antibody had been omitted. Image c was obtained after mouse IgGl 
antibody had been added instead o f  primary antibody. In all o f  these sections, there is 
no significant staining o f endothelium. There is some background staining o f the 
epithelium and some sweat glands.
Image 7.3 Effects of diluting the primary antibody on the staining pattern
h
Z ' Z r
d
All images have been obtained from sections o f  skin following intradermal capsaicin 
injection. ABC immunohistochemistry was performed using human e-selectin as the 
primary antibody. Images a, b, c, and d use a fold dilution o f  50, 800, 50,000 and
150,000 respectively. Faint staining can be seen in image c (arrowed), but not in 
image d. The ‘end point’ o f  this reaction would therefore be 150,000. Not all o f  the 
dilutions that were performed have been shown here to save space.
Two separate analyses were made, one o f E-selectin, and the other o f  CD31 in 
adjacent sections. First, the total area o f  E-selectin stained tissue (in pixels) was 
calculated and corrected for the total area o f the tissue (Image 7.4). Second, in order 
to compare the E-selectin staining in two tissue samples meaningfully, a correction 
for endothelial density (anti-CD31 staining density on the adjacent section) was 
made.
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Image 7.4 Highlighted regions of interest using Zeiss Image Analysis
Image a is analysed using the ‘Interactive’ function in the Zeiss Image Analysis 3.01 
software program. This allows each region o f  interest to be identified manually (in 
green). Note that in image b, not all o f  the staining regions have been identified. This 
is because these regions were thought to have irrelevant staining when viewed at high 
power magnification. This degree o f subjectivity highlights the need for repeated 
observations using independent observers when using this form o f  analysis.
Intra- and inter-observer counts were therefore obtained. Both observers were blinded 
to the original results and evaluated 10 slides, a mix o f  both E-selectin and CD31 
stains. Figures 7.1 and 7.2 detail the results o f  the intra- and inter-observer 
differences respectively.
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Figure 7.1 Bland-Altman plot of intraobserver readings for staining percentages 
from 10 samples with a mixture of E-selectin and CD31 stained sections
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Figure 7.2 Bland-Altman plot of interobserver readings for staining percentages 












Average percentage o f  two readings
Intraobserver values gave a variability of 8.8% (95% confidence interval (Cl): 39.8%) 
from the original reading, with an absolute minimum detectable difference o f 0.72% 
from the original reading. Interobserver values for the same data set gave similar 
values. There was an average of 4.7% deviation between the two readings with a 95% 
Cl of 53.6%. This translated into an absolute minimum detectable difference of 1.0% 
from the original reading in the density of staining for either E-selectin or CD31.
The immunohistochemical technique and subsequent image analysis demonstrated 
staining densities o f between 0.5-4% in the tissue. The minimum detectable 
differences that could not be attributable to observer variability to a level o f 95% 
chance is therefore between 0.7-1%. This technique would be useful for detecting 
large differences in the staining densities between two tissue samples.
7.6.1 Subject recruitment
All subjects were students recruited within 3 days o f having a Mumps, Measles and 
Rubella triple immunisation booster at the University o f Bath. Each student was given 
a £100 stipend to compensate for time and inconvenience. This study had received the 
approval of the Bath LREC (BA 172).
7.6.2 Skin biopsy protocol
Two areas o f skin were identified. The experimental (upper) site was identified on the 
exact area contralateral to the immunisation (dermatome C5/C6). The control (lower) 
site was identified on the forearm of the contralateral arm (dermatome C7/C8).
The site was sterilised with liberal amounts o f chlorhexidine, air-dried and injected 
with 1ml o f 1% lidocaine. A 4mm punch biopsy was obtained, placed into Optimum 
Cutting Compound (OCT) and then plunged into isopentane before being placed into 
liquid nitrogen. Specimens were then stored in a -70°C freezer and used within 6 
months. Standard aftercare was offered to all students. There were no complications. 
No volunteer for this protocol had been included in any previous protocol.
15 students volunteered, 10 males and 5 females. Their average age was 20.3 years 
(range 18-23 years). 13 had been immunised in the left arm, 2 in the right. All were fit 
and well with no illnesses and were taking no medication.
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7.6.3 Immunohistochemistrv protocol (ABC method)
Consecutive Sections were cut 7-10 pm thick using a cryostat (Brights, UK) at -  
20°C. Some o f the sections were manipulated so that the interposing surfaces were 
face-up on two successive slides. These ‘flip-flop’ sections allow more reliable 
staining for the purposes of comparative semi-quantitative analysis and were used 
when the supraoptimal staining compared to optimal staining was analysed.
Sections were then thawed at room temperature for 30 minutes before being placed 
into acetone for 5 minutes and rehydrated in phosphate buffered saline (PBS) for 5 
minutes. Sections were then washed in 0.3% hydrogen peroxide twice, each for 3 
minutes, and then placed in PBS for 5 minutes. An Elite ABC kit (VectaStain, PK- 
6102) was used. Blocking peptide (horse serum) was added for 20 minutes and 
shaken off before 50pm of the primary antibody was added for one hour. Sections 
were washed twice in PBS, each for 5 minutes. Secondary antibody (ABC kit) was 
added for 30 minutes. Sections were washed twice in PBS, each for 5 minutes. 
Avidin-Biotin-peroxidase complex (made up 30 minutes previously) was then added 
to the sections for 30 minutes. Sections were washed twice in PBS, each for 5 
minutes. Copper-enriched diaminobenzidine was prepared from a kit (Vector 
Laboratories, SK-4100) and added for 5 minutes before being stopped in tap water. 
Sections were then dehydrated in industrial methylated spirit for 2 minutes and then 
xylene for 2 minutes, mounted in DPX and left overnight before analysis.
All reagents were made fresh for each experiment. Primary antibodies were all from 
the same lot number. The ABC kit was sufficient for all experiments.
The primary monoclonal antibodies were human E-selectin raised in mouse (R&D 
Systems, IgGl isotype from clone BBIG-E4 (5D11), lot AQE02); and human CD-31 
raised in mouse (BD Pharmingen, IgGl isotype from clone WM59, lot G74641E).
Negative controls omitting primary or secondary antibody steps were obtained for 
each biopsy. Neither of these controls produced any significant staining. Irrelevant 
mouse IgGl antibodies (DAKO, X0931) were also used instead of primary antibody 
for each biopsy as a control.
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7.6.4 Analysis
The outcomes to be semi-quantitatively analysed are 
A the end-point dilution
B the percentage supra-optimal staining compared to optimal dilution.
C the slope of the titration curve
These outcomes are all defined on non-linear or non-parametric scales and to be 
analysed comparatively between the experimental and control groups. The Wilcoxon 
signed rank test was used.
7.7.1 Results: End-point dilutions
Alternate sections were stained with either anti-CD31 or E-selectin. Only sections 
stained for E-selectin that co-localised with anti-CD31 were counted as having E- 
selectin positivity. Serial dilutions of the E-selectin monoclonal antibody were made 
from 1:20 to 1:150,000 (see 6.5.2). The end-point was defined as the dilutional level 
where no staining was detected (Table 7.1). The median end-point for the upper arm 
was a dilution o f 5000 and this was the same value for the median in the lower arm. 
There were no significant differences when these results were analysed with the 
Wilcoxon signed-rank test.
7.7.2 Results: Supraoptimal compared to optimal staining
Using Zeiss Image Analysis 3.0, the density of E-selectin staining in both the optimal 
and supra-optimal sections was first determined (Table 7.2). The density o f CD31 
staining in adjacent sections was then determined (Table 7.3). The E-selectin staining 
was then expressed as a percentage of endothelial density (Table 7.4) to give a 
density o f E-selectin staining corrected for endothelial density. Finally, the expression 
of supraoptimal staining expressed as a percentage of optimal staining was calculated 
(Figure 7.3). There were no significant differences between the experimental and 
control groups using the Wilcoxon signed-rank test.
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The E-selectin end-dilution for each volunteer’s skin biopsy (upper contralateral to 
the immunisation site, lower acting as control) was calculated as described in section
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Table 7.2 Density percentage of E-selectin staining in both upper (experimental)









1 0.23 0.09 0.40 0.22
2 1.11 1.28 0.32 0.20
3 0.36 0.17 3.04 1.95
4 1.24 0.50 1.54 0.24
5 0.50 0.28 1.86 1.45
6 1.31 0.24 2.37 0.69
7 0.31 0.20 0.53 0.15
8 1.65 0.90 0.33 0.33
9 1.20 1.05 1.01 0.46
10 0.81 0.54 2.21 0.63
11 1.41 0.76 0.43 0.21
12 0.82 0.31 2.77 1.41
13 0.25 0.16 0.32 0.27
14 1.79 0.38 0.90 0.40
15 1.09 0.35 0.55 0.27
The density o f E-selectin postitive staining was expressed as a percentage of total 
area of each skin biopsy. This was calculated for each volunteer’s skin biopsy (upper 
contralateral to the immunisation site, lower acting as control) at the supraoptimal 
dilution as well as the optimal.
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The density o f CD31 positive staining was expressed as a total percentage of the skin 
biopsy’s surface area. This was calculated separately for both upper and lower 
regions.
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Table 7.4 E-selectin density expressed as a percentage of CD31 staining in both










1 10.0 3.9 20.0 11.0
2 48.3 55.7 8.2 5.1
3 27.7 13.1 84.4 54.2
4 25.8 10.4 20.3 3.2
5 12.5 7.0 74.4 58.0
6 62.4 11.4 67.7 19.7
7 4.4 2.8 6.0 1.7
8 71.7 39.1 20.6 20.6
9 52.2 45.7 31.6 14.4
10 21.9 14.6 78.9 22.5
11 52.2 28.2 26.9 13.
12 24.9 9.4 89.4 45.5
13 22.7 14.6 15.2 12.9
14 85.2 18.0 33.3 14.8
15 83.9 26.9 32.4 15.9
The E-selectin density is expressed as a percentage o f the CD31 staining for each 
sample (upper and lower) for each volunteer. This is done at both supraoptimal and 
optimal dilutions.
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7.7.3 Titration curve slope
The titration curve o f  the primary antibody dilution was plotted against the staining 
percentage. There were no significant differences between these groups when these 
results were analysed (figure 7.4).
7.8.1 Discussion
A reliable, semi-quantitative, immunohistochemical method to investigate differences 
in the E-selectin staining density, corrected for endothelial density, has been 
demonstrated. However no differences in E-selectin staining density were found 
between experimental and control skin biopsies taken from the arm contralateral to an 
MMR immunisation in 15 human volunteers in any o f  the outcome measures. The 
following discussion explores possible weaknesses in the experimental technique 
used to test this hypothesis.
Upper arm Lower arm
(Experimental) (Control)
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Figure 1.4 The percentage of E-selectin staining as a proportion of CD31
(endothelial) staining at different concentrations of primary antibody (optimal 
(50): supraoptimal (200) and end-point (15000)
1.7 2.3 4.2
(50) (200) (15000)
Log Dilution of primary antibody
■ Experimental (upper) Control (lower)_
As discussed in Chapters 2 and 5, the contralateral response is small in magnitude. 
Sensitive methods are required to detect such responses. Immunohistochemical 
techniques are not as sensitive as other methods, such as in situ hybridisation or the 
polymerase chain reaction (PCR). Similarly, the immunisation may not have 
introduced a sufficiently large enough stimulus to generate the contralateral response 
or the timing o f  the experiment may have missed the contralateral response.
Recently, Roberts (2006), in our laboratory, has investigated contralateral responses 
in a rat model using the unilateral injection o f latex spheres into a hindpaw to 
introduce a mainly macrophage response. PCR was used to quantify E-selectin 
mRNA at several time points using the forepaws as control. The contralateral 
hindpaw was seen to demonstrate E-selectin mRNA expression at 6 hours following
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the stimulus, but not at baseline, 1 hour nor 24 hours. Similarly, control forepaws in 
the same rats did not demonstrate any E-selectin mRNA (unpublished data, Roberts 
(2006)). This more sensitive technique, coupled with a more inflammatory stimulus, 
was able to demonstrate a topographically precise contralateral response.
The control region was selected because it was located within a different dermatome. 
However anatomical studies demonstrate that afferent neuropeptide-containing 
neurons enter the spinal cord and travel rostro-caudally for up to two adjacent 
dermatomes before synapsing. The small number o f neurons that are seen to do this 
may have a significant role in changing spinal responses and initiating contralateral 
responses. Perhaps a more appropriate control region would therefore have been from 
a different limb. This was proposed to and rejected by the Local Research Ethics 
Committee on the grounds that it was an unnecessary intervention. However, as can 
be seen in Roberts’ albeit more aggressive rat model, differences are apparent when 
controls are taken from a different limb.
E-selectin levels may have returned to baseline before the biopsy was taken. A 
retrospective subanalysis with a linear regression model was performed using time 
since biopsy (range 1-3 days) (SPSS 12.0). This did not indicate any significant 
influence of this variable. It is possible that any E-selectin response could have 
peaked and subsided during this time, although it was felt that this was unlikely.
It is possible that E-selectin levels may not have been activated by any contralateral 
response. This was again thought to be unlikely as contralateral responses are thought 
to be neuropeptide-induced and, as outlined above, substance P and CGRP are both 
known to induce dermal E-selectin expression in humans.
7.9.1 Conclusion
No differences between experimental and control skin biopsies were found with 
respect to E-selectin expression. Although this result supports the null hypothesis, 
there was sufficient experimental doubt with regards to stimulus magnitude and 
investigational techniques as to warrant further investigation, such as with PCR 
methods.
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Chapter 8. Summary and conclusions
8.1.1 Background
Some diseases are inexplicably symmetrical in phenotype. These diseases are 
generally best described as immune-mediated inflammatory diseases (IMIDs), 
although there are exceptions such as osteoarthritis. Such examples of IMIDs include 
rheumatoid arthritis and skin psoriasis. In chapter 1, three different hypotheses are 
suggested as to what may cause the symmetry in these conditions. These are 
neurogenic, biomechanical and genetic hypotheses. The evidence for each o f these is 
evaluated and a neurogenic hypothesis is thought to be the most important to evaluate 
for two reasons. There is good evidence that it is likely to account for this symmetry 
and there is unexplored therapeutic potential should the hypothesis be supported.
The evidence for a neurogenic hypothesis via crossed afferent pathways at both a 
spinal and a supraspinal level is reviewed in chapter 2. It is seen that afferent fibres 
decussate through the dorsal commissure to synapse in the contralateral dorsal hom 
and deeper spinal laminae (Szentagothai (1964), Light and Perl (1979), Culberson et 
al (1979)). These fibres are seen throughout the spinal cord and in all species studied. 
Spinal reflex arcs affect the resting state of neurons in the contralateral dorsal hom 
following local stimuli. Although these are mainly inhibitory in otherwise healthy 
rats, this can change dependent upon previous stimuli, such as capsaicin (Fitzgerald 
1982a and b). Contralateral responses seen in the spinal cord include metabolic 
activation and the expression of immediate-early genes (see 2.6.4). This implies that 
the contralateral dorsal hom has a physiological role in the response to a unilateral 
stimulus. Contralateral responses effecting a motor reflex have been well described, 
but the anatomical position and functional nature of the areas affected in the dorsal 
hom suggest a sensory function for these contralateral effects.
The literature demonstrates that central sensory changes in response to a unilateral 
stimulus occur in rats following hindpaw inflammation (Shenker et al (2003)). 
Furthermore, in several animal models peripheral changes are also seen to occur in 
the structure contralateral to the local inflammation (Shenker et al (2003)). This
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allows a pathway to be hypothesised connecting bilateral regions through spinal 
conduits (Levine et al (1985). In a chronic setting established bilateral inflammation 
would feedback positively in a reciprocal pattern and propagate the disease process 
(Kidd et al (1989)).
Neuropeptides contained in the thinly myelinated or unmyelinated neurons can 
contribute markedly to important processes of classical inflammation (see 3.3.1-7). 
These include vasodilatation, plasma exudation, recruitment of leukocytes, activation 
of leukocytes, and the secondary recruitment of immunological elements (Garrett et 
0/(1992)).
The influence o f neurogenic inflammation on chronic inflammatory processes has not 
been elucidated and no targets have been successfully therapeutically translated. 
Laboratory work and animal models suggest that some neuropeptides and nerves are 
important in the propagation of chronic inflammation (see 3.3.1-7). The identification 
of an autoregulatory neural feedback loop that links bilateral anatomical structures 
would not only provide evidence that the nervous system is important in IMIDs, but 
highlight the unexplored potential for beneficially influencing these processes.
8.1.2 Distribution of erosions over time in a group o f patients with early RA 
The distribution and evolution o f erosions over 18 months were studied using 
macroradiographs from a cohort of 42 patients who had had 6 months o f symptoms of 
rheumatoid arthritis in chapter 4. The erosions were very symmetrical at baseline 
(odds ratio o f 6) and were more likely to become symmetrical over time (odds ratio of 
11). Some of this symmetry was accounted for by correcting for an individual site’s 
predisposition to developing an erosion and the number of erosions that an individual 
developed. The remaining symmetry appeared to derive from the patients who had 
few erosions who were far more likely to have their erosions distributed in a 
symmetrical pattern.
This apparently contradictory finding can be explained by suggesting the presence of 
two underlying mechanisms in the development of erosions. Process S might define a 
small number of highly symmetrical erosions. This could later be masked by a more 
general process (P) that affects the predisposed areas. Process P appears symmetrical
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due to its predilection towards a restricted number o f sites and as this process 
progresses the overall rate of symmetry increases. It is unclear from the data whether 
a neurogenic or biomechanical process is supported more strongly.
8.2.1 Previous work in man
Although the thesis that one side of the body can influence processes in the exact 
contralateral region was published in the 1980s (Levine et al (1985) and Kidd et al 
(1989), and several animal models have demonstrated that this is likely to have a 
physiological role in distant inflammatory responses (Shenker et al (2003), little work 
has been performed in man.
Our group has previously studied sensory changes occurring on the contralateral 
forearm within 30 minutes following a capsaicin injection (see 2.10.1-6). 
Hyperalgesia and allodynia occurred in about 50% of volunteers, either patients with 
rheumatoid arthritis or healthy volunteers, and were topographically precise and 
transient in nature suggesting that they were not an artefact. Furthermore, these 
contralateral changes were not seen in the control group.
This study was not designed to detect peripheral responses. Observations at the time 
suggested that an increase flare-wheal response occurred following Semmes- 
Weinstein monofilament stimulation in some individuals in the exact contralateral 
area to the capsaicin injection when compared to other areas of skin not contralateral 
to the capsaicin injection. Do peripheral changes occur in the exact contralateral area 
to a local stimulus in man?
8.3.1 Skin blood flow responses contralateral to an active immunisation
Chapter 5 details how a clinical model to test contralateral changes to a local 
inflammatory stimulus was established using the outcome measure of a change in 
skin blood flow over time. The skin blood flow response to topical capsaicin as a 
surrogate outcome for the neuropeptide concentration in the skin was not found to be 
useful as no differences were detectable over time in the small number of healthy 
volunteers studied. Skin blood flow was seen to increase in the region following the 
introduction o f an active immunisation and possibly in the contralateral region.
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Chapter 6 details the clinical study o f 59 healthy volunteers who had received an 
active immunisation. The contralateral region was compared with control regions and 
skin blood flow was evaluated 1-4 days following immunisation and 2 months later as 
a control time. No change in skin blood flow when compared to the control regions 
was seen.
8.3.2 E-selectin expression contralateral to an MMR immunisation 
15 healthy volunteers who had received an MMR immunisation 1-3 days prior 
donated two skin biopsies from the contralateral arm (Chapter 7). One region was 
exactly opposite the immunisation site, whereas the other was from the lower arm in a 
different region. E-selectin was semi-quantified by a supraoptimal dilutional method. 
No differences were found in any o f the three outcomes between the amount e- 
selectin between the experimental and control groups
8.4.1 Further work
The null hypothesis was supported by the experiments that were performed. This 
could mean that there are no functional crossed afferent pathways in man, but could 
also mean that these pathways were not operational in a detectable fashion following 
the first four days after an active immunisation.
Further experiments to test the hypothesis in man should focus on delivering a 
stimulus more likely to overcome the threshold required to generate a contralateral 
response. A longer time course may be need to detect contralateral responses and 
perhaps a more sensitive technique would be helpful.
8.5.1 Conclusion
This thesis provides preliminary data investigating the hypothesis that a local 
inflammatory stimulus can induce topographically precise contralateral changes in 
man. Radiographic analysis o f hands of patients with very early rheumatoid arthritis 
showed that a subpopulation of these patients demonstrated mirror-imaging of their 
erosions to a remarkable degree. Changes in skin blood flow contralateral to an active 
immunisation were seen in a small number of individuals but this did not reach 
statistically significance. No clear evidence for a contralateral response was achieved
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immunohistochemically in terms o f E-selectin expression following an active 
immunisation. The hypothesis therefore remains open.
Now that preliminary studies have been completed further work should address the 
questions of stimulus and timing of contralateral responses in man as it is clear that 
these may differ extensively from those observed in model systems.
163
Bibliography
Dequeker J and Dieppe P. Disorders of Bone and Cartilage. In “Rheumatology” 2nd 
Ed. Klippel and Dieppe. 1997. Mosby, London. Sections 8.2 -  8.4.
Daly LE and Bourke GJ. Interpretation and Uses of Medical Statistics 5tb Edition, 
Blackwell Science Ltd, 2000, Oxford. ppl36.
Dixon A. Hemiplegia, hand dominance and asymmetry o f expression of arthritis in 
relation to intra-articular pressure. In “Raised intra-articular pressure -  clinical 
consequences”. Edited by Dixon A and Hawkins C. Bath Institute for Rheumatic 
Diseases, Bath, 1989. pp 65.
Gordon DA and Hastings DE. Rheumatoid arthritis: clinical features and systemic 
involvement. In “Rheumatology” 2nd Ed. Klippel and Dieppe. 1997. Mosby, London. 
Section 5.3.1-14.
Hokfelt T, Xu ZD, Broberger C, Shi TS and Zhang X. General Overview of 
Neuropeptdes. “Psychopharmacology, Fourth Generation o f Progress” American 
College of Neuropsychopharmacology, 2004.
Lotz M. Neuropeptides and free radicals in RA. In “Rheumatology” 2nd Ed. Klippel 
and Dieppe. 1997. Mosby, London. Section 5.11.1-5.
Polak JM and Van Noorden S. “Introduction to Immunocytochemistry”. 2nd Edition. 
BIOS Scientific Publishers, Oxford, 1997. pp52 &pp99-100.
Thompson DW “On Growth and Form” Ed Bonner JT. Cambridge University Press, 
London, 1965.
Roberts E, PhD Thesis, University of Bath, 2006.
Stewart I and Golubitsky M. “Fearful symmetry: is God a geometer”. Penguin, 1992.
164




Al’Abadie MS, Senior HJ, Bleehen SS and Gawkrodger DJ. Neuropeptides and 
general neuronal marker in psoriasis -  an immunohistochemical study. Clin Exp 
Dermatol, 1995; 20: 384-389.
Alexander CM and Harrison PJ. The bilateral control of the trapezius muscle in 
humans. Exp Brain Res, 2002; 142: 418.
Allsup SJ, Gosney M, Regan M, Haycox A, Fear S and Johnstone FC. Side effects of 
influenza vaccination in healthy older people: a randomised single-blind placebo- 
controlled trial. Gerontology, 2001; 47: 311-314.
Aloisi AM, Porro CA, Cavazzuti M, Baraldi P and Carli G. ‘Mirror pain’ in the 
formalin test: behavioural and 2-deoxyglucose studies. Pain, 1993; 55: 267-273.
Amann R, Sirinathsinghji DJ, Donnerer J, Liebmann I and Schuligoi R. Stimulation 
by nerve growth factor of neuropeptide synthesis in the adult rat in vivo: bilateral 
response to unilateral intraplantar injections. Neurosci Lett, 1996; 203: 171-4.
Andersson SE, Lexmuller K and Ekstrom GM. Physiological characterization of 
mBSA antigen induced arthritis in the rat. I. Vascular leakiness and pannus growth. J 
Rheum, 1998; 25: 1772-1777.
Arantes RME and Nogueira AMMF. Increased intracellular content of 
enteroglucagon in proximal colon is related to intestinal adaptation to germ-free 
status. Cell Tissue Res, 2001; 303: 447-450.
Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 
1987 revised criteria for the classification o f rheumatoid arthritis. Arth Rheum, 1988; 
31:315-324.
166
Asai R, Taguchi E, Kume Y, Saito M and Kondo S. Zebrafish leopard gene as a 
component of the putative reaction-diffusion system. Mech Dev, 1999. 89: 87-92.
Badavi M, Khoshbaten A and Hajizadeh S. Decreased response of rat knee joint 
blood vessels to phenylephrine in chronic inflammation: involvement o f nitric oxide. 
Exp Physiol, 2000; 85: 49-55.
Barnes, PJ and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in 
chronic inflammatory diseases. NEJM, 1997; 336: 1066.
Bedoui S, Kawamura N, Straub RH, Pabst R, Yamamura T and von Horsten S. J 
Neuroimmunol, 2003; 134: 1-11.
Benjamin M and McGonagle D. The anatomical basis for disease localisation in 
seronegative spondyloarthropathy at entheses and related sites. J Anat, 2001; 903- 
926.
Betoin F, Ardid D, Herbet A, Aumaitre O, Kemeny JL, Duchene-Marullaz P, 
Lavarenne J and Eschalier A. Evidence for a central long-lasting antinociceptive 
effect o f vapreotide, an analog of somatostatin, involving an opioidergic mechanism. 
J Pharmacol Exp Ther, 1994; 269: 7-14.
Bevan SJ and Szolcsanyi J. Sensory neuron-specific actions o f capsaicin: mechanisms 
and applications. Trends Pharmacol Sci, 1990; 11: 330-333.
Bhatia AJ, Blades S, Cambridge G and Edwards J. Differential distribution of 
FcyRIIIa in normal human tissues and co-localization with DAF and fibrillin-1: 
implications for immunological microenvironments. Immunology, 1998; 94: 56-63.
Bhattacharya SK, Das N and Rao PJ. Effect of pre-existing inflammation on 
carrageenan-induced paw oedema in rats. J Pharm Pharmacol, 1987; 39: 854-6.
167
Bileviciute I, Lundeberg T, Ekblom A and Theodorsson E. Bilateral changes of 
substance P, neurokinin A, calcitonin gene-related peptide and neuropeptide Y-like 
immunoreactivity in rat knee joint synovial fluid during acute monoarthritis. Neurosci 
Lett, 1993; 153: 37-40.
Bileviciute I, Stenfors C, Theodorsson E and Lundeberg T. Unilateral injection of 
calcitonin gene-realted peptide (CGRP) induces bilateral oedema formation and 
release of CGRP-like immunoreactivity in the rat hindpaw. Br J Pharmacol, 1998; 
125: 1304-1312.
Bileviciute-Ljungar I and Lundeberg T. Contralateral but not systemic administration 
o f bupivacaine reduces acute inflammation in the rat hindpaw. Somatosens Mot Res, 
2000; 17: 285-293.
Bileviciute-Ljungar I and Spetea M. Contralateral but not systemic administration of 
the k-opioid agonist U-50,488H induces anti-nociception in acute hindpaw 
inflammation. British Journal o f Pharmacology, 2001; 132: 252-258.
Bird HA, Ring EJF and Bacon PA. A thermographic and clinical comparison of three 
intra-articlar steroid preparations in rheumatoid arthritis. Ann Rheum Dis, 1979; 38: 
36-39.
Bland JH and Eddy WM. Hemiplegia and rheumatoid hemiarthritis. Arth Rheum, 
1968;11:72-80.
Boonsaner K, Louthrenoo W, Meyer S and Schumacher HR. Effect of dominancy on 
severity in rheumatoid arthritis. Br J Rheum, 1992; 31: 77-80.
Borum S, Nielsen K, Bisgaard H and Mygind N. Experimentally induced nasal 
hypersecretion does not reduce the efficacy of intranasal levocabastine. Rhinology, 
1998; 36: 153-155.
168
Boyle DL, Nguyen KH, Zhuang S, Shi Y, McCormack JE, Chada S and Firestein GS. 
Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced 
th2 activity. Gene Ther, 1999; 6: 1911-8.
Brain SD, Williams TJ, Tippins JR, Morris HR and MacIntyre I. Calcitonin gene- 
related peptide is a potent vasodilator. Nature, 1985; 313: 54-56.
Brennum J, Kjeldsen M, Jensen K and Jensen TS. Measurements of human pressure- 
pain thresholds on fingers and toes. Pain, 1989; 38: 211-217.
Brizzolara AL and Bumstock G. Endothelium-dependent and endothelium- 
independent vasodilatation o f the hepatic artery of the rabbit. Br J Pharmacol, 1991; 
103: 1206-1212.
Brook A and Corbett M. Radiographic changes in early rheumatoid disease. Ann 
Rheum Dis, 1977; 36: 71-73.
Buckland-Wright JC. Microfocal radiographic examination of erosions in the wrists 
and hands of patients with rheumatoid arthritis. Ann Rheum Dis, 1984; 43: 160-171.
Buckland-Wright JC, Carmichael I and Walker SR. Quantitative microfocal 
radiography accurately detects joint changes in rheumatoid arthritis. Ann Rheum Dis, 
1986; 45:379-383.
Buckland-Wright JC and Walker SR. Incidence and size o f erosions in the wrist and 
hand o f rheumatoid arthritis: a quantitative microfocal radiographic study. Ann 
Rheum Dis, 1987; 46: 463-467.
Buckland-Wright JC and Bradshaw CR. Clinical applications o f high-defmition 
microfocal radiography. Br JRad, 1989a; 62: 209-217.
Buckland-Wright JC, Clarke GS and Walker SR. Erosion number and area 
progression in the wrists and hands of rheumatoid patients: a quantitative microfocal 
radiographic study. Ann Rheum Dis, 1989b; 48: 25-29.
169
Buckland-Wright JC, Clarke GS, Chikanza IC and Grahame R. Quantitative 
microfocal radiography detects changes in erosion area in patients with early 
rheumatoid arthritis treated with myocrisine. J Rheumatol, 1993; 20: 243-247.
Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DJ and Silman A. Erosions in 
inflammatory polyarthritis are symmetrical regardless o f rheumatoid factor status: 
results from a primary care-based inception cohort of patients. Rheumatology 
(Oxford), 2002; 41: 246-252.
Carrasquillo Y and Gereau RW. Rodent models clarify the role of cells expressing the 
substance P receptor in pain. Drug Discovery Today, 2004; 1: 107-113.
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, and Julius D. 
The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature, 
1997; 389: 816-824.
Ceccherelli F, Gagliardi G, Faggian L, Loprete F and Giron G. Analgesic effect of 
subcutaneous administration of oxygen-ozone. A blind study in the rat on the 
modulation of the capsaicin-induced edema. Acupunct Electrother Res, 1998; 23:
171-184.
Chaisson CE, Zhang Y, Sharma L, Kannel W and Felson DT. Grip strength and the 
risk o f developing radiographic hand osteoarthritis: results from the Framingham 
study. Arth Rheum, 1999; 42: 33-38.
Chan J, Smoller BR, Raychauduri SP, Jiang WY and Farber EM. Intraepidermal 
nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide 
and substance P in psoriasis. Arch Dermatol Res, 1997; 289: 611-616.
Chandrasekhar S, Harvey AK, Hrubey PS and Bendele AM. Arthritis induced by 
interleukin-1 is dependent on the site and frequency of intraarticular injection. Clin 
Immunol Immunopathol, 1990; 55: 382-400.
170
Charkoudian N. Skin blood flow in adult human thermoregulation: how it works, 
when it does not, and why. Mayo Clin Proc, 2003; 78: 603-12.
Chen J, Luo C, Li H and Chen H. Primary hyperalgesia to mechanical and heat 
stimuli following subcutaneous bee venom injection into the plantar surface o f 
hindpaw in the conscious rat: a comparative study with the formalin test. Pain, 1999; 
83: 67-76.
Chong BF, Murphy J, Kupper TS and Fuhlbrigge R. E-selectin, thymus- and 
activation-regulated chemokine/CCL17, and intercellular adhesion molecule-1 are 
constitutively coexpressed in dermal microvessels: a foundation for a cutaneous 
immunosurveillance system. J Immunology, 2004; 172: 1575-1581.
Clapp BR, Hingorani AD, Kharbanda RK, Mohamed-Ali V, Stephens JW, Vallance P 
and MacAllister RJ. Inflammation-induced endothelial dysfunction involves reduced 
nitric oxide bioavailability and increased oxidant stress. Cardiovasc Res, 2004; 64:
172-178.
Clarke GS, Buckland-Wright JC and Grahame R. Symmetry o f radiological features 
in the wrist and hands of patients with early to moderate rheumatoid arthritis: a 
quantitative microfocal radiographic study. Br J Rheum, 1994; 33: 249-254.
Clarke JA, Hollinger FB, Lewis E, Russell LA, Miller CH, Huntley A and Flynn NM. 
Intradermal inoculation with Heptavax-B. Immune response and histological 
evaluation of injection sites. JAMA, 1989; 262: 2567-2571.
Clough GF, Boutsiouki P and Church MK. Comparison of the effects of 
levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human 
skin. Allergy, 2001; 56: 985-988.
Coderre TJ and Melzack R. Cutaneous hyperalgesia: contributions of the peripheral 
and central nervous system to increase in the pain sensitivity after injury. Brain Res, 
1987; 404: 95-106.
171
Coderre TJ and Melzack R. Increased pain sensitivity following heat injury involves a 
central mechanism. Behav Brain Res, 1985; 15: 259-262.
Coghill RC, Price DD, Hayes RL and Mayer DJ. Spatial distribution o f nociceptive 
processing in the rat spinal cord. J Neurophysiol, 1991; 65: 133-140.
Coma S, Galante M, Grasso M, Nardone A and Schieppati M. Unilateral 
displacement of lower limb evokes bilateral EMG responses in leg and foot muscles 
in standing humans. Exp Brain Res, 1996; 109: 83-91.
Coste F and Forestier J. Hemiplegie et nodosites d’Heberden contralaterales. Bull 
Mem Soc Med Hopitaux Paris, 1935; 5: 772.
Cotran RS, Gimbrone MA, Bevilacqua MP, Mendrick DL and Pober JS. Induction 
and detection o f a human endothelial activation antigen in vivo. J Exp Med, 1986; 
164: 661-666.
Courtwright LJ and Kuzell WC. Sparing effect of neurological deficit and trauma on 
the course of adjuvant arthritis in the rat. Ann Rheum Dis, 1965; 24: 360-368.
Culberson JL, Haines DE, Kimmel DL and Brown PB. Contralateral projection of 
primary afferent fibres to mammalian spinal cord. Expl Neurol, 1979; 64: 83-97.
Da Silva P and Carmo-Fonseca M. Peptide containing nerves in human synovium: 
immunohistochemical evidence for decreased innervation in rheumatoid arthritis. J 
Rheum, 1990; 17: 1592-1599.
Day RM, Harbord M, Forbes A and Segal AW. Cantharidin blisters: a technique for 
investigating leukocyte trafficking and cytokine production at sites of inflammation in 
humans. J Immunol Methods, 2001; 257: 213-220.
De Ceballos ML, Jenner P and Marsden CD. Increased [Met]enkephalin and 
decreased substance P in spinal cord following thermal injury to one limb. 
Neuroscience, 1990; 36: 731-736.
172
De Stefano N, Narayanan S, Matthews PM, Francis GS, Antel JP and Arnold DL. In 
vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the 
type seen in multiple sclerosis. Brain, 1999; 122: 1933-1939.
Decaris E, Guingamp C, Chat M, Philippe L, Grillasca J-P, Abid A, Minn A, Gillet P, 
Netter P and Terlain B. Evidence for neurogenic transmission inducing degenerative 
cartilage damage distant from local inflammation. Arth Rheum, 1999; 42: 1951-1960.
Delgado M, Abad C, Martinez C, Lecta J and Gomariz RP. Vasoactive intestinal 
peptide prevents experimental arthritis by downregulating both autoimmune and 
inflammatory components of the disease. Nat Med, 2001; 7: 563-568.
Delgado, M, Pozo D and Ganea D. The significance o f vasoactive intestinal peptide 
in immunomodulation. Pharmacol Rev, 2004; 56: 249-290.
Denko CW and Petricevic M. Sympathetic or reflex footpad swelling due to crystal 
induced inflammation in the opposite foot. Inflammation, 1978; 3: 81-86.
Devlin J, Gough A, Huissoon A, Perkins P, Jubb R and Emery P. The outcome of 
knee synovitis in early arthritis provides guidelines for management. Clin Rheumatol, 
2000; 19: 82-85.
Donaldson LF, McQueen DS and Seckl JR. Neuropeptide gene expression and 
capsaicin-sensitive primary afferents: maintenance and spread of adjuvant arthritis in 
the rat. J Physiol, 1995; 486: 473-482.
Donaldson LF, Seckl JR and McQueen DS. A discrete adjuvant-induced 
monoarthritis in the rat; effects of adjuvant dose. Journal o f Neurosci Meth, 1993; 49: 
5-10.
Dye SF, Vaupel and Dye CC. Conscious neurosensory mapping of the internal 
structures of the human knee without intraarticular anesthesia. Am J Sports Med, 
1998; 26: 773-777.
173
Eccles JC and Sherrington CS. Studies on the flexor reflex. VI. Inhibition. Proc Roy 
SocB, 1931;109:91-113.
Egan CL, Viglione-Schneck MJ, Walsh LJ, Green B, Trojanowski JQ, Whitaker- 
Menezes D and Murphy GF. Characterization of unmyelinated axons uniting 
epidermal and dermal immune cells in primate and murine skin. J Cutan Pathol, 1998; 
25: 20-29.
Esselinckx W, Bacon PA, Ring EFJ, Crooke D, Collins AJ and Demottaz D. A 
thermographic assessment of three intra-articular prednisolone analogues given in 
rheumatoid synovitis. British J Clin Pharm, 1978; 5: 447-451.
Essex TJ and Byrne PO. A laser Doppler scanner for imaging blood flow in skin. J 
BiomedEng, 1991; 13: 189-194.
Falcini F, Matucci Cerinic M, Lombardi A, Generini S, Pignone A, Tirassa P, Ermini 
M, Lepore L, Partsch G and Aloe L. Increased circulating nerve growth factor is 
directly correlated with disease activity in juvenile chronic arthritis. Ann Rheum Dis, 
1996; 555: 745-748.
Fang J-Y, Tsai M-J, Huang Y-B, Wu P-C and Tsai Y-H. Percutaneous absorption and 
skin erythema: Quantification of capsaicin and its synthetic derivatives from gels 
incorporated with benzalkonium chloride by using non-invasive bioengineering 
methods. Drug Development Research, 1997; 40: 56-67.
Farber EM, Nickoloff BJ, Recht B and Fraki JE. Stress, symmetry and psoriasis: 
possible role of neuropeptides. J Am Acad Dermatol, 1986; 14: 305-311.
Feige U, Karbowski A, Rordorf-Adam C and Pataki A. Arthritis induced by 
continuous infusion of hr-interleukin-la into the rabbit knee joint. Int J Tiss React, 
1989; 11:225-238.
174
Finnerup NB, Johannesen IL, Fuglsang-Frederiksen A, Bach FW and Jensen TS. 
Sensory function in spinal cord injury patients with and without central pain. Brain, 
2003; 126: 57-70.
Fitzgerald M. The contralateral input to the dorsal horn of the spinal cord in the 
decerebrate rat. Brain Res, 1982a; 236: 275-287.
Fitzgerald M. Alterations in the ipsi- and contralateral afferent inputs of dorsal horn 
cells produced by capsaicin treatment of one sciatic nerve in the rat. Brain Res, 
1982b; 248: 97-107.
Flemming A, Crown JM and Corbett M. Early rheumatoid disease. Patterns of joint 
involvement. Ann Rheum Dis, 1976; 35: 361-364.
Forestier MJ. Rheumatism d’Heberden chez un hemilplegique. Lesions articulaires 
limitees au cote sain. Rev Neurol (Paris), 1935; 63: 442-452.
Fraser SE and Harland RM. The molecular metamorphosis of experimental 
embryology. Cell, 2000; 100: 41-55.
Fuchs EA, Callahan LF, Kay JJ, Brooks RH, Nance EP and Pincus T. Radiographic 
and joint count findings o f the hand in rheumatoid arthritis: related and unrelated 
findings. Arth Rheum, 1988; 31: 44-51.
Galeazza MT, Stucky CL and Seybold VS. Changes in [125I]hCGRP binding in rat 
spinal cord in an experimental model o f acute, peripheral inflammation. Brain Res, 
1992; 591: 198-208.
Gallagher P, Blake DR and Lever J. Audit of closed synovial biopsy in the diagnosis 
o f inflammatory joint disease. Scand J Rheum, 1985; 14: 307-314.
Ganju P, Davis A, Patel S, Nunez X and Fox A. p38 stress-activated protein kinase 
inhibitor reverses bradykinin B(l) receptor-mediated component of inflammatory 
hyperalgesia. Eur J Pharmacol, 2001; 421: 191-199.
175
Garrett NE, Mapp PI, Cruwys SC, Kidd BL and Blake DR. Role o f substance P in 
inflammatory arthritis. Ann Rheum Dis, 1992; 51: 1014-1018.
Gault SJ and Spyker MJ. Beneficial effect o f immobilization of joints in rheumatoid 
and related arthrtitides: a splint study using sequential analysis. Arth Rheum, 1969; 
12: 34-44.
Glick EN. Asymmetrical rheumatoid arthritis after poliomyelitis. BMJ, 1967; 3: 26- 
28.
Glyn JH, Sutherland I, Walker GF and Young AC. Low incidence o f osteoarthritis in 
hip and knee after anterior poliomyelitis: a late review. BMJ, 1966; 2: 739-742.
Goldberger AL, Amaral LAN, Glass L, Hausdorff JM, Ivanov PCh, Mark RG, Mietus 
JE, Moody GB, Peng C-K and Stanley HE. PhysioBank, PhysioToolkit, and 
PhysioNet: Components of a New Research Resource for Complex Physiologic 
Signals. Circulation, 2000; 101: 215-220.
Gothefors L, Bergstrom E and Backman M. Immunogenicity and reactogenicity o f a 
new measles, mumps and rubella vaccine when administered as a second dose at 12 
years o f age. Scand J Infect Dis, 2001; 33: 545-549.
Gronblad M, Konttinen YT, Korkala O, Liesi P, Hukkanen M and Polak J. 
Neuropeptides in the synovium of patients with rheumatoid arthritis and 
osteoarthritis. J Rheum, 1988; 15: 1807-1810.
Grossman M, Jamieson MJ, Kellogg DL, Kosiba WA, Pergola PE, Crandall CG and 
Shepherd AMM. The effect o f iontophoresis on the cutaneous vasculature: evidence 
for current-induced hyperemia. Micro vascular Research, 1995; 50: 444-452.
Groves RW, Allen MH, Barker J, Haskard DO and MacDonald DM. Endothelial 
leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br 
J Dermatol, 1991; 124: 117-123.
176
Groves, RW, Ross E, Barker J, Ross JS, Camp RDR and MacDonald DM. Effect of 
in vivo interleukin-1 on adhesion molecule expression in normal human skin. J Invest 
Dermatol, 1992; 98: 384.
Grubb BD, Stiller RU and Schaible HG. Dynamic changes in the receptive field 
properties o f spinal cord neurons with ankle input in rats with chronic unilateral 
inflammation in the ankle region. Exp Brain Res, 1993; 92: 441-452.
Halla JT, Fallahi S and Hardin JG. Small joint involvement: a systematic 
roentgenographic study in rheumatoid arthritis. Ann Rheum Dis, 1986; 45: 327-330.
Halliday DA, Zettler C, Rush RA, Scicchitano R and McNeil JD. Elevated nerve 
growth factor levels in the synovial fluid o f patients with inflammatory joint disease. 
Neurochem Res, 1998; 23: 919-922.
Harding LM, Murphy A, Kinnman E and Baranowski AP. Characterization of 
secondary hyperalgesia produced by topical capsaicin jelly- a new experimental tool 
for pain research. Eur J Pain, 2001; 5: 363-71.
Harris R and Copp EP. Immobilisation of the knee joint in rheumatoid arthritis. Ann 
Rheum Dis, 1962; 21: 353-359.
Helliwell PS, Hetthen J, Sokoll K, Green M, Marchesoni A, Lubrano E, Veale D and 
Emery P. Joint symmetry in early and late rheumatoid and psoriatic arthritis. Arth 
Rheum, 2000; 43: 865-871.
Helme RD and McKeman S. Neurogenic flare responses following topical 
application of capsaicin in humans. Ann Neurol, 1985; 18: 505-509.
Helyes Z, Szabo A, Nemeth J, Jakab B, Pinter E, Banvolgyi A, Kereskai L, Keri G 
and Szolcsanyi J. Antiinflammatory and analgesic effects of somatostatin released 
from capsaicin-sensitive nerve terminals in a Freund’s adjuvant-induced chronic 
arthritis model in the rat. Arth Rheum, 2004; 50: 1677-1685.
177
Herdegen T, Walker T, Leah JD, Bravo R and Zimmerman M. The Krox-24 protein, 
a new transcription regulating factor: expression in the rat central nervous system 
following afferent somatosensory stimulation. Neurosci Lett, 1990; 120: 21-24.
Herdegen T, Tolle TR, Bravo R, Zieglgansberger W and Zimmerman M. Sequential 
expression of Jun B, Jun D and Fos B proteins in rat spinal neurons: cascade of 
transcriptional operations during nociception. Neurosci Lett, 1991a; 129: 221-224.
Herdegen T, Leah JD, Manisali A, Bravo R and Zimmermann M. c-JUN-like 
immunoreactivity in the CNS of the adult rat: basal and transsynaptically induced 
expression of an immediate-early gene. Neuroscience, 1991b; 41: 643-654.
Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M, Donald AE, 
Palacios M, Griffin GE, Deanfield JE, MacAllister RJ and Vallance P. Acute 
systemic inflammation impairs endothelium-dependent dilatation in humans. 
Circulation, 2000; 102: 994-999.
Holzer P. Local effector function of capsaicin-sensitive sensory nerve endings: 
involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. 
Neurosci, 1988; 24: 739-768.
Hood VC, Cruwys SC, Urban L and Kidd BL. The neurogenic contribution to 
synovial leucocyte infiltration and other outcome measures in a guinea pig model of 
arthritis. Neurosci Lett, 2001; 299: 201-204.
Hsu SM, Raine L and Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in 
immunoperoxidase techniques: a comparison between ABC and unlabeled antibody 
(PAP) procedures. J Histochem Cytochem, 1981; 29: 577-580.
Ianaro A, Cicala C, Calignano A, Koteliansky V, Gotwals P, Bucci M, Gerli R, 
Santucci L, Fiorucci S and Cirino G. Anti-very late antigen-1 monoclonal antibody 
modulates the development of secondary lesion and T-cell response in experimental 
arthritis. Lab Invest, 2000; 80: 73-80.
178
Jacqueline F. Un cas de polyarthrite evolutive a localisations contralaterales d’une 
hemiplegie. Rev Rhum Malad Osteoartic, 1953; 20: 323.
Jayson MI, Rubenstein D and Dixon AS. Intra-articular pressure and rheumatoid 
geodes (bone ‘cysts’). Ann Rheum Dis, 1970; 29: 496-502.
Johansson O, Han SW and Enhamre A. Altered cutaneous innervation in psoriatic 
skin as revealed by PGP 9.5 immunohistochemistry. Arch Dermatol Res, 1991; 283: 
519-523.
Jolliffe VA, Anand P and Kidd BL. Assessment of cutaneous sensory and autonomic 
axon reflexes in rheumatoid arthritis. Ann Rheum Dis, 1995; 54: 251-255.
Kamermann JS. Protective effect of traumatic lesions on rheumatoid arthritis. Ann 
Rheum Dis, 1966; 25: 361-363.
Kane D, Lockhart JC, Balint PV, Mann C, Ferrell WR and Mclnnes IB. Protective 
effect of sensory denervation in inflammatory arthritis (evidence of regulatory 
neuroimmune pathways in the arthritic joint). Ann Rheum Dis, 2005; 64: 325-327.
Kantner RM, Kirby ML and Goldstein BD. Increase in substance P levels in the 
dorsal hom of rat spinal cord during a chemogenic nociceptive stimulus. Brain Res, 
1985; 338: 196-199.
Kayser V and Guilbaud G. Local and remote modifications of nociceptive sensitivity 
during carrageenan-induced inflammation in the rat. Pain, 1987; 28: 99-107.
Kayser V, Benoist JM, Neil A, Gautron M and Guilbaud G. Behavioural and 
electrophysio logical studies on the paradoxical antinociceptive effects of an 
extremely low dose o f naloxone in an animal model o f acute and localized 
inflammation. Exp Brain Res, 1988; 73: 402-10.
Kellgren JH and Samuel EP. The sensitivity and innervation of the articular capsule. J 
Bone Joint Surg, 1950; 32B: 84-92.
179
Kharbanda RK, Walton B, Allen M, Klein N, Hingorani AD, MacAllister RJ and 
Vallance P. Prevention o f inflammation-induced endothelial dysfunction: a novel 
vasculo-protective action of aspirin. Circulation, 2002; 105: 2600-2604.
Kidd BL, Cruwys SC, Garrett NE, Mapp PI, Jolliffe VA and Blake DR. Neurogenic 
influences on contralateral responses during experimental rat monoarthritis. Brain 
Research, 1995; 688: 72-76.
Kidd BL, Mapp PI, Gibson SJ, Polak JM, O’Higgins F, Buckland-Wright JC and 
Blake DR. A neurogenic mechanism for symmetrical arthritis. Lancet, 1989; 1128- 
1129.
Kissin I, Lee SS and Bradley EL Jr. Effect of prolonged nerve block on inflammatory 
hyperalgesia in rats: prevention o f late hyperalgesia. Anesthesiology, 1998; 88: 224- 
232.
Koch AE, Szekanecz Z, Friedman J, Haines GK, Langman CB and Bouck NP. 
Effects of thrombospondin-1 on disease course and angiogenesis in rat adjuvant- 
induced arthritis. Clin Immunol Immunopathol, 1998; 86: 199-208.
Koepp H, Eger W, Muehleman C, Valdellon A, Buckwalter JA, Kuettner KE and 
Cole AA. Prevalence of articular cartilage degeneration in the ankle and knee joints 
o f human organ donors. J Orthop Sci, 1999; 4: 407-412.
Koltzenburg M, Wall PD and McMahon SB. Does the right side know what the left 
side is doing? TINS, 1999; 22: 122-127.
Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR and Spritz RA. 
Early disease onset and increased risk of other autoimmune diseases in familial 
generalized vitiligo. Pigment Cell Res, 2005; 18: 300-5.
Lam FY and Ferrell WR. Capsaicin suppresses substance P-induced joint 
inflammation in the rat. Ann Rheum Dis, 1989; 48: 928-932.
180
Lambrecht BN. Immunologists getting nervous: neuropeptides, dendritic cells and T 
cell activation. Resp Res, 2001; 2: 133-138.
LaMotte RH, Lundberg LE and Torebjork HE. Pain, hyperalgesia and activity in 
nociceptive C units in humans after intradermal injection of capsaicin. J Physiol, 
1992; 448: 749-764.
Landis JR and Koch GG. The measurement of observer agreement for categorical 
data. Biometrics, 1977; 33: 159-174.
Langley RG, Krueger GG and Griffiths CE. Psoriasis: epidemiology, clinical features 
and quality of life. Ann Rheum Dis, 2005; Suppl 2: 18-25.
Lassere M, Boers M, van der Heijde D, Boonen A, Edmonds J, Saudan and 
Verhoeven AC. Smallest detectable difference in radiological progression. J 
Rheumatol, 1999; 26: 731-739.
Leah JD, Porter J, de-Pommery J, Menetrey D and Weil-Fuguzza J. Effect o f acute 
stimulation on Fos statement in spinal neurons in the presence of persisting C-fiber 
activity. Brain Res, 1996; 719: 104-111.
Leak RS, Rayan GM and Arthur RE. Longitudinal radiographic analysis of 
rheumatoid arthritis in the hand and wrist. J Hand Surg, 2003; 28: 427-434.
Lechman ER, Jaffurs D, Ghivizzani SC, Gambotto A, Kovesdi I, Mi Z, Evans CH and 
Robbins PD. Direct adenoviral gene transfer of viral IL-10 to rabbit knees with 
experimental arthritis ameliorates disease in both injected and contralateral control 
knees. J Immunol, 1999; 163: 2202-8.
Levine JD, Clark R, Devor M, Helms C, Moskowitz MA and Basbaum AI. 
Intraneuronal substance P contributes to the severity o f experimental arthritis. 
Science, 1984; 226: 547-549.
181
Levine JD, Collier D H, Basbaum AI, Moskowitz MA and Helms CA. Hypothesis. 
The nervous system may contribute to the pathophysiology of rheumatoid arthritis. J 
Rheum, 1985a; 12:406-411.
Levine JD, Dardick SJ, Basbaum AI and Scipio E. Reflex neurogenic inflammation. 
I. Contribution of the peripheral nervous system to spatially remote inflammatory 
responses that follow injury. J Neurosci, 1985b; 5: 1380-1386.
Levine JD, Dardick SJ, Roizen MF, Helms CA and Basbaum AI. Contribution of 
sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J. 
Neuroscience, 1986; 6: 3423-3429.
Levite M. Neuropeptides, by direct interaction with T cells, induce cytokine secretion 
and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci USA, 
1998; 95: 12544-12554.
Light AR and Perl ER. Reexamination o f the dorsal root projection to the spinal 
dorsal horn including observation of the differential termination of coarse and fine 
fibres. J Comp Neurol, 1979; 186: 117-132.
Lippe IT and Holzer P. Participation of endothelium-derived nitric oxide but not 
prostacyclin in the gastric mucosal hyperemia due to acid back-diffusion. Br J 
Pharmacol, 1992; 105: 708-714.
Li-Tsang CW, Hung LK and Mak AF The effect o f corrective splinting on flexion 
contracture of rheumatoid fingers. J Hand Ther, 2002; 15: 185-191.
Liu JB, Li M, Yang S, Gui JP, Wang HY, Du WH, Zhao XY, Ren YQ, Zhu YG and 
Zhang XJ. Clinical profiles o f vitiligo in China: an analysis o f 3742 patients. Clin Exp 
Dermatol, 2005; 3: 327-331.
Lorton D, Lubahn C, Engan C, Schaller J, Felten DL and Bellinger DL. Local 
application o f capsaicin into the draining lymph nodes attenuates expression of 
adjuvant-induced arthritis. Neuroimmunomodulation, 2000; 7: 115-125.
182
Manal K, Lu X, Nieuwenhuis MK, Helders PJ and Buchanan TS. Force transmission 
through the juvenile idiopathic arthritis wrist: a novel approach using a sliding rigid 
body spring model. J Biomech, 2002; 35: 125-133.
Manni L, Lundeberg T, Fiorito S, Bonini S, Vigneti E and Aloe L. Nerve growth 
factor release by human synovial fibroblasts prior to and following exposure to 
tumour necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible 
role ofNGF in the inflammatory response. Clin Exp Rheum, 2003; 21: 617-614.
Manni L, Lundeberg T, Tirassa P and Aloe L. Role of cholecystokinin-8 in nerve 
growth factor and nerve growth factor mRNA expression in carrageenan-induced 
joint inflammation in adult rats. Rheumatology (Oxford), 2002; 41: 787-792.
Mapp PI, Terenghi G, Walsh DA, Chen ST, Cruwys SC, Garrett N, Kidd BL, Polak 
JM and Blake DR. Monoarthritis in the rat knee induces bilateral and time-dependent 
changes in substance P and calcitonin gene-related peptide immunoreactivity in the 
spinal cord. Neuroscience, 1993; 57: 1091-1096.
Mapp PI. Innervation of the synovium. Ann Rheum Dis, 1995; 54: 398-403.
Martel W, Hayes JT and Duff IF. The pattern of bone erosion in the hand and wrist in 
rheumatoid arthritis. Radiology, 1965; 84: 204-214.
Masters BR. Fractal analysis o f the vascular tree in the human retina. Ann Rev 
Biomed Eng, 2004; 6: 427-452.
Mattingley PC, Matheson JA and Dickson RA. The distribution o f radiological joint 
damage in the rheumatoid hand. Rheum Rehab, 1979; 18: 142-147.
Menetrey D, Gannon A, Levine JD and Basbaum AI. Expression of c-fos protein in 
interneurons and projection neurons o f the rat spinal cord in response to noxious 
somatic, articular and visceral stimulation. J Comp Neurol, 1989; 285: 177-195.
183
Mentzel K and Brauer R. Matrix metalloproteinases, IL-6, and nitric oxide in rat 
antigen-induced arthritis. Clin & Exp Rheum, 1998; 16: 269-276.
Merighi, A, Polak, JM, Gibson, SJ, Gulbenkian, S, Valentino, KL and Peirone, SM. 
Ultrastructural studies on calcitonin gene-related peptide-, tachykinins- and 
somatostatin-immunoreactive neurones in rat dorsal root gangha: evidence for the 
colocalization o f different peptides in single secretory granules. Cell Tissue Res, 
1988;254: 101-109.
Meyer P, Burkhardt H, Palombo-Kirme E, Grunder W, Brauer R, Stiller KJ, Kalden 
JR, Becker W and Kinne RW. 123-I-antileukoproteinase scintigraphy reveals 
microscopic cartilage alterations in the contralateral knee joint o f rats with 
‘monoarticular’ antigen-induced arthritis. Arth Rheum, 2000; 43: 279-284.
Miagkov AV, Kovalenko DV, Brown CE, Didsbury JR, Cogswell JP, Stimpson SA, 
Baldwin AS and Makarov SS. NF-kappaB activation provides the potential link 
between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci U S A  
1998; 95: 13859-13864.
Millan MJ and Colpaert FC. The influence of sustained opioid receptor blockade in a 
model o f long-term, localized inflammatory pain in rats. Neurosci Lett, 1990; 113: 
50-55.
Millan MJ and Colpaert FC. Opioid systems in the response to inflammatory pain: 
sustained blockade suggests role of kappa- but not mu-opioid receptors in the 
modulation of nociception, behaviour and pathology. Neuroscience, 1991; 42: 541- 
553.
Mine T, Kimura M, Sakka A and Kawai S. Innervation o f nociceptors in the menisci 
of the knee joint: an immunohistochemical study. Arch Orth Traum Surg, 2000; 120: 
201-204.
184
Mohammadian P, Andersen OK and Arendt-Nielsen L. Correlation between local 
vascular and sensory changes following tissue inflammation induced by repetitive 
application of topical capsaicin. Brain Res, 1998; 792: 1-9.
Morris GC, Gibson, SJ and Helme RD. Capsaicin-induced flare and vasodilation in 
patients with post-herpetic neuralgia. Pain, 1995; 63: 93-101.
Morris S and Shore A. Skin blood flow responses to the iontophoresis of 
acetylcholine and sodium nitroprusside in man: possible mechanisms. J Physiol, 
1996; 496; 531-542.
Mottonen TT, Hannonen P, Toivanen J, Rekonen A and Oka M. Value of joint 
scintigraphy in the prediction o f erosiveness in early rheumatoid arthritis. Ann Rheum 
Dis, 1988; 47: 183-189.
Mulherin D, Bresnihan B and Fitzgerald O. Digital denervation is associated with 
absence of nail and distal interphalangeal joint involvement in psoriatic arthritis. J 
Rheumatol, 1995; 22: 1211-1212.
Murray CD. The physiological principle of minimum work. I. The vascular system 
and the cost of blood volume. PNAS, 1926a; 12: 295-299.
Murray CD. The physiological principle of minimum work. II. Oxygen exchange in 
capillaries. PNAS, 1926b; 12: 299-304.
Naukkarinen A, Harvima I , Paukkonen K, Aolto ML and Horsmanheimo M. 
Immunohistochemical analysis of sensory nerves and neuropeptides, and their 
contacts with mast cells in developing and mature psoriatic lesions. Arch Dermatol 
Res, 1993;285:341-346.
Nava P. Atrite reumatoide antiga. Icte cerebral surto exolutive agude nas articulacoes 
doentes do lado hemiplegico. Brasil-med, 1953; 67: 318.
185
Neugebauer V and Schaible HG. Evidence for a central component in the 
sensitization o f spinal neurons with joint input during development of acute arthritis 
in cat's knee. J Neurophysiol, 1990; 64: 299-311.
Newton DJ, Khan F and Belch JF. Assessment of microvascular endothelial function 
in human skin. Clinical Science 2001; 101: 567-572.
Niu J, Zhang Y, LaValley M, Chaisson CE, Aliabadi P and Felson DT. Symmetry 
and clustering of symptomatic hand osteoarthritis in elderly men and women: the 
Framingham study. Rheumatology (Oxford), 2003. 42: 343-348.
Njoo MD, Westerhof W. Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol 
2001; 2: 167-181.
Noguchi K, Kowalski K, Traub R, Solodkin A, Iadarola MJ and Ruda MA. 
Dynorphin expression and Fos-like immunoreactivity following inflammation 
induced hyperalgesia are colocalised in spinal cord neurons. Mol Brain Res, 1991; 10: 
227-233.
Oh U, Hwang SW and Kim D. Capsaicin activates a non-selective cation channel in 
cultured rat dorsal root ganglion neurons. J Neurosci, 1996; 16: 659-667.
Owsianik WD, Kundi A, Whitehead JN, Kraag GR and Goldsmith C. Radiological 
articular involvement in the dominant hand in rheumatoid arthritis. Ann Rheum Dis, 
1980; 39: 508-510.
Panchanathan V, Kumar S, Yeap W, Devi S, Ismail R, Sarijan S, Sam SM, Jusoh Z, 
Nordin S, Leboulleux D and Pang T. Comparison of safety and immunogenicity of a 
Vi polysaccharide typhoid vaccine with a whole-cell killed vaccine in Malaysian Air 
Force recruits. Bull World Health Organ, 2001; 79: 811-817.
Partridge REH and Duthie JJR. Controlled trial of the effects of complete 
immobilization o f the joint in rheumatoid arthritis. Ann Rheum Dis, 1963; 22: 91-99.
186
Pedersen JL and Kehlet H. Secondary hyperalgesia to heat stimuli after bum injury in 
man. Pain, 1998; 76: 377-84.
Pedersen JL. Inflammatory pain in experimental bums in man. Dan Med Bull, 2000; 
47: 168-95.
Pergolizzi S, Vaccaro M, Magaudda L, Mondello MR, Arco A, Bramanti P, Cannavo 
SP and Guaneri B. Immunohistochemical study of epidermal nerve fibres in involved 
and uninvolved psoriatic skin using confocal laser scanning microscopy. Arch 
Dermatol Res, 1998; 290: 483-489.
Pierre-Jerome C, Bekkelund SI, Mellgren SI, Torbergsen T, Husby G and Nordstrom 
R. The rheumatoid wrist MR analysis o f the distribution o f rheumatoid lesions in 
axial plan in a female population. Clin Rheumatol, 1997; 16: 80-86.
Pincelli C. Nerve growth factor and keratinocytes: a role in psoriasis. Eur J Derm, 
2000; 10: 85-90.
Pinter E and Szolcsanyi J. Inflammatory and antiinflammatory effects o f antidromic 
stimulation of dorsal roots in the rat. Agents Actions, 1988; 25: 240-242.
Pitzalis C, Cauli A, Pipitone N, Smith C, Barker J, Marchesoni A, Yanni G and 
Panayi GS. Cutaneous lymphocyte antigen-positive T lymphocytes preferentially 
migrate to the skin but not to the joint in psoriatic arthritis. Arthritis Rheum, 1996; 
39: 137-145.
Plassman P and Jones TD. MAVIS: a non-invasive instrument to measure area and 
volume of wounds. Med Eng Phys, 1998; 20: 332-338.
Porro CA, Cavazzuti M, Galetti A, Sassatelli L and Barbier GC. Functional activity 
of the rat spinal cord during formalin-induced noxious stimulation. Neuroscience, 
1991;41:655-665.
187
Rachaudhuri SP, Sanyal M, Weltman H and Kundu-Raychaudhuri S. K252a, a high- 
affinity nerve growth factor receptor blocker, improves psoriasis: an in vivo study 
using the sever combined immunodeficient mouse-human skin model. J Inv Derm, 
2004; 122: 812-819.
Raines SA and Cox NH. ‘Minerva’ BMJ, 2002; 324: 434.
Ramsay JE, Simms RJ, Ferrell WR, Crawford L, Greer IA, Lumsden MA and Sattar 
N. Enhancement of endothelial function by pregnancy: inadequate response in 
women with type 1 diabetes. Diabetes Care 2003; 26: 475-9.
Ranson SW, Davenport HK and Doles EA. Intramedullary course of the dorsal root 
fibres of the first three cervical nerves. J Comp Neurol, 1932; 54: 1-12.
Rotshenker S and Tal M. The transneuronal induction of sprouting and synapse 
formation in intact mouse muscles. J Physiol, 1985; 360: 387-396.
Ruckman A, Ehle B and Trampisch H. How to evaluate measuring methods in the 
case of non-defined external validity. J Rheumatology, 1995; 22: 1998-2000.
Sabitha P, Prabha Adhikari MR, Chowdary A, Prabhu M, Soofi M, Shetty M, Kamath 
A, Lokaranjan SS and Bangera SS. Comparison of the immunogenicity and safety of 
two different brands o f salmonella typhi VI capsular polysaccharide vaccine. Indian J 
MedSci. 2004; 58: 141-149.
Sais G, Vidaller A, Jucgla A, Condom E and Peyri J. Adhesion molecule expression 
and endothelial cell activation in cutaneous leukocytoclastic vasculitis: an 
immunohistologic an clinical study in 42 patients. Arch Dermatol, 1997; 133: 443- 
450.
Schade Willis TM, Hopp RJ, Romero JR and Larsen PD. The protective effect of 
brachial plexus palsy in purpura fulminans. Pediatr Neurol, 2001; 24: 379-381.
188
Schadrack J, Neto FL, Ableitner A, Castro-Lopes JM, Willoch F, Bartenstein P, 
Zieglgansberger W and Tolle TR. Metabolic activity changes in the rat spinal cord 
during adjuvant monoarthritis. Neuroscience, 1999; 94: 595-605.
Segal R, Avrahami E, Lebdinski E, Habut B, Leibovitz A, Gil I, Yaron M and Caspi 
D. The impact of hemiparalysis on the expression of osteoarthritis. Arth Rheum, 
1998;41:2249-2256.
Sepp NT, Gille J, Li JL, Caughman SW, Lawley TJ and Swerlick RA. A factor in 
human plasma permits persistent expression o f E-selectin by human endothelial cells. 
Journal of Inv Derm, 1994; 102: 445-450.
Shenker N, Haigh R, Roberts E, Mapp P, Harris N and Blake D. A review of 
contralateral responses to a unilateral inflammatory lesion. Rheumatology, 2003; 42: 
1279-1286.
Sigurdsson V, de Vries IJ, Toonstra J, Bihari IC, Thepen T, Bruijnzeel-Koomen CA 
and van Vloten WA. Expression o f VCAM-1, ICAM-1, E-selectin, and P-selectin on 
endothelium in situ in patients with erythroderma, mycosis fungoides and atopic 
dermatitis. J Cutan Pathol, 2000; 27: 436-440.
Simone DA, Baumann TK and LaMotte RH. Dose-dependent pain and mechanical 
hyperalgesia in humans after intradermal injection of capsaicin. Pain, 1989; 38: 99- 
107.
Skaare AB, Kjaerheim V, Barkvoll P and Rolla G. Does the nature of the solvent 
affect the anti-inflammatory capacity o f triclosan? An experimental study. J Clin 
Periodontol, 1997; 24: 124-128.
Smith CH, Barker JN, Morris RW, MacDonald DM and Lee TH. Neuropeptides 
induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic 
infiltration in human skin. J Immunol, 1993; 151: 3274-3282.
189
Soila P. A roentgenological study o f asymmetry in rheumatoid arthritis. A 
preliminary communication. Acta Rheum Scand, 1963; 9: 264-268.
Sotgui ML, Brambilla M, Valente M and Biella GEM. Contralateral input modulates 
the excitability o f dorsal horn neurons involved in noxious signal processed. Potential 
role in neuronal sensitization. Somat Mot Res, 2004; 21:211-215.
Springall DR, Collina G, Barer G, Suggett AJ, Bee D and Polak JM Increased 
intracellular levels of calcitonin gene-related peptide-like immunoreactivity in 
pulmonary endocrine cells of hypoxic rats. J Pathol, 1988; 155: 259-267.
Squarcione S, Sgricia S, Biasio LR, Perinetti E. Comparison o f the reactogenicity and 
immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly 
subjects. Vaccine, 2003; 21: 1268-1274.
Stecher RM and Kamosh LJ. Heberden’s nodes. VI. The effect of nerve injury upon 
the formation of degenerative joint disease o f the fingers. Am J Med Sci, 1947; 213: 
181.
Stemberger NH and Stemberger LA. The unlabeled antibody method. Comparison of 
the sensitivity o f peroxidase-antiperoxidase with avidin-biotin complex method by a 
new mode of quantitative immunocytochemistry. J Histochem Cytochem, 1986; 34: 
599-605.
Strickland I, Rhodes LE, Flanagan BF and Friedmann PS. TNF-alpha and IL-8 are 
upregulated in the epidermis of normal human skin after UVB exposure: correlation 
with neutrophil accumulation and E-selectin expression. J Invest Dermatol, 1997; 
108: 763-768.
Stucker M, Heese A, Hoffmann K, Rochling A and Altmeyer P. Precision of laser 
Doppler scanning in clinical use. Clin Exp Dermatol, 1995; 20: 371-376.
190
Stucker M, Reuther T, Hoffmann K, Aicher B and Altmeyer P. Quantification of 
cutaneous pharmacological reactions - comparison of Laser Doppler Scanning, 
colorimetry, planimetry and skin temperature measurement. Skin Research and 
Technology, 1996; 2: 18-22.
Stucky CL, Galeazza MT and Seybold VS. Time dependent changes in Bolton- 
Hunter-labelled 125-I-substance P in rat spinal cord following unilateral adjuvant- 
induced peripheral inflammation. Neuroscience, 1993; 57: 397-409.
Szentagothai J. Neuronal and synaptic arrangement in the substantia gelatinosa 
rolandi. J Comp Neurol, 1964; 122: 219-239.
Takeuchi F, Streilein RD and Hall RP. Increased E-selectin, IL-8 and IL-10 gene 
expression in human skin after minimal trauma. ExpDerm, 2003; 12: 777.
Tarkowski E, Naver H, Wallin BG, Blomstrand C, Grimby G and Tarkowski A. 
Lateralization of cutaneous inflammatory responses in patients with unilateral paresis 
after poliomyelitis. J Neuroimmunol, 1996; 67: 1-6.
Taub A. Local, segmental and supraspinal interactions with a dorsolateral spinal 
cutaneous afferent system. Exp Neurol, 1964; 10: 357-364.
Terajima, SM, Higaki, Y. Igarashi T, Nogita M and Kawashima M. An important role 
of tumor necrosis factor-alpha in the induction of adhesion molecules in psoriasis. 
Arch Dermatol Res, 1998; 290: 246-252.
Thompson M and Bywaters EGL. Unilateral rheumatoid arthritis following 
hemiplegia. Ann Rheum Dis, 1962; 21: 370-377.
Tsuchida Y. Rate of skin blood flow in various regions of the body. Plast Reconstr 
Surg, 1979; 64: 505-508.
Tsuchida Y. Age-related changes in skin blood flow at four anatomic sites o f the 
body in males studied by xenon-133. Plast Reconstr Surg, 1990; 85: 556-561.
191
Tsuchida Y, Fukuda O and Kamata S. The correlation o f skin blood flow with age, 
total cholesterol, hematocrit, blood pressure and haemoglobin. Plast Reconstr Surg, 
1991; 88: 844-850.
Turing, AM. The chemical basis of morphogenesis. Phil Trans R Soc London B, 
1952. 237: 37-72.
Turner PJ, Dear JW and Foreman JC. Involvement o f kinins in hyperresponsiveness 
induced by platelet activating factor in the human nasal airway. Br J Pharmacol, 
2000; 129: 525-523.
Vacca-Galloway LL. Differential immunostaining for substance P in Hungtington’s 
diseased and normal spinal cord: significance of serial (optimal, supra-optimal and 
end-point) dilutions of primary anti-serum in comparing biological specimens. 
Histochemistry, 1985; 83: 561-569.
Veale D, Farrell and Fitzgerald O. Mechanism of joint sparing in a patient with 
unilateral psoriatic arthritis and a longstanding hemiplegia. Br J Rheum, 1993; 32: 
413-416.
Von Banchet SG, Petrow P, Brauer PK and Schaible HG. Monoarticular antigen- 
induced arthritis leads to pronounced bilateral up-regulation of the expression of 
neurokinin 1 and bradykinin 2 receptors in dorsal root ganglion neurons of rats. 
Arthritis Research, 2000; 2: 424-427.
Von Euler US and Gaddum JH. An unidentified depressor substance in certain tissue 
extracts. J Physiol, 1931; 72: 577-583.
Wagman IH and Price DD. Responses of dorsal horn cells o f M. mulatta to cutaneous 
and sural nerve A and C fibre stimulation. J Neurophys, 1969; 32: 803-817.
Wardell K, Jakobsson A and Nilsson GE. Laser Doppler perfusion imaging by 
dynamic light scattering. IEEE Trans Biomed Eng, 1993; 40: 309-16.
192
Werring DJ, Brassat D, Droogan AG, Clark CA, Symms MR, Barker GJ, MacManus 
DG, Thompson AJ and Miller DH. The pathogenesis o f lesions and normal-appearing 
white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain, 2000; 
123: 1667-1676.
Williams S, Evan GI and Hunt SP. Changing patterns of c-fos induction in spinal 
neurons following thermal cutaneous stimulation in the rat. Neuroscience, 1990; 36: 
73-81.
Winter S. Unilateral Heberden’s nodes in a case o f hemiplegia. New York J Med, 
1952; 52: 349-350.
Wongsurakiat P, Maranetra KN, Gulprasutdilog P, Aksomint M, Srilum W, 
Ruengjam C and Sated W. Adverse effects associated with influenza vaccination in 
patients with COPD: a randomized controlled study. Respirology, 2004; 9: 550-556.
Woolf CJ, Allchome A, Safieh-Garabedian B and Poole S. Cytokines, nerve growth 
factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor 
alpha. Br J Pharmacol, 1997; 121: 417-424.
Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. 
Nature, 1983; 306: 686-688.
Yaighmai I, Rooholamini SM and Faunce HF. Unilateral rheumatoid arthritis: 
protective effect of neurologic deficits. Am J Roentgenol, 1977; 128: 199-201.
Yu LC, Hansson P, Brodda-Jansen G, Theodorsson E and Lundeberg T. Intrathecal 
CGRP8-37-induced bilateral increase in hindpaw withdrawal latency in rats with 
unilateral inflammation. Br J Pharmacol, 1996; 117: 43-50.
Zamir M. Arterial branching with the confines o f fractal L-system formalism. J Gen 
Phys, 2001; 118:267-276.
193
Zangger P, Kachura JR, Bombardier C, Redelmeier DA, Badley EM and Bogoch ER. 
Assessing damage in individual joints in rheumatoid arthritis: a new method based on 
the Larsen system. Joint Bone Spine, 2004; 71: 389-396.
Zangger P, Keystone EC and Bogoch ER. Asymmetry of small joint involvement in 
rheumatoid arthritis: prevalence and tendency towards symmetry over time. Joint 
Bone Surgery, 2005; 72: 241-247.
Zhelev Z and Bakalova R. Laser-Doppler imaging o f activation-flow coupling in the 
somatosensory cortex: normalization o f signal when the baseline changes 
significantly. Methods Find Exp Clin Pharmacol, 2002; 24: 559-64.
Zhong J, Seifalian AM, Salerud GE and Nilsson GE. A mathematical analysis on the 
biological zero problem in laser Doppler flowmetry. IEEE Trans Biomed Eng, 1998; 
45: 354-364.
Ziljstra TR, Heijnsdijk-Rouwenhorst L and Rasker JJ. Silver ring splints improve 
dexterity in patients with rheumatoid arthritis. Arth Rheum, 2004; 51: 947-951.
194
